Loading organization details...
Loading organization details...
SEE ATTACHMENT 1
Source: IRS Form 990 (Tax Year 2023)
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2022
Total Revenue
▼$6.7B
Program Spending
91%
of total expenses go to program services
Total Contributions
$2B
Total Expenses
▼$6.4B
Total Assets
$23.6B
Total Liabilities
▼$4.9B
Net Assets
$18.7B
Officer Compensation
→$17.2M
Other Salaries
$3.1B
Investment Income
$423.9M
Fundraising
▼$1.5M
Tax Year 2022 · Source: IRS Form 990, Schedule I (Grants and Other Assistance)
Total grants awarded: $162.8M
| Recipient | Location | Amount | Type | Purpose |
|---|---|---|---|---|
Columbia University Health Care Inc13-3948652 | New York, NY | $13.1M | Cash | Capital Contribution |
Weill Medical College of Cornell Univers13-1623978 | NEW YORK, NY | $7.9M | Cash | Research |
RESEARCH FOUNDATION FOR MENTAL14-1410842 | MENANDS, NY | $4.2M | Cash | Research |
New York University13-5562308 | BOSTON, MA | $3.2M | Cash | Research |
| New York, NY | $2.8M | Cash | Capital Contribution | |
UNIVERSITY OF COLORADO84-6000555 | DENVER, CO | $2.8M | Cash | Research |
NEW YORK GENOME CTR INC80-0631734 | NEW YORK, NY | $2.8M | Cash | Research |
UNIVERSITY OF CALIFORNIA BERKELEY94-6002123 | BERKELEY, CA | $2.7M | Cash | Research |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI13-6171197 | NEW YORK, NY | $2.7M | Cash | Research |
JOHNS HOPKINS UNIVERSITY52-0595110 | CHICAGO, IL | $2.7M | Cash | Research |
UNIVERSITY OF CHICAGO36-2177139 | CHICAGO, IL | $2.5M | Cash | Research |
REGENTS OF THE UNIVERSITY OF MICHIGAN38-6006309 | PITTSBURGH, PA | $2.4M | Cash | Research |
ALBERT EINSTEIN COLLEGE OF MEDICINE83-0621846 | BRONX, NY | $2.4M | Cash | Research |
THE REGENTS OF UNIVERSITY OF CALIFORNIA94-6036493 | BERKELEY, CA | $2.3M | Cash | Research |
UNIVERSITY OF CINCINNATI31-6000989 | CLEVELAND, OH | $2.2M | Cash | Research |
UNIVERSITY OF PENNSYLVANIA23-1352685 | PHILADELPHIA, PA | $2.2M | Cash | Research |
RESEARCH FOUNDATION OF THE STATE14-1368361 | ALBANY, NY | $2.1M | Cash | Research |
UNIVERSITY OF ALABAMA AT BIRMINGHAM63-6005396 | BIRMINGHAM, AL | $2M | Cash | Research |
University of Washington60-5799469 | CHICAGO, IL | $1.9M | Cash | Research |
HARVARD UNIVERSITY | BOSTON, MA | $1.8M | Cash | Research |
RUSH UNIVERSITY MEDICAL CENTER36-2174823 | CHICAGO, IL | $1.8M | Cash | Research |
UNIVERSITY OF CALIFORNIA LOS ANGELES95-6006143 | LOS ANGELES, CA | $1.7M | Cash | Research |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $1.7M | Cash | Research |
UNIVERSITY OF MIAMI59-0624458 | ATLANTA, GA | $1.7M | Cash | Edu/Research |
GEORGE WASHINGTON UNIVERSITY53-0196584 | PHILADELPHIA, PA | $1.6M | Cash | Research |
RESEARCH FOUNDATION OF THE CITY13-1988190 | NEW YORK, NY | $1.6M | Cash | Research |
YALE UNIVERSITY | NEW HAVEN, CT | $1.6M | Cash | Research |
MICHIGAN STATE UNIVERSITY38-6005984 | EAST LANSING, MI | $1.6M | Cash | Research |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | CAMBRIDGE, MA | $1.5M | Cash | Research |
NEW YORK BLOOD CENTER13-1949477 | BOSTON, MA | $1.5M | Cash | Research |
THE BRIGHAM AND WOMENS HOSPITAL INC | BOSTON, MA | $1.5M | Cash | Research |
BAYLOR COLLEGE OF MEDICINE74-1613878 | HOUSTON, TX | $1.5M | Cash | Research |
PRINCETON UNIVERSITY21-0634501 | PRINCETON, NJ | $1.5M | Cash | Research |
RUTGERS UNIVERSITY22-6001086 | PISCATAWAY, NJ | $1.4M | Cash | Research |
Reid Hall Inc13-1611126 | New York, NY | $1.4M | Cash | Capital Contribution |
Henry Jackson Foundation52-1317896 | BETHESDA, MD | $1.3M | Cash | Research |
DUKE UNIVERSITY56-0532129 | CHARLOTTE, NC | $1.3M | Cash | Research |
MEDICAL UNIVERSITY OF SOUTH CAROLINA57-6000722 | CHARLESTON, SC | $1.3M | Cash | Research |
Kaiser Foundation Hospitals94-1105628 | OAKLAND, CA | $1.3M | Cash | Research |
BOSTON UNIVERSITY | NEW YORK, NY | $1.2M | Cash | Research |
REGENTS OF THE UNIVERSITY OF CALIFORNIA95-2226406 | IRVINE, CA | $1.2M | Cash | Research |
Washington University43-0653611 | ST LOUIS, MO | $1.2M | Cash | Research |
UNIVERSITY OF PITTSBURGH25-0965591 | PITTSBURGH, PA | $1.2M | Cash | Research |
MEMORIAL SLOAN-KETTERING CANCER CENTER13-1924236 | NEW YORK, NY | $1.1M | Cash | Research |
REGENTS OF THE UNIVERSITY OF MINNESOTA41-6007513 | MINNEAPOLIS, MN | $1.1M | Cash | Research |
NEW YORK CITY HEALTH AND HOSPITALS13-2655001 | NEW YORK, NY | $1M | Cash | Research |
| LOS ANGELES, CA | $1M | Cash | Research | |
THE CHILDRENS HOSPITAL OF PHILADELPHIA23-1352166 | PHILADELPHIA, PA | $997.1K | Cash | Research |
COLD SPRING HARBOR LABORATORY11-2013303 | COLD SPRING HA, NY | $996.3K | Cash | Research |
BATTELLE MEMORIAL INSTITUTE31-4379427 | SEATTLE, WA | $979.2K | Cash | Research |
CORNELL UNIVERSITY15-0532082 | ITHACA, NY | $966.4K | Cash | Research |
UNIV OF NORTH CAROLINA AT CHAPEL HILL56-6001393 | ATLANTA, GA | $950.1K | Cash | Research |
UNIVERSITY OF VIRGINIA54-6046419 | CHARLOTTESVILLE, VA | $940.3K | Cash | Research |
HEALTH RESEARCH INCORPORATED14-1402155 | MENANDS, NY | $922.3K | Cash | Research |
UNIVERSITY OF UTAH87-6000525 | SALT LAKE CITY, UT | $906.4K | Cash | Research |
NORTHWESTERN UNIVERSITY36-2167817 | EVANSTON, IL | $885.5K | Cash | Research |
State of Maryland52-6002033 | TOWSON, MD | $850.2K | Cash | Research |
State University of Iowa42-6004813 | IOWA CITY, IA | $803.7K | Cash | Research |
GEORGETOWN UNIVERSITY53-0196603 | WASHINGTON, DC | $802.3K | Cash | Research |
BOSTON MEDICAL CENTER | BOSTON, MA | $796.5K | Cash | Research |
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH11-2673595 | PHILADELPHIA, PA | $731.6K | Cash | Research |
STATE OF MISSISSIPPI-UNIVERSITY64-6008520 | JACKSON, MS | $711.3K | Cash | Research |
UNIVERSITY OF VERMONT AND STATE | WILLISTON, VT | $696.2K | Cash | Research |
INDIANA UNIVERSITY35-6001673 | DETROIT, MI | $692.9K | Cash | Research |
UNIVERSITY OF TEXAS SOUTHWESTERN75-6002868 | DALLAS, TX | $678.1K | Cash | Research |
CITYMEALS-ON-WHEELS13-3634381 | NEW YORK, NY | $651K | Cash | Program Services |
| NEW YORK, NY | $651K | Cash | Program Services | |
| NEW YORK, NY | $651K | Cash | Program Services | |
SOUTHERN POVERTY LAW CENTER INC63-0598743 | MONTGOMERY, AL | $651K | Cash | Program Services |
CASE WESTERN RESERVE UNIVERSITY34-1018992 | CLEVELAND, OH | $646.2K | Cash | Research |
TEACHERS COLLEGE13-1624202 | NEW YORK, NY | $631.3K | Cash | Research |
ROCKEFELLER UNIVERSITY13-1624158 | NEW YORK, NY | $620.3K | Cash | Research |
HEBREW HOME FOR THE AGED AT RIVERDALE13-1739971 | RIVERDALE, NY | $592K | Cash | Research |
NORTHEASTERN UNIV | BOSTON, MA | $584.6K | Cash | Research |
MARINE BIOLOGICAL LAB | BOSTON, MA | $582K | Cash | Research |
UNIVERSITY OF ILLINOIS37-6000511 | CHICAGO, IL | $579.7K | Cash | Research |
UNIVERSITY OF CALIFORNIA SAN DIEGO95-6006144 | LOS ANGELES, CA | $561.7K | Cash | Research |
National Jewish Medical and Research74-2044647 | DENVER, CO | $558.9K | Cash | Research |
CALIFORNIA INSTITUTE OF TECHNOLOGY95-1643307 | PASADENA, CA | $558.7K | Cash | Research |
CHRISTIANA CARE HEALTH SYSTEM51-0103684 | NEWARK, DE | $546.1K | Cash | Research |
SLOAN KETTERING INST FOR13-1624182 | NEW YORK, NY | $542.1K | Cash | Research |
HUNTER COLLEGE13-6001027 | NEW YORK, NY | $536.8K | Cash | Research |
UNIVERSITY OF WISCONSIN MADISON39-6006492 | MILWAUKEE, WI | $536K | Cash | Research |
UNIVERSITY OF ARIZONA86-6004791 | TUCSON, AZ | $529.9K | Cash | Research |
UNIVERSITY OF PUERTO RICO66-0433762 | SAN JUAN, PR | $506.5K | Cash | Research |
| NEW YORK, NY | $500K | Cash | Program Services | |
THE RAND CORPORATION95-1958142 | SANTA MONICA, CA | $491K | Cash | Research |
Clinical Directors Network Inc14-1717344 | NEW YORK, NY | $486.9K | Cash | Research |
WAKE FOREST UNIVERSITY56-0532138 | WINSTON SALEM, NC | $459.2K | Cash | Research |
TRUSTEES OF TUFTS COLLEGE | BOSTON, MA | $455.6K | Cash | Research |
MEDICAL COLLEGE OF WISCONSIN39-0806261 | MILWAUKEE, WI | $446.9K | Cash | Research |
CARNEGIE MELLON UNIVERSITY25-0969449 | PITTSBURGH, PA | $442.8K | Cash | Research |
COM AFFILIATION INC47-2209056 | BRONX, NY | $442.8K | Cash | Research |
Albany Medical CenterCollege14-1338310 | ALBANY, NY | $419.1K | Cash | Research |
CHILDRENS HOSPITAL BOSTON | BOSTON, MA | $415.6K | Cash | Research |
UNIVERSITY OF MISSOURI43-6003859 | KANSAS CITY, MO | $414.8K | Cash | Research |
University of Massachusetts Lowell | LOWELL, MA | $412.7K | Cash | Research |
BETH ISRAEL DEACONESS MEDICAL CENTER | BOSTON, MA | $412.6K | Cash | Research |
VANDERBILT UNIVERSITY MEDICAL CENTER35-2528741 | DALLAS, TX | $409.6K | Cash | Research |
HACKENSACK UNIVERSITY MEDICAL CENTER22-1487576 | NUTLEY, NJ | $404.7K | Cash | Research |
FRIENDS OF UNITED NATIONS POPULATION13-3996346 | NEW YORK, NY | $400K | Cash | Research |
WOODS HOLE OCEANOGRAPHIC INSTITUTION | WOODS HOLE, MA | $388.7K | Cash | Edu/Research |
THE SCRIPPS RESEARCH INSTITUTE33-0435954 | LOS ANGELES, CA | $386.8K | Cash | Research |
COMMUNITY OPPORTUNITY FUND81-3704165 | COLD SPRING, NY | $385.1K | Cash | Research |
UNIVERSITY OF OREGON46-4727800 | EUGENE, OR | $380.7K | Cash | Research |
AVERA MCKENNAN46-0224743 | SIOUX FALLS, SD | $377.3K | Cash | Research |
THE JACKSON LABORATORY | BAR HARBOR, ME | $367.3K | Cash | Research |
BLOODWORKS91-1019655 | SEATTLE, WA | $361K | Cash | Research |
UNIVERSITY OF TEXAS AT AUSTIN74-6000203 | AUSTIN, TX | $360.9K | Cash | Research |
Columbia Barnard Hillel Inc23-7077182 | NEW YORK, NY | $360K | Cash | Program Services |
Scintillon Institute The45-4323888 | SAN DIEGO, CA | $346K | Cash | Research |
VISITING NURSE SERVICE OF NEW YORK13-3189926 | NEW YORK, NY | $345.8K | Cash | Research |
OREGON STATE UNIVERSITY61-1730890 | CORVALLIS, OR | $329.9K | Cash | Research |
CHILDRENS HOSPITAL OF PHILADELPHIA23-1352166 | PHILADELPHIA, PA | $315.1K | Cash | Research |
CEDAR SINAI MEDICAL CENTER95-1644600 | LOS ANGELES, CA | $293.1K | Cash | Research |
MAYO CLINIC IN ROCHESTER41-6011702 | MINNEAPOLIS, MN | $278.5K | Cash | Research |
COOPER HEALTH SYSTEMCOOPER UNIVERSITY21-0634462 | CAMDEN, NJ | $275.4K | Cash | Research |
UNIVERSITY OF SOUTHERN CALIFORNIA95-1642394 | LOS ANGELES, CA | $274K | Cash | Research |
| NEW YORK, NY | $272.8K | Cash | Program Services | |
UNIVERSITY OF TEXAS HEALTH SCIENCE CNTR74-1586031 | SAN ANTONIO, TX | $271.7K | Cash | Research |
EMORY UNIVERSITY58-0566256 | ATLANTA, GA | $270K | Cash | Research |
KENNEDY HEALTHCARE FOUNDATION INC80-0550282 | PHILADELPHIA, PA | $265.8K | Cash | Research |
UNIVERSITY OF CALIFORNIA DAVIS95-6006143 | LOS ANGELES, CA | $263.4K | Cash | Research |
| CHICAGO, IL | $259.9K | Cash | Research | |
TEXAS A&M UNIVERSITY74-6000531 | COLLEGE STN, TX | $256.2K | Cash | Research |
George Mason University54-0836354 | FAIRFAX, VA | $251.6K | Cash | Research |
TRUSTEES OF DARTMOUTH COLLEGE | HANOVER, NH | $245.6K | Cash | Research |
UNIVERSITY OF HEALTH AND PHARMACY43-0652675 | ST LOUIS, MO | $230K | Cash | Research |
Pennsylvania State University The24-6000376 | STATE COLLEGE, PA | $229.1K | Cash | Research |
CHILDRENS HOSPITAL MEDICAL CENTER31-0833936 | Cincinnati, OH | $226.4K | Cash | Research |
UNIVERSITY OF HOUSTON SYS74-6001399 | HOUSTON, TX | $224K | Cash | Research |
COLORADO STATE UNIVERSITY84-6000545 | FORT COLLINS, CO | $223K | Cash | Research |
UNIVERSITY OF HAWAII99-6000354 | HONOLULU, HI | $222.9K | Cash | Research |
MCLAUGHLIN RESEARCH INSTITUTE81-0459235 | GREAT FALLS, MT | $214.4K | Cash | Research |
Ohio State University The31-6025986 | DETROIT, MI | $208.4K | Cash | Research |
TEMPLE UNIVERSITY23-1365971 | NEW YORK, NY | $207.1K | Cash | Research |
UNIVERSITY OF ROCHESTER16-0743209 | ROCHESTER, NY | $206.6K | Cash | Research |
Vanderbilt University62-0476822 | DALLAS, TX | $201.1K | Cash | Research |
SMITH COLLEGE | NORTHAMPTON, MA | $200K | Cash | Program Services |
CITY COLLEGE OF NY13-6000565 | NEW YORK, NY | $193.6K | Cash | Research |
FOX CHASE CANCER CENTER23-2003072 | PHILADELPHIA, PA | $184.5K | Cash | Research |
DREXEL UNIVERSITY23-1352630 | PHILADELPHIA, PA | $173.3K | Cash | Research |
UNIVERSITY OF TEXAS74-6000949 | DALLAS, TX | $164.8K | Cash | Research |
NEW YORK HOSPITAL OF QUEENS11-1839362 | FLUSHING, NY | $163.7K | Cash | Research |
UNIVERSITY OF FLORIDA59-6002052 | GAINESVILLE, FL | $162.8K | Cash | Research |
UPPER ROOM AIDS MINISTRY INC13-3841701 | NEW YORK, NY | $157.8K | Cash | Research |
CODE FOR SCIENCE AND SOCIETY INC81-3791683 | PORTLAND, OR | $155.9K | Cash | Research |
SAN DIEGO STATE UNIVERSITY FOUNDATION95-6042721 | SAN DIEGO, CA | $155.7K | Cash | Research |
UNIV OF TEXAS AT ARLINGTON75-6000121 | ARLINGTON, TX | $155.3K | Cash | Research |
LA JOLLA INSTITUTE FOR ALLERGY33-0328688 | LA JOLLA, CA | $155.3K | Cash | Research |
SOUTHERN METHODIST UNIVERSITY75-0800689 | DALLAS, TX | $154.3K | Cash | Research |
BROWN UNIVERSITY | PROVIDENCE, RI | $150.1K | Cash | Edu/Research |
VIVIAN BEAUMONT THEATER INC13-3004747 | NEW YORK, NY | $150K | Cash | Program Services |
FRED HUTCHINSON CANCER RESEARCH CENTER23-7156071 | SEATTLE, WA | $146.8K | Cash | Research |
UTAH STATE UNIVERSITY87-6000528 | SEATTLE, WA | $146.3K | Cash | Research |
TELECOMMUNICATIONS DEVELOPMENT FUND INC52-2077863 | CHEVY CHASE, MD | $142.4K | Cash | Program Services |
THE METROPOLITAN MUSEUM OF ART13-1624086 | NY, NY | $140K | Cash | Program Services |
UNIVERSITY OF RHODE ISLAND | KINGSTON, RI | $139.3K | Cash | Research |
MEDSTAR HEALTH RESEARCH INSTITUTE52-6056274 | BOSTON, MA | $137.1K | Cash | Research |
SAINT PETERS UNIVERSITY HOSPITAL22-1487330 | NEW BRUNSWICK, NJ | $136.7K | Cash | Research |
THE BRONX VETERANS MEDICAL RESEARCH13-3699250 | BRONX, NY | $136.6K | Cash | Research |
HIGH POINT UNIVERSITY56-0529999 | HIGH POINT, NC | $132.5K | Cash | Research |
AMERICAN MUSEUM OF NATURAL HISTORY13-6162659 | NEW YORK, NY | $128.6K | Cash | Research |
MUSEUM OF ARTS AND DESIGN13-3585408 | NEW YORK, NY | $125K | Cash | Program Services |
FORDHAM UNIVERSITY13-1740451 | BRONX, NY | $124.6K | Cash | Research |
UNIVERSITY OF ALASKA92-6000147 | FAIRBANKS, AK | $124.2K | Cash | Research |
THE UNIVERSITY OF SOUTHERN MISSISSIPPI64-6000818 | HATTIESBURG, MS | $123K | Cash | Research |
UNIVERSITY OF CALIFORNIA SANTA BARBARA95-6006145 | SANTA BARBARA, CA | $119.6K | Cash | Research |
HEALTH PEOPLE INC51-0418243 | BRONX, NY | $117.8K | Cash | Research |
SEATTLE CHILDRENS HOSPITAL91-0564748 | SEATTLE, WA | $117.2K | Cash | Research |
TEXAS TECH UNIVERSITY75-6002622 | LUBBOCK, TX | $117K | Cash | Research |
SMITHSONIAN INSTITUTION53-0206027 | CHICAGO, IL | $116.4K | Cash | Research |
FLORIDA STATE UNIVERSITY59-1961248 | TALLAHASSEE, FL | $114.9K | Cash | Research |
LAWRENCE LIVERMORE NATL SEC20-5624386 | LIVERMORE, CA | $113.9K | Cash | Research |
BARNARD COLLEGE13-1628149 | NEW YORK, NY | $111.2K | Cash | Research |
PROJECT ALS13-4019464 | HUNTINGTOWN, MD | $110K | Cash | Program Services |
UNIVERSITY OF SOUTH FLORIDA59-3102112 | TAMPA, FL | $110K | Cash | Research |
MAYO CLINIC IN JACKSONVILLE59-3337028 | MINNEAPOLIS, MN | $109.3K | Cash | Research |
| NORTH CHICAGO, IL | $108.6K | Cash | Research | |
BRANDEIS UNIVERSITY | WALTHAM, MA | $107.4K | Cash | Research |
CHILDRENS HOSPITAL OF LOS ANGELES95-1690977 | LOS ANGELES, CA | $100.4K | Cash | Research |
MOHONK PRESERVE INC14-1609484 | NEW PALTZ, NY | $100K | Cash | Program Services |
RESEARCH INSTITUTE AT NATIONWIDE31-6056230 | DETROIT, MI | $98.2K | Cash | Research |
OCHSNER CLINIC FOUNDATION72-0502505 | JEFFERSON, LA | $98K | Cash | Research |
BOARD OF REGENTS OF THE UNIVERSITY OF OK73-1377584 | OKLAHOMA CITY, OK | $97.7K | Cash | Research |
REGENTS OF THE UNIVERSITY OF CA MERCED27-0093858 | MERCED, CA | $97.7K | Cash | Research |
CALLEN-LORDE COMMUNITY HEALTH CENTER13-3409680 | NEW YORK, NY | $96.4K | Cash | Research |
LITTLE SISTERS OF THE ASSUMPTION13-2867881 | NEW YORK, NY | $94.9K | Cash | Research |
LOYOLA UNIVERSITY OF CHICAGO36-1408475 | CHICAGO, IL | $94.8K | Cash | Research |
University Corporation for Atmospheric84-0412668 | BOULDER, CO | $92.2K | Cash | Research |
STEVENS INSTITUTE OF TECHNOLOGY22-1487354 | HOBOKEN, NJ | $90.5K | Cash | Research |
STATE OF SOUTH DAKOTA46-6000364 | RAPID CITY, SD | $87.9K | Cash | Research |
CALYX SYSTEMS88-3758640 | NEW YORK, NY | $87.5K | Cash | Research |
UNIVERSITY OF KANSAS48-0680117 | LAWRENCE, KS | $84.3K | Cash | Research |
STATE OF CO SCH OF MINES84-6000551 | DALLAS, TX | $83.8K | Cash | Research |
QUINTESSENT INC83-4668682 | GOLETA, CA | $83.1K | Cash | Research |
UNIVERSITY OF TENNESSEE62-6001636 | KNOXVILLE, TN | $81.5K | Cash | Research |
CHILD MIND INSTITUTE80-0478843 | NEW YORK, NY | $79K | Cash | Research |
RHODE ISLAND HOSPITAL | PROVIDENCE, RI | $78K | Cash | Research |
CHARLES B WANG COMMUNITY HEALTH CENTER13-2739694 | NEW YORK, NY | $77.3K | Cash | Research |
TEXAS BIOMEDICAL RESEARCH INSTITUTE74-1109630 | SAN ANTONIO, TX | $77.1K | Cash | Research |
GEORGIA INSTITUTE OF TECHNOLOGY58-0603146 | ATLANTA, GA | $77K | Cash | Research |
BRIGHAM YOUNG UNIVERSITY87-0217280 | PROVO, UT | $76.4K | Cash | Research |
Riverdale Country School13-1740483 | BRONX, NY | $76K | Cash | Program Services |
THE UNIVERSITY OF CENTRAL FLORIDA59-2924021 | ORLANDO, FL | $75.1K | Cash | Research |
AMERICAN ISRAEL EDUCATION FOUNDATION52-1623781 | WASHINGTON, DC | $75K | Cash | Program Services |
OKLAHOMA STATE UNIVERSITY73-1383996 | OKLAHOMA CITY, OK | $72.3K | Cash | Research |
NEW JERSEY INSTITUTE OF TECHNOLOGY22-6000910 | NEWARK, NJ | $70.7K | Cash | Research |
NEW YORK STATE ASSOCIATION OF COUNTY14-1747742 | LATHAM, NY | $70K | Cash | Research |
RETINA FOUNDATION OF THE SOUTHWEST51-0151514 | DALLAS, TX | $69.4K | Cash | Research |
UNIVERSITY SYSTEM OF NEW HAMPSHIRE | DURHAM, NH | $68.7K | Cash | Research |
North Carolina A&T State University56-6000007 | GREENSBORO, NC | $67K | Cash | Research |
VIRGINIA POLYTECHNICAL INSTITUTE AND54-6001805 | BLACKSBURG, VA | $67K | Cash | Research |
UNIVERSITY OF LOUISIANA AT LAFAYETTE72-6000820 | LAFAYETTE, LA | $66.9K | Cash | Research |
NATIONAL KIDNEY FOUNDATION INC13-1673104 | NEW YORK, NY | $65.6K | Cash | Research |
BANNER SUN HEALTH RESEARCH INSTITUTE45-0233470 | PHOENIX, AZ | $64.9K | Cash | Research |
Regents of the University of California95-6006142 | RIVERSIDE, CA | $64.6K | Cash | Research |
CHESTNUT HEALTH SYSTEMS37-0964629 | BLOOMINGTON, IL | $63.5K | Cash | Research |
Open Imagery Network Inc81-3160991 | WASHINGTON, DC | $62.9K | Cash | Research |
GREAT PLAINS TRIBAL LEADERS HEALTH BOARD46-0420063 | RAPID CITY, SD | $62.1K | Cash | Research |
BIGELOW LABORATORY FOR OCEAN SCIENCES | E BOOTHBAY, ME | $60.6K | Cash | Research |
PLANETARY SCIENCE INSTITUTE33-0175263 | TUCSON, AZ | $60.2K | Cash | Research |
WEST HARLEM ENVIRONMENTAL ACTION INC13-3800068 | NY, NY | $60.2K | Cash | Research |
Colorado School of Mines Foundation84-0509064 | GOLDEN, CO | $60K | Cash | Program Services |
ARIZONA STATE UNIVERSITY86-0196696 | TEMPE, AZ | $59.6K | Cash | Research |
CITY OF HOPE NATIONAL MEDICAL CENTER95-1683875 | DUARTE, CA | $58.8K | Cash | Research |
SALK INSTITUTE FOR BIOLOGICAL STUDIES95-2160097 | LA JOLLA, CA | $57.1K | Cash | Research |
BIRMINGHAM AIDS OUTREACH INC63-0948495 | BIRMINGHAM, AL | $56.6K | Cash | Research |
DANA FARBER CANCER INSTITUTE | BOSTON, MA | $56.1K | Cash | Research |
ASSOCIATION TO BENEFIT CHILDREN13-3303089 | NEW YORK, NY | $55.7K | Cash | Research |
TUFTS MEDICAL CENTER INC | BOSTON, MA | $55.4K | Cash | Research |
AMERICAN UNIVERSITY OF BEIRUT13-5596846 | NEW YORK, NY | $55.2K | Cash | Research |
HASTINGS CTR13-2662222 | GARRISON, NY | $55K | Cash | Research |
THOMAS JEFFERSON UNIVERSITY23-1352651 | PHILADELPHIA, PA | $54.2K | Cash | Research |
TULANE UNIVERSITY72-0423889 | NEW ORLEANS, LA | $52.9K | Cash | Research |
THE BOARD OF REGENTS OF THE73-1377584 | NORMAN, OK | $51.6K | Cash | Research |
THE CLEVELAND CLINIC FOUNDATION34-0714585 | CLEVALAND, OH | $51.3K | Cash | Research |
COUNCIL ON FOREIGN RELATIONS13-1628168 | NEW YORK, NY | $50K | Cash | Program Services |
Seattle Institute for Biomedical and91-1452438 | SEATTLE, WA | $48.5K | Cash | Research |
UNIVERSITY OF CALIFORNIA AT SANTA CRUZ94-1539563 | SANTA CRUZ, CA | $47.7K | Cash | Research |
ASSOCIATION OF UNIVERSITIES FOR RESEARCH86-0138043 | BALTIMORE, MD | $47.5K | Cash | Research |
| SAN FRANCISCO, CA | $47.4K | Cash | Research | |
CARNEGIE INST OF WA53-0196523 | WASHINGTON, DC | $46.2K | Cash | Research |
BOARD OF REGENTS OF THE NSHE OBO THE88-6000024 | RENO, NV | $45.9K | Cash | Research |
ROCHESTER INSTITUTE OF TECHNOLOGY16-0743140 | ROCHESTER, NY | $45.2K | Cash | Research |
RESEARCH TRIANGLE INSTITUTE56-0686338 | CHARLOTTE, NC | $44K | Cash | Research |
KOTZEBUE IRA COUNCIL92-0060128 | KOTZEBUE, AK | $43.2K | Cash | Research |
Dominican Womens Development Center13-3593885 | NY, NY | $43K | Cash | Program Services |
UNIVERSITY OF GEORGIA58-1353149 | ATHENS, GA | $42.8K | Cash | Research |
WGBH EDUCATIONAL FOUNDATION | BOSTON, MA | $42.5K | Cash | Program Services |
THE COLLEGE OF WILLIAM & MARY54-6001718 | WILLIAMSBURG, VA | $42.3K | Cash | Research |
RUTGERS THE STATE UNIVERSITY OF NJ46-2354111 | PISCATAWAY, NJ | $42.2K | Cash | Research |
UNIVERSITY OF ARKANSAS FOR MEDICAL71-6046242 | LITTLE ROCK, AR | $42.2K | Cash | Research |
NORTHERN ILLINOIS UNIVERSITY36-6008480 | DEKALB, IL | $41.8K | Cash | Research |
UNIVERSITY OF NEBRASKA MEDICAL CENTER47-0049123 | LINCOLN, NE | $39.7K | Cash | Research |
CHILDRENS NATIONAL MEDICAL CENTER52-1640403 | SILVER SPRING, MD | $39.4K | Cash | Research |
SAN JOSE STATE UNIVERSITY94-6017638 | SAN JOSE, CA | $39.4K | Cash | Research |
MOUNT SINAI MEDICAL CTR13-1624096 | NY, NY | $39K | Cash | Research |
KENT STATE UNIVERSITY31-6402079 | KENT, OH | $37.9K | Cash | Research |
HOSPITAL FOR SPECIAL SURGERY13-1624135 | NEW YORK, NY | $37.8K | Cash | Research |
J DAVID GLADSTONE INSTITUTES23-7203666 | SAN FRANCISCO, CA | $37.7K | Cash | Research |
TEXAS A&M UNIVERSITY AT GALVESTON74-2125225 | COLLEGE STATION, TX | $37.6K | Cash | Research |
KANSAS STATE UNIVERSITY48-0771751 | MANHATTAN, KS | $37.1K | Cash | Research |
JAMES MADISON UNIVERSITY54-6001756 | HARRISONBURG, VA | $36.9K | Cash | Research |
UNIVERSITY OF KENTUCKY RESEARCH61-6033693 | LEXINGTON, KY | $36.7K | Cash | Research |
UNIVERSITY OF WISCONSIN SYSTEMS39-1805963 | OSHKOSH, WI | $36.4K | Cash | Research |
PURDUE UNIVERSITY35-6002041 | CHICAGO, IL | $35.4K | Cash | Research |
NEW YORK ACADEMY OF MEDICINE13-1656674 | NEW YORK, NY | $35.3K | Cash | Research |
THE PINGRY CORPORATION THE PINGRY SCHOOL22-1493168 | BASKING RIDGE, NJ | $35K | Cash | Program Services |
| NEW YORK, NY | $35K | Cash | Program Services | |
ARKANSAS CHILDRENS RESEARCH INSTITUTE71-0694931 | LITTLE ROCK, AR | $34.6K | Cash | Research |
BOARD OF TRUSTEES OF SANTA CLARA COLLEGE94-1156617 | SANTA CLARA, CA | $34.5K | Cash | Research |
THE ARMORY FOUNDATION13-3680286 | NEW YORK, NY | $34K | Cash | Program Services |
UNIVERSITY OF TEXAS MEDICAL74-1761309 | DALLAS, TX | $33.2K | Cash | Research |
SPORTS AND ARTS IN SCHOOLS FOUNDATION11-3112635 | WOODSIDE, NY | $32.5K | Cash | Research |
MONTCLAIR STATE UNIVERSITY22-6017209 | MONTCLAIR, NJ | $32.3K | Cash | Research |
OLD DOMINION UNIVERSITY54-6000884 | NORFOLK, VA | $32K | Cash | Research |
SAN FRANCISCO STATE UNIVERSITY93-1137247 | SAN FRANCISCO, CA | $30.7K | Cash | Research |
WESTERN WASHINGTON UNIVERSITY91-6000562 | BELLINGHAM, WA | $30.7K | Cash | Research |
COLUMBIA UNIV PRESS13-1623968 | NEW YORK, NY | $30.5K | Cash | Program Services |
URBAN SUSTAINABILITY DIRECTORS NETWORK82-5015863 | SANFORD, NC | $30K | Cash | Research |
URBAN HEALTH PLAN INC23-7360305 | BRONX, NY | $29.9K | Cash | Research |
MOVING FOR LIFE46-5251831 | NEW YORK, NY | $29.9K | Cash | Program Services |
| WASHINGTON, DC | $29.8K | Cash | Program Services | |
MOUNT SINAI MED CENTER OF FLORIDA INC59-0624424 | MIAMI, FL | $29.8K | Cash | Research |
WAYNE STATE UNIV38-6028429 | DETROIT, MI | $28.7K | Cash | Research |
UNIVERSITY OF NOTRE DAME35-0868188 | NORTRE DAME, IN | $28.7K | Cash | Research |
DEPARTMENTS OF NYS STATE13-6400434 | LONG ISLAND CITY, NY | $28K | Cash | Research |
INWOOD ART WORKS INC81-4379932 | NEW YORK, NY | $27.5K | Cash | Program Services |
VASSAR COLLEGE14-1338587 | POUGHKEEPSIE, NY | $27.3K | Cash | Research |
THE CORPORATION OF HAVERFORD COLLEGE23-6002304 | HAVERFORD, PA | $26.9K | Cash | Research |
ADDO FOUNDATION INC82-1469026 | BROOKLYN, NY | $25.8K | Cash | Program Services |
MONTANA STATE UNIVERSITY81-6010045 | BOZEMAN, MT | $25.6K | Cash | Research |
THE UNIVERSITY OF ALABAMA IN HUNTSVILLE63-0520830 | HUNTSVILLE, AL | $25.4K | Cash | Research |
UNIVERSITY OF LOUISVILLE61-1029626 | LOUISVILLE, KY | $25.3K | Cash | Research |
HARBOR-UCLA RESEARCH & ED INST95-2138184 | TORRANCE, CA | $25.1K | Cash | Research |
ARNOLD P GOLD FOUND22-3052098 | ENGLEWOOD CLIFFS, NJ | $25K | Cash | Program Services |
Quad Preparatory School The46-5652622 | NEW YORK, NY | $25K | Cash | Program Services |
THE GREATER HARLEM CHAMBER OF COMMERCE13-3662434 | NEW YORK, NY | $25K | Cash | Program Services |
TRIBE MEDIA CORP THE JEWISH JOURNAL95-4019743 | LOS ANGELES, CA | $25K | Cash | Program Services |
| SOUTH DENNIS, MA | $25K | Cash | Program Services | |
| NEW YORK, NY | $25K | Cash | Program Services | |
Tribe Media Corp (DBA Jewish Journal)95-4019743 | LOS ANGELES, CA | $25K | Cash | Program Services |
REGENTS OF THE UNIVERSITY OF IDAHO82-6000945 | MOSCOW, ID | $25K | Cash | Research |
PITTSBURGH DATAWORKS46-2212103 | PITTSBURGH, PA | $24.7K | Cash | Research |
CIUDADANOS DEL KARSO INC66-0514059 | SAN JUAN, PR | $24.6K | Cash | Research |
THE BROAD INSTITUTE INC26-3428781 | CAMBRIDGE, MA | $24.4K | Cash | Research |
SOUTH FLORIDA VA FOUNDATION65-0207903 | MIAMI, FL | $24.3K | Cash | Research |
BAYLOR UNIVERSITY74-1159753 | WACO, TX | $24.2K | Cash | Research |
FRIENDS OF THE NATL INST52-1832014 | LEXINGTON, KY | $24K | Cash | Program Services |
DARTMOUTH COLLEGE | HANOVER, NH | $23.1K | Cash | Research |
INST FOR ADVANCED STUDY21-0634988 | PRINCETON, NJ | $23.1K | Cash | Research |
HEBREW REHABILITATION CENTER | BOSTON, MA | $21.3K | Cash | Research |
BROADWAY MALL ASSN13-3419786 | NEW YORK, NY | $21K | Cash | Program Services |
TOURO COLLEGE13-2676570 | NEW YORK, NY | $21K | Cash | Research |
CEGAANA46-5178306 | MILPITAS, CA | $20K | Cash | Program Services |
SOCIETY FOR CONSUMER PSYCHOLOGY36-3607499 | FORT WORTH, TX | $20K | Cash | Program Services |
COMMUNITY LEAGUE OF THE HEIGHTS INC13-2564241 | NY, NY | $20K | Cash | Program Services |
| AURORA, CO | $19.2K | Cash | Research | |
PLANNED PARENTHOOD LEAGUE OF | BOSTON, MA | $19.1K | Cash | Research |
AMERICAN ACADEMY OF NURSING52-2213870 | WASHINGTON, DC | $19K | Cash | Program Services |
FLORIDA ATLANTIC UNIVERSITY65-0385507 | ATLANTA, GA | $18.9K | Cash | Research |
BURKE MED RES INST13-1739937 | WHITE PLAINS, NY | $18.7K | Cash | Research |
TRUDEAU INSTITUTE INC14-1401413 | SARANAC LAKE, NY | $18.5K | Cash | Research |
CATHEDRAL CHURCH OF ST JOHN THE DIVINE13-1623934 | NEW YORK, NY | $18K | Cash | Program Services |
RICE UNIVERSITY74-1109620 | HOUSTON, TX | $18K | Cash | Research |
THE UNIVERSITY CORPORATION95-1992732 | NORTHRIDGE, CA | $17.5K | Cash | Research |
MASONIC MEDICAL RESEARCH INSTITUTE13-5648611 | UTICA, NY | $16.7K | Cash | Research |
WASHINGTON STATE UNIVERSITY91-6001108 | PULLMAN, WA | $16.7K | Cash | Research |
UNIVERSITY OF NORTH TEXAS75-6002149 | FORT WORTH, TX | $16.5K | Cash | Research |
EARTH AND SPACE RESEARCH91-1663391 | SEATTLE, WA | $15.6K | Cash | Research |
UNIVERSITY OF DELAWARE51-6000297 | NEWARK, DE | $15.5K | Cash | Research |
Mount Sinai Medical Center Foundation59-1711400 | MIAMI BEACH, FL | $15K | Cash | Program Services |
NEW YORKERS TO CURE PARALYSIS INC46-4135776 | NEW YORK, NY | $15K | Cash | Program Services |
UNITED HOSPITAL FUND OF NEW YORK INC13-1562656 | NEW YORK, NY | $15K | Cash | Program Services |
PAROLE PREPARATION PROJECT82-1096572 | NEW YORK, NY | $15K | Cash | Program Services |
ST JOHNS UNIVERSITY11-1630830 | QUEENS, NY | $15K | Cash | Research |
NATIONAL NETWORK OF PUBLICH HEALTH72-1505359 | NEW ORLEANS, LA | $14.9K | Cash | Research |
PUBLIC HEALTH FOUNDATION ENTERPRISES INC95-2557063 | CITY OF INDUSTRY, CA | $14.6K | Cash | Research |
RENSSELAER POLYTECHNIC INSTITUTE14-1340095 | TROY, NY | $14.3K | Cash | Research |
| NEW YORK, NY | $13.6K | Cash | Program Services | |
Oligo Nation46-3087590 | SEBASTOPOL, CA | $13K | Cash | Program Services |
OKLAHOMA STATE DEPARTMENT OF HEALTH73-6017987 | OKLAHOMA CITY, OK | $12.8K | Cash | Research |
LOUISIANA STATE UNIVERSITY72-6000848 | BATON ROUGE, LA | $12.7K | Cash | Research |
LEUKEMIA & LYMPHOMA SOCI13-5644916 | RYE BROOK, NY | $12.5K | Cash | Program Services |
MASSACHUSETTS EYE & EAR INFIRMARY | BOSTON, MA | $12.1K | Cash | Research |
NEW YORK COMMON PANTRY INC13-3127972 | NEW YORK, NY | $12K | Cash | Program Services |
BLOOMINGDALE FAMILY PROGRAM INC13-2638566 | NEW YORK, NY | $12K | Cash | Program Services |
BOOMER ESIASON FOUNDATION11-3142753 | NEW YORK, NY | $12K | Cash | Program Services |
WEST SIDE CENTER FOR COMMUNITY LIFE71-0908184 | NEW YORK, NY | $12K | Cash | Program Services |
AMERICA SCORES NEW YORK13-4189653 | NEW YORK, NY | $12K | Cash | Program Services |
HARLEM CHAMBER PLAYERS INC45-2160781 | NEW YORK, NY | $12K | Cash | Program Services |
NORTHERN ARIZONA UNIVERSITY74-2579628 | FLAGSTAFF, AZ | $11.8K | Cash | Research |
OREGON HEALTH AND SCIENCES UNIV93-1176109 | PORTLAND, OR | $11.8K | Cash | Research |
WEST VIRGINIA UNIVERSITY RESEARCH CORPOR55-0665758 | MORGANTOWN, WV | $11.6K | Cash | Research |
NEW YORK MEDICAL COLLEGE13-1099420 | NEW YORK, NY | $11.5K | Cash | Research |
THE ALEXANDRIA ARCHIVE INSTITUTE91-2146202 | SAN FRANCISCO, CA | $11.5K | Cash | Research |
UNIVERSITY OF TEXAS HSC HOUSTON74-1761309 | DALLAS, TX | $11.1K | Cash | Research |
| NEW YORK, NY | $11K | Cash | Program Services | |
BATEMAN HORNE CENTER87-0687610 | SALT LAKE CITY, UT | $11K | Cash | Research |
HARLEM ACADEMY56-2454573 | NEW YORK, NY | $11K | Cash | Program Services |
| ORADELL, NJ | $10.5K | Cash | Program Services | |
TRINITY COMMUNITY CONNECTION94-3447082 | NEW YORK, NY | $10K | Cash | Program Services |
AATS FOUNDATION23-7288866 | BEVERLY, MA | $10K | Cash | Program Services |
AMERICAN HEART ASSOCIATION13-5613797 | DES MOINES, IA | $10K | Cash | Program Services |
ASSOCIATED MEDICAL SCHOOLS OF NEW YORK13-6214887 | NEW YORK, NY | $10K | Cash | Program Services |
BROADWAY COMMUNITY INC13-3652817 | NEW YORK, NY | $10K | Cash | Program Services |
WE THE PROTESTERS81-3764408 | NEW YORK, NY | $10K | Cash | Research |
Clinical Legal Education Association | DURHAM, NC | $10K | Cash | Program Services |
DOMINICANOS PRO AYUDA A LA NINEZ INC13-3673457 | NEW YORK, NY | $10K | Cash | Program Services |
HIT THE BOOKS INC84-2795993 | NEW YORK, NY | $10K | Cash | Program Services |
| CHICAGO, IL | $10K | Cash | Program Services | |
JONAS PHILANTHROPIES INC82-1843824 | NEW YORK, NY | $10K | Cash | Program Services |
NORTHERN MANHATTAN IMPROVEMENT CORP13-4167218 | NEW YORK, NY | $10K | Cash | Program Services |
ONE TO WORLD INC13-3179151 | NEW YORK, NY | $10K | Cash | Program Services |
PALTREK INC83-1620495 | NAPERVILLE, IL | $10K | Cash | Program Services |
PEOPLES THEATRE PROJECT INC26-4705999 | BRONX, NY | $10K | Cash | Program Services |
PRATHAM USA76-0620808 | HOUSTON, TX | $10K | Cash | Program Services |
RC CHURCH OF THE ASCENSION13-1628191 | NEW YORK, NY | $10K | Cash | Program Services |
| WALLA WALLA, WA | $10K | Cash | Program Services | |
THE CORBIN HILL FOOD PROJECT INC46-1206478 | NEW YORK, NY | $10K | Cash | Program Services |
VOCATIONAL INSTRUCTION PROJECT COMMUNITY13-3224700 | BRONX, NY | $10K | Cash | Program Services |
FRESH YOUTH INITIATIVES INC13-3723207 | NEW YORK, NY | $9,000 | Cash | Program Services |
RIVERSIDE HAWKS HHH INC ATTN MARK JEROME | NEW YORK, NY | $9,000 | Cash | Program Services |
NJEDGE NET INC22-3781807 | NEWARK, NJ | $8,997 | Cash | Research |
ADELPHI UNIVERSITY11-1630741 | GARDEN CITY, NY | $8,898 | Cash | Research |
H LEE MOFFITT CANCER CENTER INC59-3238634 | TAMPA, FL | $8,859 | Cash | Research |
University of Kansas Medical Center48-1108830 | KANSAS CITY, KS | $8,695 | Cash | Research |
DOROT INC13-3264005 | NEW YORK, NY | $8,500 | Cash | Program Services |
DANCE PROJECT OF WASHINGTON HEIGHTS INC47-1583227 | NEW YORK, NY | $8,500 | Cash | Program Services |
BEHIND THE BOOK INC32-0086097 | NEW YORK, NY | $8,500 | Cash | Program Services |
BROOKHAVEN SCIENCE ASSOCIATES LLC11-3403915 | UPTON, NY | $8,493 | Cash | Research |
HOWARD UNIVERSITY53-0204707 | WASHINGTON, DC | $8,439 | Cash | Research |
| NEW YORK, NY | $8,370 | Cash | Program Services | |
BALL STATE UNIVERSITY35-6000221 | MUNCIE, IN | $8,231 | Cash | Research |
NIDO DE ESPERANZA CHARITABLE SOCIETY82-5510616 | NEW YORK, NY | $8,000 | Cash | Program Services |
THE COMMUNITY INITIATIVES OF NC81-3983435 | NEW YORK, NY | $8,000 | Cash | Program Services |
ALLIANCE FOR GLOBAL JUSTICE52-2094677 | TUCSON, AZ | $8,000 | Cash | Research |
| JAMAICA QUEENS, NY | $8,000 | Cash | Program Services | |
AMERICAN ACADEMY OF PEDIATRICS36-2275597 | CHICAGO, IL | $7,573 | Cash | Research |
FRACTURED ATLAS INC11-3451703 | HARTSDALE, NY | $7,512 | Cash | Program Services |
HOLYROOD CHURCH IGLESIA SANTA CRUZ13-1844844 | NEW YORK, NY | $7,500 | Cash | Program Services |
SNACK & FRIENDS INC20-5934666 | NEW YORK, NY | $7,000 | Cash | Program Services |
THE PARRIS FOUNDATION INC27-1408011 | NY, NY | $7,000 | Cash | Program Services |
SDSN ASSOCIATION47-3511012 | NEW YORK, NY | $6,542 | Cash | Research |
RIVERSTONE SENIOR LIFE SERV13-3355074 | NY, NY | $6,500 | Cash | Program Services |
FUND FOR THE CITY OF NEW YORK13-2612524 | NEW YORK, NY | $6,500 | Cash | Program Services |
| NEW YORK, NY | $6,000 | Cash | Program Services | |
TOP HONORS INC75-3062601 | NEW YORK, NY | $6,000 | Cash | Program Services |
WE ARE NOT AFRAID COMMUNITY RESOURCE CTR84-3462208 | NEW YORK, NY | $6,000 | Cash | Program Services |
ARTS AND MINDS INC27-3733512 | NEW YORK, NY | $6,000 | Cash | Program Services |
I CHALLENGE MYSELF INC56-2423423 | NEW YORK, NY | $5,500 | Cash | Program Services |
EASTERN NURSING RES SOCIE | LEESBURG, VA | $5,250 | Cash | Program Services |
WESTERN MICHIGAN UNIVERSITY38-6007327 | KALAMAZOO, MI | $5,013 | Cash | Research |
| Total | $162.8M | |||
New York, NY
$13.1M
NEW YORK, NY
$7.9M
MENANDS, NY
$4.2M
BOSTON, MA
$3.2M
New York, NY
$2.8M
DENVER, CO
$2.8M
NEW YORK, NY
$2.8M
BERKELEY, CA
$2.7M
NEW YORK, NY
$2.7M
CHICAGO, IL
$2.7M
CHICAGO, IL
$2.5M
PITTSBURGH, PA
$2.4M
BRONX, NY
$2.4M
BERKELEY, CA
$2.3M
CLEVELAND, OH
$2.2M
PHILADELPHIA, PA
$2.2M
ALBANY, NY
$2.1M
BIRMINGHAM, AL
$2M
CHICAGO, IL
$1.9M
HARVARD UNIVERSITY
BOSTON, MA
$1.8M
CHICAGO, IL
$1.8M
LOS ANGELES, CA
$1.7M
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$1.7M
ATLANTA, GA
$1.7M
PHILADELPHIA, PA
$1.6M
NEW YORK, NY
$1.6M
YALE UNIVERSITY
NEW HAVEN, CT
$1.6M
EAST LANSING, MI
$1.6M
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
CAMBRIDGE, MA
$1.5M
BOSTON, MA
$1.5M
THE BRIGHAM AND WOMENS HOSPITAL INC
BOSTON, MA
$1.5M
HOUSTON, TX
$1.5M
PRINCETON, NJ
$1.5M
PISCATAWAY, NJ
$1.4M
New York, NY
$1.4M
BETHESDA, MD
$1.3M
CHARLOTTE, NC
$1.3M
CHARLESTON, SC
$1.3M
OAKLAND, CA
$1.3M
BOSTON UNIVERSITY
NEW YORK, NY
$1.2M
IRVINE, CA
$1.2M
ST LOUIS, MO
$1.2M
PITTSBURGH, PA
$1.2M
NEW YORK, NY
$1.1M
MINNEAPOLIS, MN
$1.1M
NEW YORK, NY
$1M
LOS ANGELES, CA
$1M
PHILADELPHIA, PA
$997.1K
COLD SPRING HA, NY
$996.3K
SEATTLE, WA
$979.2K
ITHACA, NY
$966.4K
ATLANTA, GA
$950.1K
CHARLOTTESVILLE, VA
$940.3K
MENANDS, NY
$922.3K
SALT LAKE CITY, UT
$906.4K
EVANSTON, IL
$885.5K
TOWSON, MD
$850.2K
IOWA CITY, IA
$803.7K
WASHINGTON, DC
$802.3K
BOSTON MEDICAL CENTER
BOSTON, MA
$796.5K
PHILADELPHIA, PA
$731.6K
JACKSON, MS
$711.3K
UNIVERSITY OF VERMONT AND STATE
WILLISTON, VT
$696.2K
DETROIT, MI
$692.9K
DALLAS, TX
$678.1K
NEW YORK, NY
$651K
NEW YORK, NY
$651K
NEW YORK, NY
$651K
MONTGOMERY, AL
$651K
CLEVELAND, OH
$646.2K
NEW YORK, NY
$631.3K
NEW YORK, NY
$620.3K
RIVERDALE, NY
$592K
NORTHEASTERN UNIV
BOSTON, MA
$584.6K
MARINE BIOLOGICAL LAB
BOSTON, MA
$582K
CHICAGO, IL
$579.7K
LOS ANGELES, CA
$561.7K
DENVER, CO
$558.9K
PASADENA, CA
$558.7K
NEWARK, DE
$546.1K
NEW YORK, NY
$542.1K
NEW YORK, NY
$536.8K
MILWAUKEE, WI
$536K
TUCSON, AZ
$529.9K
SAN JUAN, PR
$506.5K
$500K
SANTA MONICA, CA
$491K
NEW YORK, NY
$486.9K
WINSTON SALEM, NC
$459.2K
TRUSTEES OF TUFTS COLLEGE
BOSTON, MA
$455.6K
MILWAUKEE, WI
$446.9K
PITTSBURGH, PA
$442.8K
BRONX, NY
$442.8K
ALBANY, NY
$419.1K
CHILDRENS HOSPITAL BOSTON
BOSTON, MA
$415.6K
KANSAS CITY, MO
$414.8K
University of Massachusetts Lowell
LOWELL, MA
$412.7K
BETH ISRAEL DEACONESS MEDICAL CENTER
BOSTON, MA
$412.6K
DALLAS, TX
$409.6K
NUTLEY, NJ
$404.7K
NEW YORK, NY
$400K
WOODS HOLE OCEANOGRAPHIC INSTITUTION
WOODS HOLE, MA
$388.7K
LOS ANGELES, CA
$386.8K
COLD SPRING, NY
$385.1K
EUGENE, OR
$380.7K
SIOUX FALLS, SD
$377.3K
THE JACKSON LABORATORY
BAR HARBOR, ME
$367.3K
SEATTLE, WA
$361K
AUSTIN, TX
$360.9K
NEW YORK, NY
$360K
SAN DIEGO, CA
$346K
NEW YORK, NY
$345.8K
CORVALLIS, OR
$329.9K
PHILADELPHIA, PA
$315.1K
LOS ANGELES, CA
$293.1K
MINNEAPOLIS, MN
$278.5K
CAMDEN, NJ
$275.4K
LOS ANGELES, CA
$274K
$272.8K
SAN ANTONIO, TX
$271.7K
ATLANTA, GA
$270K
PHILADELPHIA, PA
$265.8K
LOS ANGELES, CA
$263.4K
CHICAGO, IL
$259.9K
COLLEGE STN, TX
$256.2K
FAIRFAX, VA
$251.6K
TRUSTEES OF DARTMOUTH COLLEGE
HANOVER, NH
$245.6K
ST LOUIS, MO
$230K
STATE COLLEGE, PA
$229.1K
Cincinnati, OH
$226.4K
HOUSTON, TX
$224K
FORT COLLINS, CO
$223K
HONOLULU, HI
$222.9K
GREAT FALLS, MT
$214.4K
DETROIT, MI
$208.4K
NEW YORK, NY
$207.1K
ROCHESTER, NY
$206.6K
DALLAS, TX
$201.1K
SMITH COLLEGE
NORTHAMPTON, MA
$200K
NEW YORK, NY
$193.6K
PHILADELPHIA, PA
$184.5K
PHILADELPHIA, PA
$173.3K
DALLAS, TX
$164.8K
FLUSHING, NY
$163.7K
GAINESVILLE, FL
$162.8K
NEW YORK, NY
$157.8K
PORTLAND, OR
$155.9K
SAN DIEGO, CA
$155.7K
ARLINGTON, TX
$155.3K
LA JOLLA, CA
$155.3K
DALLAS, TX
$154.3K
BROWN UNIVERSITY
PROVIDENCE, RI
$150.1K
NEW YORK, NY
$150K
SEATTLE, WA
$146.8K
SEATTLE, WA
$146.3K
CHEVY CHASE, MD
$142.4K
$140K
UNIVERSITY OF RHODE ISLAND
KINGSTON, RI
$139.3K
BOSTON, MA
$137.1K
NEW BRUNSWICK, NJ
$136.7K
BRONX, NY
$136.6K
HIGH POINT, NC
$132.5K
NEW YORK, NY
$128.6K
NEW YORK, NY
$125K
BRONX, NY
$124.6K
FAIRBANKS, AK
$124.2K
HATTIESBURG, MS
$123K
SANTA BARBARA, CA
$119.6K
BRONX, NY
$117.8K
SEATTLE, WA
$117.2K
LUBBOCK, TX
$117K
CHICAGO, IL
$116.4K
TALLAHASSEE, FL
$114.9K
LIVERMORE, CA
$113.9K
NEW YORK, NY
$111.2K
HUNTINGTOWN, MD
$110K
TAMPA, FL
$110K
MINNEAPOLIS, MN
$109.3K
NORTH CHICAGO, IL
$108.6K
BRANDEIS UNIVERSITY
WALTHAM, MA
$107.4K
LOS ANGELES, CA
$100.4K
NEW PALTZ, NY
$100K
DETROIT, MI
$98.2K
JEFFERSON, LA
$98K
OKLAHOMA CITY, OK
$97.7K
MERCED, CA
$97.7K
NEW YORK, NY
$96.4K
NEW YORK, NY
$94.9K
CHICAGO, IL
$94.8K
BOULDER, CO
$92.2K
HOBOKEN, NJ
$90.5K
RAPID CITY, SD
$87.9K
NEW YORK, NY
$87.5K
LAWRENCE, KS
$84.3K
DALLAS, TX
$83.8K
GOLETA, CA
$83.1K
KNOXVILLE, TN
$81.5K
NEW YORK, NY
$79K
RHODE ISLAND HOSPITAL
PROVIDENCE, RI
$78K
NEW YORK, NY
$77.3K
SAN ANTONIO, TX
$77.1K
ATLANTA, GA
$77K
PROVO, UT
$76.4K
BRONX, NY
$76K
ORLANDO, FL
$75.1K
WASHINGTON, DC
$75K
OKLAHOMA CITY, OK
$72.3K
NEWARK, NJ
$70.7K
LATHAM, NY
$70K
DALLAS, TX
$69.4K
UNIVERSITY SYSTEM OF NEW HAMPSHIRE
DURHAM, NH
$68.7K
GREENSBORO, NC
$67K
BLACKSBURG, VA
$67K
LAFAYETTE, LA
$66.9K
NEW YORK, NY
$65.6K
PHOENIX, AZ
$64.9K
RIVERSIDE, CA
$64.6K
BLOOMINGTON, IL
$63.5K
WASHINGTON, DC
$62.9K
RAPID CITY, SD
$62.1K
BIGELOW LABORATORY FOR OCEAN SCIENCES
E BOOTHBAY, ME
$60.6K
TUCSON, AZ
$60.2K
$60.2K
GOLDEN, CO
$60K
TEMPE, AZ
$59.6K
DUARTE, CA
$58.8K
LA JOLLA, CA
$57.1K
BIRMINGHAM, AL
$56.6K
DANA FARBER CANCER INSTITUTE
BOSTON, MA
$56.1K
NEW YORK, NY
$55.7K
TUFTS MEDICAL CENTER INC
BOSTON, MA
$55.4K
NEW YORK, NY
$55.2K
GARRISON, NY
$55K
PHILADELPHIA, PA
$54.2K
NEW ORLEANS, LA
$52.9K
NORMAN, OK
$51.6K
CLEVALAND, OH
$51.3K
NEW YORK, NY
$50K
SEATTLE, WA
$48.5K
SANTA CRUZ, CA
$47.7K
BALTIMORE, MD
$47.5K
SAN FRANCISCO, CA
$47.4K
WASHINGTON, DC
$46.2K
$45.9K
ROCHESTER, NY
$45.2K
CHARLOTTE, NC
$44K
KOTZEBUE, AK
$43.2K
$43K
ATHENS, GA
$42.8K
WGBH EDUCATIONAL FOUNDATION
BOSTON, MA
$42.5K
WILLIAMSBURG, VA
$42.3K
PISCATAWAY, NJ
$42.2K
LITTLE ROCK, AR
$42.2K
DEKALB, IL
$41.8K
LINCOLN, NE
$39.7K
SILVER SPRING, MD
$39.4K
SAN JOSE, CA
$39.4K
NY, NY
$39K
KENT, OH
$37.9K
NEW YORK, NY
$37.8K
SAN FRANCISCO, CA
$37.7K
COLLEGE STATION, TX
$37.6K
MANHATTAN, KS
$37.1K
HARRISONBURG, VA
$36.9K
LEXINGTON, KY
$36.7K
OSHKOSH, WI
$36.4K
CHICAGO, IL
$35.4K
NEW YORK, NY
$35.3K
BASKING RIDGE, NJ
$35K
NEW YORK, NY
$35K
LITTLE ROCK, AR
$34.6K
SANTA CLARA, CA
$34.5K
NEW YORK, NY
$34K
DALLAS, TX
$33.2K
WOODSIDE, NY
$32.5K
MONTCLAIR, NJ
$32.3K
NORFOLK, VA
$32K
SAN FRANCISCO, CA
$30.7K
BELLINGHAM, WA
$30.7K
NEW YORK, NY
$30.5K
SANFORD, NC
$30K
BRONX, NY
$29.9K
NEW YORK, NY
$29.9K
WASHINGTON, DC
$29.8K
$29.8K
DETROIT, MI
$28.7K
NORTRE DAME, IN
$28.7K
LONG ISLAND CITY, NY
$28K
NEW YORK, NY
$27.5K
POUGHKEEPSIE, NY
$27.3K
HAVERFORD, PA
$26.9K
BROOKLYN, NY
$25.8K
BOZEMAN, MT
$25.6K
HUNTSVILLE, AL
$25.4K
LOUISVILLE, KY
$25.3K
TORRANCE, CA
$25.1K
ENGLEWOOD CLIFFS, NJ
$25K
NEW YORK, NY
$25K
NEW YORK, NY
$25K
LOS ANGELES, CA
$25K
SOUTH DENNIS, MA
$25K
$25K
LOS ANGELES, CA
$25K
MOSCOW, ID
$25K
PITTSBURGH, PA
$24.7K
SAN JUAN, PR
$24.6K
CAMBRIDGE, MA
$24.4K
MIAMI, FL
$24.3K
WACO, TX
$24.2K
LEXINGTON, KY
$24K
DARTMOUTH COLLEGE
HANOVER, NH
$23.1K
PRINCETON, NJ
$23.1K
HEBREW REHABILITATION CENTER
BOSTON, MA
$21.3K
NEW YORK, NY
$21K
NEW YORK, NY
$21K
MILPITAS, CA
$20K
FORT WORTH, TX
$20K
$20K
$19.2K
PLANNED PARENTHOOD LEAGUE OF
BOSTON, MA
$19.1K
WASHINGTON, DC
$19K
ATLANTA, GA
$18.9K
WHITE PLAINS, NY
$18.7K
SARANAC LAKE, NY
$18.5K
NEW YORK, NY
$18K
HOUSTON, TX
$18K
NORTHRIDGE, CA
$17.5K
UTICA, NY
$16.7K
PULLMAN, WA
$16.7K
FORT WORTH, TX
$16.5K
SEATTLE, WA
$15.6K
NEWARK, DE
$15.5K
MIAMI BEACH, FL
$15K
NEW YORK, NY
$15K
NEW YORK, NY
$15K
NEW YORK, NY
$15K
QUEENS, NY
$15K
NEW ORLEANS, LA
$14.9K
CITY OF INDUSTRY, CA
$14.6K
TROY, NY
$14.3K
$13.6K
SEBASTOPOL, CA
$13K
OKLAHOMA CITY, OK
$12.8K
BATON ROUGE, LA
$12.7K
RYE BROOK, NY
$12.5K
MASSACHUSETTS EYE & EAR INFIRMARY
BOSTON, MA
$12.1K
NEW YORK, NY
$12K
NEW YORK, NY
$12K
NEW YORK, NY
$12K
NEW YORK, NY
$12K
NEW YORK, NY
$12K
NEW YORK, NY
$12K
FLAGSTAFF, AZ
$11.8K
PORTLAND, OR
$11.8K
MORGANTOWN, WV
$11.6K
NEW YORK, NY
$11.5K
SAN FRANCISCO, CA
$11.5K
DALLAS, TX
$11.1K
$11K
SALT LAKE CITY, UT
$11K
NEW YORK, NY
$11K
$10.5K
NEW YORK, NY
$10K
BEVERLY, MA
$10K
DES MOINES, IA
$10K
NEW YORK, NY
$10K
NEW YORK, NY
$10K
NEW YORK, NY
$10K
Clinical Legal Education Association
DURHAM, NC
$10K
NEW YORK, NY
$10K
NEW YORK, NY
$10K
$10K
NEW YORK, NY
$10K
NEW YORK, NY
$10K
NEW YORK, NY
$10K
NAPERVILLE, IL
$10K
BRONX, NY
$10K
HOUSTON, TX
$10K
NEW YORK, NY
$10K
WALLA WALLA, WA
$10K
NEW YORK, NY
$10K
$10K
NEW YORK, NY
$9,000
RIVERSIDE HAWKS HHH INC ATTN MARK JEROME
NEW YORK, NY
$9,000
NEWARK, NJ
$8,997
GARDEN CITY, NY
$8,898
TAMPA, FL
$8,859
KANSAS CITY, KS
$8,695
NEW YORK, NY
$8,500
NEW YORK, NY
$8,500
NEW YORK, NY
$8,500
UPTON, NY
$8,493
WASHINGTON, DC
$8,439
$8,370
MUNCIE, IN
$8,231
NEW YORK, NY
$8,000
NEW YORK, NY
$8,000
TUCSON, AZ
$8,000
JAMAICA QUEENS, NY
$8,000
CHICAGO, IL
$7,573
HARTSDALE, NY
$7,512
NEW YORK, NY
$7,500
NEW YORK, NY
$7,000
$7,000
NEW YORK, NY
$6,542
$6,500
NEW YORK, NY
$6,500
$6,000
NEW YORK, NY
$6,000
NEW YORK, NY
$6,000
NEW YORK, NY
$6,000
NEW YORK, NY
$5,500
EASTERN NURSING RES SOCIE
LEESBURG, VA
$5,250
KALAMAZOO, MI
$5,013
Source: USAspending.gov · Searched by organization name
VA/DoD Awards
$19.9M
VA/DoD Award Count
2
Funding from the Department of Veterans Affairs and/or Department of Defense.
Total Federal Funding (partial)
$5.8B
Awards Found
200+
Additional awards may exist. View all on USAspending.gov →
Department of Health and Human Services
$374.4M
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
Department of Health and Human Services
$194M
HIV-FOCUSED POPULATION SURVEYS IN COUNTRIES SUPPORTED UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
Department of Health and Human Services
$191.3M
GH14-1409, POPULAR-BASED HIV IMPACT ASSESSMENTS IN RESOURCE-CONSTRAINED SETTINGS UNDER PEPFAR
Department of Health and Human Services
$125.1M
SUPPORTING SUSTAINABLE IMPLEMENTATION OF HIV AND TB SERVICES FOR EPIDEMIC CONTROL IN THE REPUBLIC OF
Department of Health and Human Services
$122.1M
SUSTAIN AND ACCELERATE A COMPREHENSIVE HIV RESPONSE IN THE UNITED REPUBLIC OF TANZANIA UNDER PEPFAR - ICAP IS UNIQUELY POSITIONED TO LEAD THE MULTI-YEAR SUSTAIN AND ACCELERATE A COMPREHENSIVE HIV RESPONSE IN THE UNITED REPUBLIC OF TANZANIA (TZ) UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) ON BEHALF OF CDC IN TZ. ICAP HAS BEEN A PREMIER U.S. GOVERNMENT IMPLEMENTING PARTNER (IP) IN TZ SINCE 2005, FIRST AS A PEPFAR-FUNDED HEALTH FACILITY (HF) IP THAT TRANSITIONED ACTIVITIES TO THE MINISTRY OF HEALTH (MOH) AND LOCAL NON-GOVERNMENTAL ORGANIZATIONS (NGO) (2005?2014); NEXT CONDUCTING KEY STUDIES TO INFORM THE HIV LANDSCAPE AND BUILDING HEALTHCARE WORKER CAPACITY THROUGH INNOVATIVE LEARNING PLATFORMS; AND FOR THE LAST FIVE YEARS AS A COMMUNITY IP WITH ITS PEPFAR-FUNDED FIKIA (?TO REACH? IN KISWAHILI) PROJECT. AS A DRIVING FORCE BEHIND MANY OF TZ?S STRIDES IN PREVENTION, TESTING, TREATMENT INITIATION, AND VIRAL LOAD (VL) SUPPRESSION, ICAP NOW PROPOSES TO TRANSFORM CLIENT-CENTERED HIV TESTING, PREVENTION, AND TREATMENT SERVICES OVER THE NEXT FIVE YEARS. THIS PROJECT RESPONDS TO TZ?S GENERALIZED HIV EPIDEMIC WITH 4.8% ADULT PREVALENCE AND APPROXIMATELY 1.7 MILLION PEOPLE LIVING WITH HIV (PLHIV). AS OF 2019, 83% OF PLHIV IN TZ KNOW THEIR STATUS, 75% OF ALL PLHIV ARE ON ANTIRETROVIRAL THERAPY (ART), AND 69% ARE VIRALLY SUPPRESSED, WITH SIGNIFICANT VARIATIONS IN GEOGRAPHY AND POPULATIONS ACROSS THESE GLOBAL TARGETS. TO ACHIEVE THE 95-95-95 GOALS, TZ MUST IMPROVE SERVICE COVERAGE AND QUALITY FOR MEN, ESPECIALLY THOSE IN MIGRATORY OCCUPATIONS, AND CHILDREN, WHO FALL BEHIND ACROSS THE CASCADE; ONLY 81% AND 66%, RESPECTIVELY, OF PLHIV IN THESE GROUPS KNOW THEIR STATUS. THE RESPONSE WILL ALSO TAILOR INTERVENTIONS TO MEET THE NEEDS OF ADOLESCENT GIRLS AND YOUNG WOMEN AT HIGH RISK OF ACQUIRING HIV, AND KEY POPULATIONS FACING STIGMA, DISCRIMINATION, AND HIGH HIV PREVALENCE, INCLUDING PEOPLE WHO INJECT DRUGS (36%), FEMALE SEX WORKERS (26%), AND MEN WHO HAVE SEX WITH MEN (25%).THE PURPOSE OF THIS PROJECT IS TO PROVIDE RAPID, FLEXIBLE SUPPORT TO AC CELERATE EVIDENCE-BASED HIV PREVENTION AND TREATMENT PROGRAM IMPLEMENTATION IN HF AND COMMUNITIES AND ALIGNED HEALTH SYSTEMS STRENGTHENING ACTIVITIES TOWARD EPIDEMIC CONTROL IN TZ. WORKING DIRECTLY ALONGSIDE REGIONAL AND COUNCIL HEALTH MANAGEMENT TEAMS (R/CHMT), ICAP WILL PROVIDE A TAILORED PACKAGE OF TECHNICAL SUPPORT FEATURING: 1) MULTI-MODAL TRAINING AND HUMAN RESOURCES FOR HEALTH CAPACITY BUILDING; 2) STRENGTHENED SERVICE CONTINUITY ACROSS HEALTH FACILITY (HF) AND COMMUNITY SETTINGS USING DIFFERENTIATED SERVICE DELIVERY MODELS; 3) AND COLLABORATIVE CONTINUOUS QUALITY IMPROVEMENT (CQI) AT HF, REGIONAL, AND NATIONAL LEVELS. ANTICIPATED SHORT TERM OUTCOMES INCLUDE: IMPROVED IDENTIFICATION AND TIMELY INITIATION ON ART OF ALL NEWLY IDENTIFIED HIV+ CLIENTS, INCLUDING HARD-TO-REACH SUB-GROUPS IN SUPPORTED LOCATIONS; INCREASED ART COVERAGE, ADHERENCE, RETENTION, AND VL TESTING OF PLHIV, AMONG ALL SUB-GROUPS; INCREASED COVERAGE OF OPTIMAL ART REGIMENS AMONG ALL SUB-GROUPS; IMPROVED COVERAGE OF COMPREHENSIVE CARE SERVICES, SUCH AS DETECTION AND TREATMENT OF OPPORTUNISTIC INFECTIONS AND PROVISION OF TUBERCULOSIS PREVENTIVE THERAPY; INCREASED COVERAGE OF HIV PREVENTION SERVICES INCLUDING VOLUNTARY MEDICAL MALE CIRCUMCISION, PRE-EXPOSURE PROPHYLAXIS AND MEDICATION ASSISTED TREATMENT, AMONG TARGETED GROUPS; INCREASED HIV-EXPOSED INFANTS RECEIVING EARLY DIAGNOSIS AT SUPPORTED HF IN LINE WITH NORMATIVE GUIDANCE; AND ENHANCED MONITORING AND EVALUATION SYSTEMS IN PLACE FOR IMPROVED DATA COLLECTION, DATA QUALITY, AND OVERSIGHT OF PROGRAM PERFORMANCE.THIS PROJECT WILL OPTIMIZE ICAP?S EXTENSIVE PARTNER NETWORK BUILT OVER 17 YEARS IN TZ COLLABORATING WITH GOVERNMENT OF TZ PARTNERS, LOCAL INSTITUTIONS THAT OVERSEE THE HEALTH SYSTEM (E.G., RHMT IN THE FOUR TARGET REGIONS, ALL 32 RELATED CHMT); A ROBUST NGO NETWORK, AND OTHER STRATEGIC COLLABORATORS. ICAP BUILDS LONG-TERM, HIGH-IMPACT RELATIONSHIPS THAT HELP AD
Department of Health and Human Services
$108.8M
ADVANCING SUSTAINABLE IMPLEMENTATION OF COMPREHENSIVE HIV/TB SERVICES FOR EPIDEMIC CONTROL IN THE REPUBLIC OF MOZAMBIQUE UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
Department of Health and Human Services
$103.6M
TARGETED PROGRAMMATIC SUPPORT ACROSS COUNTRIES UNDER THE GLOBAL FUND TO FIGHT HIV/AIDS, TUBERCULOSIS AND MALARIA AND UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) - WITH SUPPORT FROM PEPFAR AND THE GLOBAL FUND (GF), MANY COUNTRIES MOST AFFECTED BY HIV HAVE MADE GREAT STRIDES TOWARDS ENHANCED COVERAGE OF PREVENTION, DIAGNOSIS, TREATMENT, AND VIRAL SUPPRESSION (VS) FOR PEOPLE LIVING WITH HIV (PLHIV) AND THOSE AT RISK OF ACQUIRING IT. CURRENT PRIORITIES IN THE GLOBAL HIV RESPONSE FOCUS ON ADVANCING EPIDEMIC CONTROL AND ACHIEVING 95-95-95 TARGETS IN HIGH-BURDEN SETTINGS. TO TAKE NATIONAL HIV PROGRAMS TO THE NEXT LEVEL OF EFFECTIVENESS AND IMPACT, MINISTRIES OF HEALTH (MOH), PEPFAR IMPLEMENTING PARTNERS (IP), AND OTHER KEY STAKEHOLDERS IN PEPFAR- AND GF-SUPPORTED COUNTRIES REQUIRE HIGH-QUALITY, DATA-DRIVEN TECHNICAL ASSISTANCE (TA) TO IDENTIFY AND EFFECTIVELY ADDRESS REMAINING GAPS IN THE HIV PREVENTION, CARE, AND TREATMENT CASCADES USING EVIDENCE-BASED AND COST-EFFECTIVE APPROACHES. IN ADDITION, CROSS-PROGRAM, CROSS-COUNTRY LEARNING PLATFORMS ARE NEEDED TO SUPPORT BEST PRACTICE DIFFUSION AND PEER-TO-PEER KNOWLEDGE TRANSFER FOR APPROPRIATE IMPLEMENTATION AND REAL-TIME USE OF DATA FOR DECISION MAKING. THE PURPOSE OF THIS PROGRAM IS TO PROVIDE COMPREHENSIVE, COST-EFFECTIVE, TARGETED TA FOR HIV PREVENTION, CARE, AND TREATMENT AS WELL AS CAPACITY BUILDING (CB) FOR MOH, IP, AND OTHER STAKEHOLDERS TO ACHIEVE THE 95-95-95 TARGETS AND ADVANCE PROGRESS TOWARD EPIDEMIC CONTROL IN PEPFAR AND GF-SUPPORTED COUNTRIES. HARNESSING THE MOST UP-TO-DATE EVIDENCE TO INFORM ITS APPROACHES, AND IN LINE WITH CDC GUIDANCE, ICAP WILL PROVIDE TARGETED TA FOR: 1) CAPACITY BUILDING OF MOH, KEY STAKEHOLDERS, AND THE HEALTH WORKFORCE TO ACHIEVE AND SUSTAIN CONTROL OF NATIONAL EPIDEMICS; 2) SERVICE PROVISION, TO IMPROVE DELIVERY OF HIGH-QUALITY, EVIDENCE-BASED HIV PREVENTION, CARE, AND TREATMENT SERVICES, INCREASE VS, AND DECREASE HIV TRANSMISSION AMONG HIGH-RISK AND VULNERABLE POPULATIONS (VP); AND 3) STRATEGIC INFORMATION, TO GENERATE TIMELY, ACTIONABLE, HIGH-QUALITY DATA AND INCREASE ITS USE TO INFORM HIV POLICY AND PROGRAMS. IN RESPONSE TO COUNTRY TA REQUESTS, ICAP WILL SELECT SUITABLE TA AND CB APPROACHES FROM ITS EXTENSIVE CATALOGUE OF FIELD-TESTED, EVIDENCE-BASED SOLUTIONS AND WORK CLOSELY WITH CDC-PEPFAR, MOH, IP, AND OTHER IN-COUNTRY STAKEHOLDERS TO DESIGN, PLAN, AND IMPLEMENT A PACKAGE OF SUPPORT TAILORED TO THE LOCAL EPIDEMIC, POPULATION GROUPS, AND HEALTH CARE WORKER CADRES. EMPLOYING AN UNWAVERING FOCUS ON USE AND GENERATION OF ACTIONABLE DATA ACROSS ALL STRATEGIES AND TECHNICAL DOMAINS, ICAP WILL PROVIDE TA TO MOH, PEPFAR IP, AND OTHER KEY STAKEHOLDERS TO IMPROVE HEALTH WORKFORCE ALLOCATION, PRODUCTIVITY, AND PERFORMANCE; INCREASE HIV SERVICE COVERAGE, QUALITY, AND ACCESS AMONG TARGET POPULATIONS, GEOGRAPHIC AREAS, AND SERVICE AREAS; AND STRENGTHEN GENERATION AND USE OF ROUTINE AND ENHANCED DATA FOR DECISION-MAKING. A BETTER-ALIGNED, MORE PRODUCTIVE HEALTH WORKFORCE, TOGETHER WITH BETTER-TARGETED HIV SERVICE APPROACHES WILL PRODUCE HIGHER-QUALITY, MORE EFFICIENT, AND MORE EFFECTIVE HIV SERVICES, WHICH WILL IMPROVE KEY METRICS (E.G. TESTING COVERAGE, ART INITIATION, ADHERENCE, RETENTION, VS) THAT DRIVE PROGRESS TOWARD 95-95-95 AND EPIDEMIC CONTROL. BY APPLYING RIGOROUS AND COLLABORATIVE MONITORING, ICAP WILL ENSURE THAT IT MEETS OR EXCEEDS PROJECT-SPECIFIC TARGETS AND ACHIEVES ALL PROGRAM OUTCOMES. INTERMEDIATE AND LONG-TERM PROGRAM OUTCOMES WILL INCLUDE IMPROVED QUALITY AND EFFECTIVENESS OF HIV PROGRAMS TO INCREASE RETENTION AND ADHERENCE TO TREATMENT FOR ALL PLHIV AND TO EFFECTIVE PREVENTION METHODS FOR AT-RISK GROUPS; INCREASED USE OF DATA TO MEASURE PROGRESS ON 95:95:95 TARGETS AND EPIDEMIC CONTROL; INCREASED CAPACITY AND OWNERSHIP OF MOH AND OTHER KEY STAKEHOLDERS OF ALL HIV EPIDEMIC CONTROL EFFORTS IN A SUSTAINED MANNER; DECREASED HIV TRANSMISSION AMONG HIGH-RISK AND VP; AND INCREASED VS AMONG ALL PLHIV AND ALL SUBGROUPS OF PLH
Department of Health and Human Services
$99M
CLINICAL AND TRANSLATIONAL SCIENCE AWARD
Department of Health and Human Services
$90.8M
CENTER FOR HIGH-THROUGHPUT MINIMALLY-INVASIVE DOSIMETRY
Department of Health and Human Services
$85.5M
CANCER CENTER SUPPORT GRANT
Department of Health and Human Services
$81.6M
POPULAR-BASED HIV IMPACT ASSESSMENTS IN RESOURCE-CONSTRAINED STEEINGS UNDER PEPFAR
Department of Health and Human Services
$80.4M
COMPREHENSIVE COMMUNITY-BASED HIV PREVENTION, LINKAGE, AND RETENTION SERVICES FOR KEY POPULATIONS AN
Department of Health and Human Services
$77.3M
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION CARE
Department of Health and Human Services
$74.8M
CHASE: AN INNOVATIVE COUNTY-LEVEL PUBLIC HEALTH RESPONSE TO THE OPIOID EPIDEMIC IN NEW YORK STATE
National Science Foundation
$74.7M
MREFC: US ATLAS HL-LHC UPGRADE PROJECT
Department of Health and Human Services
$69.2M
NORTHEAST BIODEFENSE CENTER
Department of Health and Human Services
$66.5M
ALZHEIMER'S DISEASE AND ALZHEIMER'S DISEASE RELATED DEMENTIAS IN PREDIABETES AND TYPE 2 DIABETES: THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY AD/ADRD PROJECT - THIS U19 PROPOSAL FOCUSES ON ONE OF THE MOST IMPORTANT, COMPLEX QUESTIONS IN ALZHEIMER’S DISEASE (AD) AND ALZHEIMER’S DISEASE-RELATED DEMENTIAS (ADRD) RESEARCH: WHAT ARE THE DETERMINANTS AND THE NATURE OF COGNITIVE IMPAIRMENT AMONG PERSONS WITH PRE-DIABETES (PRED) AND TYPE 2 DIABETES (T2D), WHO ARE A HIGH-RISK GROUP FOR COGNITIVE IMPAIRMENT AND REPRESENT A LARGE FRACTION OF THE UNITED STATES (US) POPULATION? DESPITE KNOWLEDGE THAT PERSONS WITH PRED AND T2D ARE A HIGH-RISK GROUP FOR COGNITIVE DECLINE, MILD COGNITIVE IMPAIRMENT (MCI), AND DEMENTIA, THE RISK FACTORS, MECHANISMS, AND NEUROPATHOLOGY OF COGNITIVE IMPAIRMENT IN PERSONS WITH PRED AND T2D REMAIN UNCLEAR. GAPS IN KNOWLEDGE ON COGNITIVE IMPAIRMENT IN PRED AND T2D INCLUDE: (A) THE ROLE OF AD AND/OR NON-AD NEUROPATHOLOGY BEYOND VASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT AND DEMENTIA (VCID); (B) THE ROLE OF GLYCEMIA, RELATED METABOLIC FACTORS SUCH AS HYPERINSULINEMIA, AND TRADITIONAL MICRO AND MACROVASCULAR COMPLICATIONS OF PRED/T2D; (C) THE ROLE OF GLUCOSE-LOWERING MEDICATIONS, PRIMARILY METFORMIN; AND (D) THE ROLE OF PHYSICAL ACTIVITY, PHYSICAL FUNCTION, AND FRAILTY, KEY IN PRED AND T2D. WE PROPOSE 4 INTERRELATED PROJECTS THAT WILL ADDRESS THESE GAPS, LEVERAGING THE DIABETES PREVENTION PROGRAM (DPP) OUTCOMES STUDY (DPPOS) COHORT AND ITS DETAILED PRED/T2D PHENOTYPING, ADDING STATE OF THE ART AD/ADRD PHENOTYPING. THE DPPOS COHORT CURRENTLY HAS A MEAN AGE OF 72 YEARS, WITH 76% OVER THE AGE OF 65. THUS, THE COHORT IS IN A PERIOD OF THE LIFESPAN WHEN THE DEVELOPMENT OF COGNITIVE DECLINE, MCI, AND DEMENTIA ACCELERATES. THIS EXTENSIVELY PHENOTYPED COHORT REPRESENTS AN ESTIMATED 50 MILLION AMERICANS. TO ADDRESS THIS PROPOSAL’S COMPLEX INTERRELATED QUESTIONS, WE WILL PERFORM TWO WAVES OF STATE-OF-THE-ART AD/ADRD PHENOTYPING DURING THE PROPOSED 5-YEAR FUNDING PERIOD, INCLUDING COMPREHENSIVE COGNITIVE ASSESSMENTS AND SYNDROME ADJUDICATION AND PLASMA AND BRAIN IMAGING BIOMARKERS OF AD/ADRD. WE WILL ADDRESS THE COMPLEX OVERARCHING QUESTION OF OUR PROJECT THROUGH THE FOLLOWING AIMS: (1) TO ESTABLISH 5 CORES TO SUPPORT THE 4 INTEGRATED SCIENTIFIC PROJECTS: AN ADMINISTRATIVE CORE, A CLINICAL OPERATIONS AND PROCEDURES CORE, A COGNITIVE ASSESSMENT AND ADJUDICATION CORE, A NEUROIMAGING AND PLASMA BIOMARKERS CORE, AND A BIOSTATISTICS AND DATA INFRASTRUCTURE CORE: (2) TO CONDUCT 4 INTEGRATED PROJECTS FOCUSED ON KEY ASPECTS OF THE CENTRAL QUESTION OF THIS PROPOSAL: PROJECT 1 WILL EXAMINE THE ASSOCIATION OF COGNITIVE DECLINE, MCI, AND DEMENTIA IN THE DPPOS COHORT WITH BIOMARKERS OF NEUROPATHOLOGY AND BRAIN INSULIN SIGNALING, AND WITH SOCIODEMOGRAPHIC AND BEHAVIORAL FACTORS; PROJECT 2 WILL EXAMINE THE ASSOCIATIONS OF CUMULATIVE GLYCEMIA, RELATED METABOLIC FACTORS, AND MICROVASCULAR AND MACROVASCULAR COMPLICATIONS, WITH COGNITIVE SYNDROMES AND BIOMARKERS OF NEUROPATHOLOGY; PROJECT 3 WILL EXAMINE THE ASSOCIATION OF CUMULATIVE EXPOSURE TO METFORMIN AND OTHER T2D MEDICATIONS WITH COGNITIVE SYNDROMES AND BIOMARKERS OF NEUROPATHOLOGY; PROJECT 4 WILL EVALUATE THE ASSOCIATION OF TRAJECTORIES OF PHYSICAL ACTIVITY, PHYSICAL FUNCTION AND FRAILTY WITH COGNITIVE SYNDROMES AND BIOMARKERS OF NEUROPATHOLOGY.
National Science Foundation
$64.5M
SHIP OPERATIONS- R/V MARCUS G. LANGSETH
National Science Foundation
$61.1M
A PROPOSAL TO MANAGE THE U.S. SCIENCE SUPPORT PROGRAM OFFICE ASSOCIATED WITH THE INTERNATIONAL OCEAN DISCOVERY PROGRAM (USSSP-IODP)
Department of Health and Human Services
$56.4M
IMPLEMENTATION OF PROGRAMS FOR THE PREVENTION CARE AND TREATMENT OF HIV/AIDS IN
Department of Health and Human Services
$53.8M
GH11-11108: TECHNICAL ASSISTANCE TO THE MOH FOR HIV SVC (PEPFAR)
Department of Health and Human Services
$53.6M
A TOLERANCE APPROACH TO XENOTRANSPLANTATION
Department of Health and Human Services
$51.2M
INCREASE ACCESS TO COMPREHENSIVE HIV/AIDS PREVENTION, CARE AND TREATMENT SERVICES IN THE DEMOCRATIC REPUBLIC OF CONGO UNDER THE PRESIDENT'S EMERGENCY
Department of Health and Human Services
$49.3M
GH13-1368 GLOBAL TECHNICAL ASSISTANCE
Department of Health and Human Services
$48.2M
GLOBAL HIV/AIDS NURSING INITIATIVE
Department of Health and Human Services
$47.8M
BUILDING MOZAMBICAN CAPACITY TO IMPLEMENT QUALITY HIV/AIDS PREVENTION CARE AND
Department of Health and Human Services
$47.5M
TECHNICAL ASSISTANCE TO ETHIOPIA'S FEDERAL MINISTRY OF HEALTH AND REGIONAL HEALTH BUREAUS IN COMPREHENSIVE HIV/AIDS PROGRAMMING AND DIRECT SITE-LEVEL SUPPORT IN THE FOUR EMERGING REGIONS UNDER PEPFAR
Department of Health and Human Services
$46.8M
RAPID SCALE UP OF HIV/AIDS CARE AND TREATMENT SERVICES IN THE KINGDOM OF SWAZILAN
Department of Commerce
$45.2M
THE INTERNATIONAL RESEARCH INSTITUTE FOR CLIMATE PREDICTION: 2005-2010
National Science Foundation
$45M
US ATLAS OPERATIONS: EMPOWERING US UNIVERSITIES FOR DISCOVERIES AT THE ENERGY FRONTIER
Department of Health and Human Services
$44.9M
TECHNICAL ASSISTANCE FOR THE CONTINUED SUSTAINABLE PROVISION OF COMPREHENSIVE QUA
Department of Health and Human Services
$44.7M
COLUMBIA COLLABORATIVE HIV/AIDS CLINICAL TRIALS UNIT
National Science Foundation
$43.6M
U.S. ATLAS OPERATIONS PROGRAM: EMPOWERING UNIVERSITY PHYSICISTS TO MAKE DISCOVERIES AT THE ENERGY FRONTIER
Department of Health and Human Services
$40.1M
GH13-1310: TECHNICAL ASSISTANCE FOR THE TRANSITION OF COMPREHENSIVE HIV
Department of Health and Human Services
$39.9M
STRENGTHENING REGIONAL, NATIONAL, AND SUBNATIONAL INSTITUTIONAL CAPACITIES TO SUSTAINABLY COMBAT HIV/AIDS AND TUBERCULOSIS UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
Department of Health and Human Services
$37.8M
METFORMIN IN ALZHEIMER'S DEMENTIA PREVENTION (MAP)
Department of Health and Human Services
$37.2M
CLINICAL AND TRANSLATIONAL SCIENCE AWARD
Department of Health and Human Services
$36.3M
SEROTONIN AS A REGULATOR OF BONE MASS ACCRUAL: BASIC AND CLINICAL
Department of Health and Human Services
$35.5M
SUPPORT THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV CARE, PREVENTION AND
Department of Health and Human Services
$34.4M
INTERMEDIATE-SIZED EXPANDED ACCESS PROTOCOL FOR CNM-AU8 IN AMYOTROPHIC LATERAL SCLEROSIS (ALS). - ABSTRACT COLUMBIA UNIVERSITY, CLENE, AND SYNAPTICURE ARE PARTNERING AND TAKING AN INNOVATIVE APPROACH TO PROVIDE PERSONS LIVING WITH AMYOTROPHIC LATERAL SCLEROSIS ALS (PALS) ACROSS ALL 50 STATES— INCLUDING THOSE IN REMOTE/RURAL AREAS—ACCESS TO CNM-AU8®, A WELL-TOLERATED NEUROPROTECTIVE DRUG BEING INVESTIGATED FOR TREATMENT OF ALS. ALS IS A PROGRESSIVE NEURODEGENERATIVE DISEASE AFFECTING MOTOR NEURONS OF THE BRAIN AND SPINAL CORD. INVESTIGATIONS OF THE MECHANISM OF THIS DISEASE HAVE REVEALED THAT MOTOR NEURONS ARE ENERGETICALLY IMPAIRED IN ALS. SIGNS OF ENERGETIC IMPAIRMENT IN MOTOR NEURONS PRECEDE CLINICAL MANIFESTATIONS, AND ENERGETIC IMPAIRMENT IS KEY TO THE EVENTS AFFECTING MITOCHONDRIAL FUNCTION, GLUTAMATERGIC SIGNALING, CALCIUM HOMEOSTASIS, RNA PROCESSING/FUNCTION, AND PROTEOSTASIS, LEADING TO NEURONAL DEATH. CNM-AU8 IS AN ORALLY ADMINISTERED SUSPENSION OF BLOOD-BRAIN BARRIER PENETRANT, CATALYTICALLY ACTIVE GOLD NANOCRYSTALS SHOWN TO PROTECT NEURONS FROM DEATH BY RAISING INTRACELLULAR LEVELS OF ENERGY METABOLITES, NICOTINAMIDE ADENINE DINUCLEOTIDE, AND ADENOSINE TRIPHOSPHATE. PRECLINICAL STUDIES USING SEVERAL INDEPENDENT GENETIC OR CHEMICALLY INDUCED MODELS OF NEURODEGENERATIVE DISEASE HAVE DEMONSTRATED ROBUST NEUROPROTECTIVE PROPERTIES ACROSS MULTIPLE NEURONAL SUBTYPES. TWO PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTER TRIALS INVESTIGATED THE SAFETY AND EFFICACY OF CNM-AU8 IN ALS. OPEN LABEL EXTENSION (OLE) ASSOCIATED WITH EACH OF THESE TRIALS ARE ONGOING. WHILE BOTH TRIALS FAILED TO MEET PRIMARY AND SECONDARY OUTCOMES, RESULTS FROM BOTH STUDIES CONSISTENTLY DEMONSTRATED BENEFIT ON PRESPECIFIED EXPLORATORY ENDPOINTS OF DISEASE PROGRESSION AND SURVIVAL. CNM-AU8 ALSO CONSISTENTLY SHOWED FAVORABLE SAFETY AND TOLERABILITY PROFILE ACROSS ALL STUDIES, WITH NO SERIOUS ADVERSE EVENTS RELATED TO CNM-AU8 TO DATE. COLUMBIA, CLENE, AND SYNAPTICURE PROPOSE A MULTICENTER, INTERMEDIATE-SIZE EXPANDED ACCESS PROGRAM FOR THE CONTINUED INVESTIGATION OF CNM-AU8 IN 100 PALS. AN INNOVATIVE APPROACH WILL USE UP TO 10 EXPERIENCED ALS TRIAL CENTERS ACROSS THE COUNTRY THAT HAVE ESTABLISHED RELATIONSHIP WITH CLENE. IT WILL ALSO ENROLL VIA VIRTUAL CLINIC BY SYNAPTICURE TO ENABLE INCLUSION OF PATIENTS IN ALL 50 STATES. THE PRIMARY AIM OF THIS STUDY IS TO EVALUATE SAFETY IN A COHORT OF PALS THAT ARE NOT CLINICAL TRIAL ELIGIBLE. POTENTIAL EFFECTS ON SURVIVAL AND ON CLINICAL MEASURES OF DISEASE PROGRESSION WILL BE PRE-SPECIFIED AND ASSESSED USING MULTIPLE INDEPENDENT, VALIDATED STATISTICAL MODELS THAT ARE TRAINED ON LARGE CLINICAL TRIAL AND REAL-WORLD ALS DATASETS. BIOMARKERS OF DISEASE PROGRESSION, SUCH AS PLASMA NEUROFILAMENT LIGHT CHAIN (NFL), UCHL1, AND SERUM CREATININE LEVELS WILL BE ANALYZED TO ENHANCE AND CORROBORATE THE INTERPRETATION OF CLINICAL RESULTS.
Department of Health and Human Services
$34.2M
HEALTH EFFECTS AND GEOCHEMISTRY OF ARSENIC AND MANGANESE
Department of Health and Human Services
$32.3M
GH20-2024 ACHIEVING AND MAINTAINING EPIDEMIC CONTROL THROUGH COMPREHENSIVE HIV/AIDS PREVENTION, CARE AND TREATMENT SERVICES IN THE HAUT KATANGA REGION OF THE DEMOCRATIC REPUBLIC OF CONGO UNDER PEPFAR - AN EFFECTIVE NATIONAL HIV/AIDS RESPONSE DEPENDS UPON THE AVAILABILITY OF HIGH-QUALITY SERVICES ACROSS THE HIV SERVICE DELIVERY CASCADE. WHILE THE GOVERNMENT OF THE DEMOCRATIC REPUBLIC OF CONGO (GODRC) HAS MADE TREMENDOUS STRIDES TOWARD CONTROLLING THE HIV EPIDEMIC IN HAUT-KATANGA PROVINCE, STRATEGICALLY EXPANDING ACCESS TO COMPREHENSIVE HIV PREVENTION, TESTING, AND CARE AND TREATMENT (C&T) SERVICES TO THE POPULATIONS THAT MOST NEED THEM IS CRITICAL TO ENSURE THAT THE GODRC ACHIEVES UNAIDS 95-95-95 TARGETS.IN RESPONSE TO CDC-RFA-GH20-2024, ICAP AT COLUMBIA UNIVERSITY (ICAP) PROPOSES A COMPREHENSIVE APPROACH IN THE 11 TARGETED HEALTH ZONES (HZ) OF HAUT-KATANGA TO ACHIEVE THE GODRC?S PRIORITIES OF EXPANDING HIV PREVENTION AND TESTING SERVICES AMONG KEY AND PRIORITY POPULATIONS (KP AND PP) TO REACH THE FIRST 95; IMPROVING LINKAGES TO CARE AND RAPIDLY SCALING UP PROVISION OF ANTIRETROVIRAL TREATMENT TO ATTAIN THE SECOND 95; IMPROVING VIRAL LOAD TESTING AND EXPANDING COMPREHENSIVE HEALTH CARE AND SUPPORTIVE SERVICES TO ACHIEVE THE THIRD 95; AND, ACROSS THE 95-95-95 TARGETS, IMPROVING DATA QUALITY AND USE FOR POLICY AND PROGRAM DEVELOPMENT, IMPLEMENTING ACTIVITIES TAILORED TO REACH ORPHANS AND VULNERABLE CHILDREN, AND INTEGRATING SEXUAL AND GENDER-BASED VIOLENCE ACTIVITIES.ICAP HAS SUCCESSFULLY PARTNERED WITH THE MINISTRY OF HEALTH (MOH) IN HAUT-KATANGA AND KINSHASA PROVINCES IN NUMEROUS PROJECTS OVER THE LAST DECADE, INCLUDING EXPANDING INDEX TESTING AND PARTNER NOTIFICATION SERVICES (PNS) AND SUPPORTING C&T SCALE-UP IN 199 SITES. IN THE 11 TARGETED HZ OF HAUT-KATANGA, ICAP HAS PROVIDED TA TO STRENGTHEN TECHNICAL AND ADMINISTRATIVE CAPACITY WHILE WORKING HAND-IN-HAND WITH LOCAL PARTNERS TO DELIVER TARGETED SERVICES TO KP AND PP AND IMPLEMENT DIFFERENTIATED SERVICE DELIVERY MODELS (DSDM) ACROSS 114 HEALTH FACILITIES. MOST RECENTLY UNDER THE CDC/PEPFAR-FUNDED ?INCREASE ACCESS TO COMPREHENSIVE HIV/AIDS PREVENTION, CARE AND TREATMENT SERVICES IN T HE DRC UNDER PEPFAR? PROJECT, ICAP SUPPORTED HAUT-KATANGA?S HZ TEAMS TO SUCCESSFULLY PILOT DISTRIBUTION OF 164 SELF-TEST KITS AT FIVE KP FRIENDLY SITES, INTRODUCE SELF-TESTING IN PNS IN 19 HEALTH FACILITIES SERVING THE GENERAL POPULATION, AND DEVELOPED A QR CODE READER SYSTEM TO FACILITATE VIRAL LOAD DATA MANAGEMENT. ICAP WILL DRAW ON ITS GLOBAL EXPERIENCE AND TECHNICAL LEADERSHIP IN EXPANDING STRATEGIC INFORMATION CAPACITY, AND BUILD UPON THE STRONG FOUNDATION IT HAS ALREADY ESTABLISHED AS A GODRC PARTNER TO STRENGTHEN THE HIV CASCADE IN HAUT-KATANGA.OVER THE PROJECT?S FIVE-YEAR TIMEFRAME, WORKING ACROSS THE 11 TARGETED HZ, ICAP, ALONG WITH ITS RESPECTED LOCAL PARTNERS?WORLD PRODUCTION AND UNION CONGOLAISE DES ORGANISATIONS DES PVVIH (UCOP+)?WILL IMPROVE ACCESS TO HIGH QUALITY HIV-RELATED SERVICES FOR KP AND PP AND THEIR SEXUAL AND SOCIAL CONTACTS, AS WELL AS THE GENERAL POPULATION, THROUGH PATIENT-CENTERED, CLIENT-CUSTOMIZED SERVICES ACROSS THE HIV CLINICAL CASCADE. THE PROJECT WILL EXPAND INNOVATIVE DSDM TAILORED TO HAUT-KATANGA?S CONTEXT AND AFFECTED POPULATIONS?PARTICULARLY MOBILE AND HARD-TO-REACH GROUPS UNIQUE TO THE PROVINCE SUCH AS MINERS AND FISHERS?ADDRESSING MEDICAL, PSYCHOSOCIAL, AND LEGAL SUPPORT NEEDS. THE PROJECT WILL PROVIDE TA TO GODRC PARTNERS AT ALL LEVELS TO JOINTLY ENHANCE DATA COLLECTION, ANALYSIS, AND USE AND SUPPORT QUALITY IMPROVEMENT INITIATIVES TO CONTINUALLY ASSESS AND IMPROVE ITS APPROACH.THE ICAP-LED CONSORTIUM WILL UTILIZE ITS 33 YEARS OF COMBINED EXPERIENCE WORKING IN HAUT-KATANGA TO INFORM ITS APPROACH, WORKING TOGETHER WITH KEY STAKEHOLDERS AT THE NATIONAL, PROVINCIAL, AND HZ LEVELS TO DESIGN AND IMPLEMENT PROJECT ACTIVITIES TO ENABLE SUSTAINABILITY FROM THE START AND THROUGHOUT THE COURSE OF THE ICAP-LED TEAM?S FIVE-YEAR ENGAGEMENT.
Department of Health and Human Services
$32.2M
PUBLIC HEALTH SURVEILLANCE OF RECENT HIV INFECTION AND RESPONSE UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
Department of Energy
$32M
TAS::89 0227::TAS RECOVERY; RECOVERY ACT - RE-DEFINING PHOTOVOLTAIC EFFICIENCY THROUGH MOLECULE-SCALE CONTROL -- EFRC; PI - JAMES YARDLEY
Department of Health and Human Services
$31.4M
THE NATIONAL INSTITUTE ON AGING (NIA) LATE ONSET OF ALZHEIMER'S DISEASE (LOAD) FAMILY-BASED STUDY (FBS)
Department of Health and Human Services
$31.3M
CENTER FOR ENVIRONMENTAL HEALTH IN NORTHERN MANHATTAN
National Science Foundation
$31.2M
SHIP OPERATIONS AWARD 2008 - R/V MARCUS LANGSETH
Department of Health and Human Services
$31.2M
CENTER FOR RESEARCH IN DIAGNOSTICS AND DISCOVERY
Agency for International Development
$29.9M
MALARIA DIAGNOSIS AND TREATMENT ACTIVITY
Department of Health and Human Services
$29.6M
ALZHEIMER'S DISEASE RESEARCH CENTER AT COLUMBIA UNIV.
Department of Health and Human Services
$29.6M
GH13-1368, HQ, GLOBAL TECHNICAL ASSISTANCE
Department of Education
$29.4M
COLUMBIA UNIVERSITY CARE ACT APPLICATION
Department of Health and Human Services
$29.1M
MECHANISMS OF ATHEROGENESIS IN INSULIN RESISTANCE
Department of Health and Human Services
$28.8M
TECHNICAL ASSISTANCE TO NATIONAL HEALTH INFORMATION SYSTEMS AND HEALTH WORKFORCE DEVELOPMENT OF THEFEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
Department of Health and Human Services
$28.7M
DIABETES AND ENDOCRINOLOGY RESEARCH CENTER
Department of Health and Human Services
$28.5M
TISSUE COMPARTMENTALIZATION OF HUMAN LYMPHOCYTES
Department of Education
$28.4M
COLUMBIA UNIVERSITY HEERF II APPLICATION - INSTITUTIONAL PORTION
Department of Health and Human Services
$26.3M
NATION CENTER: MULTI-SCALE STUDY- CELLULAR NETWORKS(RMI)
Department of Health and Human Services
$26.3M
BIOMARKERS OF ALZHEIMER'S DISEASE IN ADULTS WITH DOWN SYNDROME
Department of Health and Human Services
$26M
GH13-1310 (ETHIOPIA): TECHNICAL ASSISTANCE FOR THE TRANSITION OF COMPREHENSIVE HIV
Department of Health and Human Services
$25.6M
MECHANISMS OF ESOPHAGEAL CARCINOGENESIS
National Science Foundation
$25.5M
GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP)
Department of Health and Human Services
$25.5M
TECHNICAL ASSISTANCE IN SUPPORT OF HIV PREVENTION CARE AND TREATMENT PROGRAMS AN
National Science Foundation
$25.5M
NSF ENGINEERING RESEARCH CENTER FOR SMART STREETSCAPES (CS3) -MORE THAN 80% OF AMERICANS AND OVER HALF THE WORLD?S POPULATION LIVE IN URBAN AREAS. HIGH-DENSITY CITIES ARE TRANSFORMING HOW PEOPLE LIVE, WORK, TRAVEL, AND MANAGE URBAN INFRASTRUCTURE. WITH THE NATION?S URBAN AREAS FACING EMERGING CHALLENGES THREATENING LIVABILITY, SAFETY, AND INCLUSION, IT IS THE STREETSCAPE ?NEIGHBORHOOD STREETS, SIDEWALKS, AND PUBLIC SPACES? THAT MARKS THE NEXUS OF PUBLIC AND COMMERCIAL ACTIVITIES, WHERE RICH, SPATIALLY AND TEMPORARILY DENSE DATA CAN BE HARNESSED FOR THE PUBLIC GOOD. THE NSF ENGINEERING RESEARCH CENTER FOR SMART STREETSCAPES (CS3), LED BY COLUMBIA UNIVERSITY, TOGETHER WITH FLORIDA ATLANTIC UNIVERSITY, RUTGERS UNIVERSITY, UNIVERSITY OF CENTRAL FLORIDA, AND LEHMAN COLLEGE, WILL DEVELOP A RICH ECOSYSTEM OF STREETSCAPE APPLICATIONS BUILT UPON REAL-TIME, HYPER-LOCAL INTELLIGENCE TO ADVANCE LIVABLE, SAFE, AND INCLUSIVE COMMUNITIES. CS3 WILL ADOPT A FUNDAMENTALLY NEW APPROACH TO ENGINEERING RESEARCH, LEVERAGING A DIVERSE COHORT OF NON-ACADEMIC STAKEHOLDERS ?INDUSTRY PARTNERS, COMMUNITY ORGANIZATIONS, MUNICIPALITIES, AND K-12 SCHOOLS? AS COLLABORATIVE CO-PRODUCERS OF KNOWLEDGE AND AUDITORS OF TECHNOLOGY RESEARCH AND DEVELOPMENT, BUILT ON A CULTURE OF INCLUSION THAT BRIDGES THE ?DIGITAL DIVIDE? THAT STARKLY DEMARCATES STAKEHOLDERSHIP. WITH AN EXTENSIVE NETWORK OF PARTNERS, CS3 WILL EXPLORE FIVE APPLICATION THEMES: ROAD SAFETY AND TRAFFIC EFFICIENCY, PUBLIC SAFETY, ASSISTIVE TECHNOLOGIES FOR PEOPLE WITH DISABILITIES, THE FUTURE OF OUTDOOR WORK, AND HYPER-LOCAL SENSING AND MODELING. CS3?S ENGINEERING PROCESS WILL BEGIN WITH THE STUDY OF COMMUNITY-SPECIFIC APPLICATION REQUIREMENTS, CONSTRAINTS, AND SENSITIVITIES. THE RESULTING COMMUNITY-INSPIRED APPLICATIONS WILL BE PILOTED WITHIN THREE DISTINCT URBAN TESTBEDS ?IN NEW YORK CITY (NY), WEST PALM BEACH (FL), AND NEW BRUNSWICK (NJ)? LEVERAGING PRIOR FEDERAL AND MUNICIPAL INVESTMENTS. OUTCOMES FROM THESE PILOTS WILL CATALYZE A NOVEL INNOVATION ECOSYSTEM, DRAWING UPON CS3?S BROAD NETWORK OF ASPIRING ENTREPRENEURS, EMERGING START-UPS, AND ESTABLISHED COMPANIES. REALIZING AND SUSTAINING THIS VISION REQUIRES A NEXT-GENERATION WORKFORCE THAT CROSS-CUTS ENGINEERING, DATA SCIENCE, SOCIAL SCIENCE, AND POLICY; CS3 WILL LEVERAGE SHARED, DAY-TO-DAY STREETSCAPE EXPERIENCES TO ATTRACT STUDENTS FROM DIVERSE DISCIPLINES AND BACKGROUNDS TO ENGAGE IN THE EMERGING DISCIPLINE OF SMART CITIES. BUILT ON THE FOUR CLOSELY INTEGRATED FOUNDATIONAL ELEMENTS OF NSF?S ERC PROGRAM ?RESEARCH, ENGINEERING WORKFORCE DEVELOPMENT, DIVERSITY AND CULTURE OF INCLUSION, AND INNOVATION ECOSYSTEM? CS3?S WORK HAS THE POTENTIAL TO REDEFINE AMERICA?S STREETSCAPES BY APPLYING A DIGITAL LAYER OVER PHYSICAL URBAN INFRASTRUCTURE, ENSURING THAT AMERICA?S CITIES MEET THE NEEDS OF LOCAL COMMUNITIES AND THAT THE TECHNOLOGIES BEING ADOPTED TAKE INTO ACCOUNT CRITICAL QUESTIONS REGARDING SAFETY, EQUITY, PRIVACY, AND SECURITY. THE NSF ENGINEERING RESEARCH CENTER FOR SMART STREETSCAPES (CS3) WILL ADVANCE LIVABLE, SAFE, AND INCLUSIVE COMMUNITIES THROUGH REAL-TIME, HYPER-LOCAL STREETSCAPE APPLICATIONS BUILT ON ADVANCEMENTS IN EDGE-CLOUD TECHNOLOGY, WIRELESS-OPTICAL ENGINEERING, VISUAL ANALYTICS, COMPUTER SECURITY, AND SOCIAL SCIENCE. CS3 WILL UNITE DIVERSE RESEARCH COMMUNITIES THROUGH A CONVERGENT RESEARCH MODEL THAT DELIVERS INNOVATIONS ACROSS FIVE ENGINEERING AND SCIENTIFIC AREAS: (1) WI-EDGE ? THE INTEGRATION OF HIGH-SPEED WIRELESS-OPTICAL NETWORKING, HIGH-PERFORMANCE EDGE-CLOUD COMPUTING, AND SOFTWARE-DEFINED RADIOS AND NETWORKING; (2) SITUATIONAL AWARENESS ? FINE-SCALE, REAL-TIME OBSERVATION, MODELING, AND FORECASTING OF HUMAN BEHAVIOR OVER VARIABLE TIME HORIZONS AT STREETSCAPE SCALES; (3) SECURITY, PRIVACY & FAIRNESS ? ADDRESSING SOCIO-TECHNICAL BARRIERS OF PRIVACY AND SECURITY WITHIN LOCALLY INTELLIGENT STREETSCAPES, YIELDING A SOFTWARE PIPELINE FOR STREETSCAPE APPLICATIONS THAT GIVES COMMUNITY-CONFIGURABLE GUARANTEES OF PRIVACY, FAIRNESS, AND TRANSPARENCY; (4) PUBLIC INTEREST TECHNOLOGY ? UNDERSTANDING HOW CS3 TECHNOLOGIES, APPLICATIONS, AND SECURITY/PRIVACY POLICIES IMPACT THE SOCIAL LANDSCAPE AND PROMOTE REGIONAL ECONOMIC DEVELOPMENT; AND (5) STREETSCAPE APPLICATIONS ? INCORPORATING THE DISTINCT WAYS IN WHICH INDIVIDUAL COMMUNITIES READ, INTERPRET, AND RESPOND TO LOCAL INTELLIGENCE WITHIN THE DESIGN PROCESS IN ORDER TO OPTIMIZE COMMUNITY-SPECIFIC BENEFITS. CS3 WILL ADVANCE FUNDAMENTAL KNOWLEDGE IN CIVIL AND URBAN SYSTEMS ENGINEERING, ELECTRICAL AND NETWORK ENGINEERING, VISUAL ANALYTICS AND SENSOR FUSION, COMPUTER PRIVACY AND SECURITY, AND PUBLIC TRUST AND TECHNOLOGY ? CATALYZING AND COALESCING THE EMERGING DISCIPLINE OF SMART CITIES. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Department of Health and Human Services
$25.4M
ALZHEIMER'S DISEASE RESEARCH CENTER
Department of Health and Human Services
$25.2M
IMPLEMENTATION OF PROGRAMS FOR THE PREVENTION, CARE AND TREATMENT OF HIV/AIDS IN THE REPUBLIC OF COTE D'IVOIRE UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
Department of Health and Human Services
$24.8M
STRENGTHENING EPIDEMIOLOGY AND STRATEGIC INFORMATION IN THE REPUBLIC OF ZIMBABWE UNDER THE PRESIDEN
Department of Health and Human Services
$24.8M
CLINICAL AND TRANSLATIONAL SCIENCE AWARD
National Science Foundation
$24.5M
STC: CENTER FOR LEARNING THE EARTH WITH ARTIFICIAL INTELLIGENCE AND PHYSICS (LEAP)
National Science Foundation
$24.5M
OCEANOGRAPHIC TECHNICAL SERVICES, LDEO, 2018-2022
Department of Health and Human Services
$24M
ENHANCING GLOBAL HEALTH SECURITY: STRENGTHENING PUBLIC HEALTH SURVEILLANCE SYSTEMS AND PREPAREDNESS GLOBALLY
Department of Health and Human Services
$24M
HUMAN ANTI-VIRAL IMMUNE RESPONSES IN TISSUES AND CIRCULATION
Department of Health and Human Services
$23.9M
CENTER TO IMPROVE CHRONIC DISEASE OUTCOMES THROUGH MULTI-LEVEL AND MULTI-GENERATIONAL APPROACHES UNIFYING NOVEL INTERVENTIONS AND TRAINING FOR HEALTH EQUITY (THE COMMUNITY CENTER) - ABSTRACT: DESPITE MEDICAL ADVANCES IN TREATING CHRONIC DISEASES AND EPIDEMIOLOGICAL FINDINGS IDENTIFYING RISK FACTORS FOR CHRONIC DISEASES, THERE REMAIN MAJOR PERSISTENT HEALTH DISPARITIES DRIVEN BY THE SOCIAL DETERMINANTS OF HEALTH (SDOH). WE HAVE COME TOGETHER TO ADDRESS THESE DISPARITIES THROUGH THE CENTER TO IMPROVE CHRONIC DISEASE OUTCOMES THROUGH MULTI-LEVEL AND MULTI-GENERATIONAL APPROACHES UNIFYING NOVEL INTERVENTIONS AND TRAINING FOR HEALTH EQUITY (COMMUNITY CENTER). OUR VISION IS ROOTED IN PUBLIC HEALTH WHICH RECOGNIZES THAT MEDICAL ADVANCES ALONE CAN ONLY PARTIALLY REDUCE THE BURDEN OF DISEASE AND THAT REDUCING HEALTH DISPARITIES IN CHRONIC DISEASES REQUIRES IMPROVING THE HEALTH AND WELLNESS OF INDIVIDUALS, FAMILIES, COMMUNITIES AND SOCIETIES THROUGHOUT LIFE. WE SEEK TO REALIZE THIS VISION WITHIN THE COMMUNITIES WE SERVE THAT ARE AMONG THE MOST HIGHLY DIVERSE IN THE U.S. WITH APPROXIMATELY 2/3 NON-WHITE, 1/3 FOREIGN-BORN, AND 1/5 LIVING BELOW THE FEDERAL POVERTY LINE. THE MISSION OF THE COMMUNITY CENTER IS TO REDUCE HEALTH DISPARITIES IN CHRONIC DISEASES IN THE NEW YORK CITY REGION THROUGH RIGOROUS TESTING, DISSEMINATING AND SUSTAINING OF INTERVENTIONS THAT INCORPORATE THE MULTIPLE LEVELS OF INFLUENCE FROM INDIVIDUAL, INTERPERSONAL, COMMUNITY AND SOCIETAL APPROACHES. WE HAVE DESIGNED THREE SYNERGISTIC PROJECTS THAT ADDRESS CHRONIC CONDITIONS IDENTIFIED BY AND RESPONSIVE TO THE VOICE AND CONCERNS OF THE COMMUNITIES WE SERVE AND EACH INVOLVE NOVEL INTERVENTIONS EMPLOYING THE COMMUNITY HEALTH WORKER (CHW) MODEL FOR ENROLLMENT AND/OR RETENTION INTO THE STUDIES WHILE ALSO CONNECTING PARTICIPANTS TO SERVICES BASED ON FIVE DOMAINS OF SDOH (HOUSING INSTABILITY, FOOD INSECURITY, TRANSPORTATION PROBLEMS, UTILITY HELP NEEDS AND INSURANCE ENROLLMENT). THE THREE PROJECTS ARE 1) COMMUNITY HEALTH WORKERS UNITED TO REDUCE COLORECTAL CANCER AND CVD AMONG PEOPLE AT HIGHER RISK (CHURCH); 2) ADDRESSING SLEEP DURATION, REGULARITY, AND EFFICIENCY: A MULTIDIMENSIONAL SLEEP HEALTH INTERVENTION FOR REDUCING DISPARITIES IN CARDIOMETABOLIC DISEASE (DREAM); AND 3) INTERVENTION TO IMPROVE ADHERENCE EQUITABLY (IMPACT TRIAL). IN ADDITION TO THE THREE RESEARCH PROJECTS, THE CENTER SUPPORTS HEALTH EQUITY SCHOLARS AND PILOTS FUNDED THROUGH THE INVESTIGATOR DEVELOPMENT CORE (IDC) AND COMMUNITY PROJECTS FUNDED THROUGH THE COMMUNITY CORE (KNOWN AS THE CONNECTOME). THE ADMINISTRATIVE CORE (ADMIN) WHICH INCLUDES FACULTY WITH EXPERTISE IN BIOSTATISTICS, IMPLEMENTATION SCIENCE, AND DATA HARMONIZATION AND BIOMEDICAL INFORMATICS. THE COMMUNITY CENTER INVOLVES STRONG COLLABORATIONS BETWEEN RESEARCHERS, COMMUNITY ORGANIZATIONS, CLINICIANS AND HEALTHCARE SYSTEMS, PUBLIC HEALTH AGENCIES AND OTHER STAKEHOLDERS AND PARTNERS COLUMBIA UNIVERSITY IRVING MEDICAL CENTER (CUIMC) AND WEILL CORNELL MEDICAL CENTER (WCM) JOINED THROUGH THE GREATER NEW YORK PRESBYTERIAN (NYP) HOSPITAL SYSTEM WITH CITY UNIVERSITY OF NEW YORK (CUNY) AND THE PHYSICIAN AFFILIATE GROUP OF NEW YORK (PAGNY). THE UNIQUE COLLABORATIVE IS POISED TO CREATE SUSTAINABLE PUBLIC HEALTH SOLUTIONS THAT WILL RESULT IN SYSTEM-LEVEL CHANGES THAT PROMOTE HEALTH EQUITY.
Department of Health and Human Services
$23.1M
ROLES AND REGULATION OF P53
Department of Health and Human Services
$22.9M
NEW YORK OBESITY RESEARCH CENTER
Department of Health and Human Services
$22M
REGIONAL PARTNERSHIPS TO STRENGTHEN NATIONAL DATA CAPACITIES FOR HIV, TB, AND OTHER PANDEMIC PREPAREDNESS AND RESPONSE UNDER PEPFAR - TO ACHIEVE AND SUSTAIN UNIVERSAL HIV EPIDEMIC CONTROL, TIMELY COLLECTION AND USE OF ACCURATE, QUALITY DATA ARE CRITICAL TO STRENGTHEN TESTING, PREVENTION AND TREATMENT CASCADES TO REDUCE NEW INFECTIONS AND DEATHS, ACHIEVE HEALTH EQUITY FOR PRIORITY AND KEY POPULATIONS, RESPOND TO PUBLIC HEALTH (PH) PRIORITIES, AND EMPOWER GOVERNMENTS TO LEAD THROUGH EVIDENCE-BASED DECISION-MAKING. ROBUST HIV DATA PLATFORMS, IF LEVERAGED FULLY, CAN ENHANCE HEALTH DATA COLLECTION, MANAGEMENT, AND ANALYSIS CAPABILITIES, INCREASE HEALTH SYSTEM RESILIENCE, AND SUPPORT MONITORING OF EMERGING PH THREATS. WITH EXPERIENCE IN OVER 40 PEPFAR-SUPPORTED COUNTRIES, INCLUDING ALL COUNTRIES IDENTIFIED IN THIS NOFO, AND A ROBUST PORTFOLIO OF STRATEGIC INFORMATION (SI) ACTIVITIES, SURVEILLANCE, SURVEYS, HIV AND PH PROGRAM SUPPORT, MULTI-COUNTRY EXPERIENCE AND GLOBAL PRESENCE, ICAP AT COLUMBIA UNIVERSITY (ICAP) AND ITS PARTNERS WILL ADVANCE THE COLLECTION, PROCESSING, AND USE OF SURVEILLANCE, SURVEY, AND PROGRAM DATA TO INFORM LOCAL AND NATIONAL RESPONSES TO HIV, TB, AND OTHER PH PRIORITIES AND CONTRIBUTE TO PANDEMIC PREPAREDNESS AND HEALTH SECURITY IN PEPFAR-SUPPORTED COUNTRIES THROUGH THE MOST APPROPRIATE COMBINATION OF CAPACITY STRENGTHENING (CS), TECHNICAL ASSISTANCE (TA), AND/OR DIRECT IMPLEMENTATION SUPPORT. THE EXPECTED LONG-TERM OUTCOMES ARE 1)SUSTAINED CAPACITY AND COUNTRY OWNERSHIP OF SI, SURVEILLANCE AND SURVEY ACTIVITIES; INCREASED INTEGRATION AND TRIANGULATION OF SURVEILLANCE AND NON-HIV REPORTABLE DISEASE/CONDITIONS SURVEILLANCE; 3) IMPROVED EQUITY IN SERVICE PROVISION; 4) SUSTAINED NATIONAL AND LOCAL M&E AND SI CAPACITY; 4) INCREASED USE OF REAL- TIME PREDICTIONS BASED ON INTEGRATED STATISTICAL AND ML MODELS; AND 5) SUSTAINED COUNTRY- OWNED AND MANAGED PROCESSES FOR DATA VISUALIZATION, ANALYSIS, AND USE TO GUIDE PH PROGRAMS. ICAP WILL COLLABORATE WITH DIVERSE STAKEHOLDERS (E.G., GOVERNMENT ENTITIES, CIVIL SOCIETY ORGANIZATIONS, CDC, PEPFAR IMPLEMENTING PARTNERS, AND OTHERS) TO PLAN, IMPLEMENT, SUPPORT, AND COORDINATE ACTIVITIES AND ENSURE A DELIBERATE, MILESTONE-DRIVEN APPROACH TO STRENGTHEN NATIONAL AND REGIONAL DATA CAPACITIES AND CAPABILITIES UNDER LOCAL LEADERSHIP AND ADVANCE DATA FOR DECISION-MAKING FOR CURRENT AND EMERGING PH PRIORITIES. ICAP TA AND CS AIMS TO ENSURE LOCAL INSTITUTIONAL FULL OWNERSHIP AND DIRECT MANAGEMENT, RESULTING IN THE GREATEST IMPACT AND SUSTAINED GAINS. ICAP’S CAPABILITY MATURITY MODEL (CMM) WILL BE COLLABORATIVELY TAILORED TO THE SCOPE OF EACH PROJECT WITH MINISTRIES OF HEALTH (MOH), NATIONAL PH INSTITUTES (NPHI), CDC, AND OTHER STAKEHOLDERS, AND USED TO PROVIDE METRICS TO 1) ASSESS BASELINE CAPABILITIES AND THEIR PROGRESSION OVER TIME; AND 2) GUIDE TYPE AND DOSAGE OF TA AND CS. EACH CMM WILL DEFINE CORE FUNCTIONAL DOMAINS IN WHICH CAPABILITY IS REQUIRED FOR A SPECIFIC PROJECT (E.G. PLAN, DESIGN, IMPLEMENT HOUSEHOLD SURVEYS), AS WELL AS A MEASURABLE INDICATOR FOR EACH STEPWISE STAGE OF ORGANIZATIONAL MATURITY IN EACH DOMAIN. COLLABORATIVE CMM ASSESSMENTS AT PROJECT INCEPTION AND AT LEAST ANNUALLY THEREAFTER, WILL GUIDE DEVELOPMENT AND UPDATING OF ORGANIZATION-TAILORED CS PLANS TO MEET THE GOALS AND OBJECTIVES OF THIS NOFO IN A SUCCESSFUL AND SUSTAINABLE WAY. ICAP WILL BLEND APPROPRIATE TA AND CS MODALITIES TO MEASURABLY STRENGTHEN SYSTEM-WIDE, INSTITUTIONAL, AND INDIVIDUAL CAPACITY IN RELEVANT DOMAINS. FOR EXAMPLE, COMPETENCY-BASED BLENDED LEARNING EDUCATION PLATFORMS, MAY BE PAIRED WITH ON-THE-JOB TRAINING, CASE-BASED LEARNING, MENTORSHIP, CASCADED TRAINING, AND SUPPORTIVE SUPERVISION INTEGRATED INTO EXISTING PROGRAMS, SERVICES, AND WORKFLOWS. ICAP WILL ALSO SUPPORT PEER LEARNING (E.G., FOR NPHI STAFF WITHIN AND ACROSS COUNTRIES), AS WELL AS TOPIC-FOCUSED COMMUNITIES OF PRACTICE AND CURATED SOUTH-SOUTH EXCHANGES TO SHARE BEST PRACTICES AND INNOVATIONS FOR THE STRATEGIES IN THIS PROPOSAL.
Department of Health and Human Services
$21.9M
DIABETES STATUS AND BRAIN AMYLOID IN MIDDLE AGED HISPANICS
National Science Foundation
$21.7M
GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP)
Department of Health and Human Services
$21.6M
TECHNICAL ASSISTANCE TO STRENGTHEN HEALTH INFORMATION SYSTEM CAPACITY IN ETHIOPIA UNDER PEPFAR - ROBUST, INTEGRATED HEALTH INFORMATION SYSTEMS (HIS) ARE CRITICAL FOR EVIDENCE-BASED DECISIONS AT THE POLICY, PROGRAM, AND INDIVIDUAL LEVELS. ICAP IS UNIQUELY POSITIONED TO SUPPORT THE MINISTRY OF HEALTH (MOH) TO BUILD ON ETHIOPIA’S PROGRESS WITH DIGITAL HEALTH, MAINTAIN, UPGRADE, AND ALIGN EXISTING SYSTEMS WITH INTERNATIONAL STANDARDS AND MOH AND PEPFAR REQUIREMENTS; BUILD LOCAL CAPACITY TO DEFINE, DEVELOP, MAINTAIN, USE, AND EVALUATE EFFICIENT, HIGH-QUALITY, SECURE, SUSTAINABLE, AND INTEROPERABLE HIS; AND IMPLEMENT DIGITAL HEALTH SOLUTIONS NEEDED TO SUPPORT CASE-BASED SURVEILLANCE (CBS) AND TRACK PROGRESS TOWARDS 95-95-95 TARGETS. THE PURPOSE OF THIS PROJECT IS TO MAINTAIN THE CONTINUITY OF CDC/PEPFAR-SUPPORTED HIS AND ENHANCE EXISTING SYSTEMS WITH GLOBALLY AND NATIONALLY RECOMMENDED WEB-BASED SOLUTIONS TO MEET PROGRAMMATIC NEEDS. ICAP WILL DRAW ON ITS EXPERTISE AND EXPERIENCE IN THE AREAS OF DIGITAL HEALTH, HIS, AND SURVEILLANCE IN ETHIOPIA AND GLOBALLY TO SUPPORT DIGITAL HEALTH SOLUTIONS AND HIGH-QUALITY INDIVIDUAL-LEVEL STRATEGIC INFORMATION (SI) TO TRACK PROGRESS TOWARDS 95-95-95 TARGETS IN ALIGNMENT WITH NATIONAL STRATEGIES AND STANDARDS. ICAP WILL ALSO ADVANCE SUSTAINABILITY STRATEGIES AND APPROACHES TO MAINTAIN PROGRESS BEYOND CDC/PEPFAR FUNDING. STRATEGIES INCLUDE PROVIDING TECHNICAL ASSISTANCE (TA) TO STRENGTHEN THE NATIONAL DIGITAL HEALTH SYSTEM, EHEALTH ARCHITECTURE, AND REALIZE THE NATIONAL INFORMATION REVOLUTION ROADMAP; SUPPORT MOH TO IMPLEMENT PERSON-CENTERED INFORMATION SYSTEMS FOR CLINICAL AND LABORATORY SERVICES WITH DATA EXCHANGE AMONG DISPARATE SYSTEMS TO MEET HIV PROGRAM DATA NEEDS AND ENHANCE INFORMATION USE AT ALL LEVELS; BUILD AND MAINTAIN HIV CBS AND OTHER SURVEILLANCE AND SURVEY SYSTEMS; STRENGTHEN DATA ANALYSIS AND USE AT NATIONAL, REGIONAL, ZONAL, WOREDA, AND HEALTH FACILITY (HF) LEVELS TO INFORM PROGRAMMATIC DIRECTION AND ACHIEVE AND SUSTAIN HIV EPIDEMIC CONTROL; AND BUILD CAPACITY AT ALL LEVELS TO SUPPORT THE IMPLEMENTATION OF SUSTAINABLE HIS, HIV CBS, AND DATA USE INTERVENTIONS. EXPECTED SHORT-TERM OUTCOMES INCLUDE IMPROVED FUNCTIONALITY OF SYSTEMS AND ENHANCED DATA EXCHANGE AMONG THE SYSTEMS; IMPROVED AVAILABILITY OF QUALITY PATIENT-LEVEL AND SURVEILLANCE DATA IN A USEFUL FORMAT AT NATIONAL, REGIONAL, AND ZONAL, WOREDA, AND HF LEVELS; INCREASED ACCESS AND AVAILABILITY OF INDIVIDUAL-LEVEL DATA FROM HIS; AND IMPROVED COMPETENCY OF MOH AND REGIONAL HEALTH BUREAU (RHB) TEAMS TO MANAGE HIS AT NATIONAL AND SUB-NATIONAL LEVELS. INTERMEDIATE OUTCOMES WILL INCLUDE INCREASED DEPLOYMENT AND USE OF PATIENT-LEVEL, LABORATORY AND SURVEILLANCE SYSTEMS; IMPROVED COVERAGE OF PATIENT-LEVEL DATA ACROSS RHB THROUGH LINKED SYSTEMS WITH STORAGE OF DE-DUPLICATED HIV CBS DATA CENTRALLY; INCREASED USE OF HIV DATA AND REPORTS FOR DECISION-MAKING WITH BETTER ALIGNMENT TO AGGREGATE REPORTING AT NATIONAL, REGIONAL, ZONAL, WOREDA, AND SITE LEVELS; AND IMPROVED QUALITY OF HEALTH CARE AND PATIENT OUTCOMES VIA HIS SUPPORT. LONG-TERM OUTCOMES INCLUDE IMPROVED TECHNICAL EXPERTISE AND RESOURCE ALLOCATION BY MOH AND RHB IN MAINTAINING THE HIS INTERVENTIONS.
Department of Health and Human Services
$21.5M
TECHNICAL ASSISTANCE TO THE PROVINCIAL HEALTH OFFICES IN ZAMBIA TO SUPPORT OPTIMIZED HIV CASE FINDING, TREATMENT, VIRAL SUPPRESSION, RETENTION AND HIV EPIDEMIC CONTROL UNDER PEPFAR
Department of Health and Human Services
$20.7M
ATRIAL CARDIOPATHY AND ANTITHROMBOTIC DRUGS IN PREVENTION AFTER CRYPTOGENICSTROKE (ARCADIA)
Department of Health and Human Services
$20.7M
GH15-1583, SWAZILAND: STRENGTHENING LOCAL CAPACITY TO DELIVER SUSTAINABLE QUALITY-ASSURED UNIVERSAL COVERAGE OF CLINICAL HIV/TB SERVICES
Department of Health and Human Services
$20.7M
IMPLEMENTATION OF PROGRAM FOR THE PREVENTION, CARE AND TREATMENT OF HIV/AIDS
Department of Health and Human Services
$20.6M
AIDS EDUCATION AND TRAINING CENTERS PROGRAM
National Science Foundation
$20.5M
OCEANOGRAPHIC TECHNICAL SERVICES, R/V MARCUS G. LANGSETH, 2012 ? 2016
Department of Health and Human Services
$19.1M
DEFINING THE EFFECT OF ALZHEIMER PATHOLOGIES ON THE AGED BRAIN IN 3 DIMENSIONS - THIS PROPOSAL, TO CREATE THE 3D AGING & ALZHEIMER BRAIN PROGRAM, ADDRESSES SEVERAL CRITICAL GAPS IN ONGOING EFFORTS TO BRIDGE THE DIVIDE BETWEEN KNOWN RISK FACTORS FOR ALZHEIMER’S DISEASE (AD) AND THE SYNDROMIC MANIFESTATIONS OF THE DISEASE. THE SIGNIFICANT GAPS ARE IN: I) HOW THE NEUROBIOLOGY OF AGING-RELATED COGNITIVE DECLINE MAY PROVIDE INSIGHTS INTO ENHANCING RESILIENCE; II) UNDERSTANDING THE MOLECULAR MECHANISMS OF AD SUSCEPTIBILITY LOCI AND DIVERSIFICATION OF AD TARGET GENES AND HOW THESE GENES CAUSE A CELLULAR EFFECT; AND III) KEY TOPOLOGICAL AND MORPHOMETRIC INFORMATION WHEN USING CURRENT SEQUENCING APPROACHES ON CORTICAL TISSUE TO IMPLICATE CELLULAR SUBTYPES CONTRIBUTING TO DISEASE. TO ADDRESS THESE GAPS, WE PROPOSE A COMPREHENSIVE PROGRAM TO SYSTEMATICALLY GENERATE AND ANALYZE MULTIPLE INTERCONNECTED REFERENCE DATA SETS, THAT INCLUDES DIVERSE INDIVIDUALS, TO (A) CHARACTERIZE THE INDIVIDUAL AND SYNERGISTIC EFFECTS THAT AD PROTEINOPATHIES, CEREBRAL AMYLOID ANGIOPATHY (CAA), AND AGING ITSELF HAVE ON THE MOLECULAR AND CELLULAR ARCHITECTURE OF THE OLDER NEOCORTEX AND (B) IDENTIFY THOSE ASPECTS THAT CONTRIBUTE TO COGNITIVE DECLINE, THE CLINICALLY MEANINGFUL OUTCOME OF AD. TO THIS END, OUR PROGRAM TARGETS THREE BRAIN REGIONS TO CAPTURE THE EFFECTS OF A RANGE OF DIFFERENT NEUROPATHOLOGIES. WE WILL ESTABLISH THREE LARGE-VOLUME MOLECULAR ATLASES OF: 1) THE AGING BRAIN BY SAMPLING THE ENTIRE LIFESPAN IN INDIVIDUALS WITH MINIMAL NEUROPATHOLOGIC BURDEN TO INVESTIGATE THE EFFECT OF AGING ITSELF IN THE BRAIN; 2) THE IMPACT OF AMYLOID AND TAU PROTEINOPATHIES, INCLUDING SPECIFIC REPRESENTATIVE CASES TO CAPTURE THE INDEPENDENT AND SYNERGISTIC EFFECTS OF SS-AMYLOID AND TAU ALONE AND IN COMBINATION WITH A-SYNUCLEIN AND TDP-43 PROTEINOPATHIES; AND 3) THE IMPACT OF CAA TO YIELD NEW INSIGHTS INTO A VERY DIFFERENT ASPECT OF AMYLOID PROTEINOPATHY AND ITS IMPACT ON THE NEUROVASCULAR UNIT. WE WILL THEN ESTABLISH A REFERENCE DATASET OF MOLECULAR DATA IN 300 DIVERSE INDIVIDUALS TO ENABLE THE ASSESSMENT OF SPATIAL MOLECULAR FEATURES IN RELATION TO PATHOLOGICAL AND COGNITIVE OUTCOMES. IN PARALLEL TO THE DEVELOPMENT OF THESE ATLASES AND REFERENCE DATASETS, WE WILL OPTIMIZE EXPERIMENTAL PROTOCOLS FOR SPATIAL TRANSCRIPTOMICS AND ITERATIVE INDIRECT IMMUNOFLUORESCENCE IMAGING (4I) TO FACILITATE LARGE-SCALE PROJECTS AND ENABLE ENHANCED DATA GENERATION OVER EXISTING, BASELINE CAPABILITIES. WE WILL DISTRIBUTE ALL PROTOCOLS AND DATA THROUGH THE NIA-FUNDED AD KNOWLEDGE PORTAL, WHICH ALREADY HOSTS MULTIOMIC DATA FROM THE SAME COHORTS AND PARTICIPANTS, TO ACCELERATE REPURPOSING OF THE DATA. FINALLY, WE WILL CREATE MAAP-BRAIN, A 3-D INTERACTIVE DATA VISUALIZER, SO THAT ALL INVESTIGATORS AND PARTICULARLY NON-COMPUTATIONAL SCIENTISTS, CAN INTERACT WITH OUR DATA AND RESULTS. THE PROGRAM TEAM BRINGS TOGETHER A HIGHLY COMPLEMENTARY CAST OF TALENTED JUNIOR AND SENIOR SCIENTISTS, AND IT RESTS ON A FOUNDATION OF MULTIPLE INTERSECTING LONG-TERM COLLABORATIVE RESEARCH PROGRAMS THAT POSITION IT WELL TO ACHIEVE ALL ITS DELIVERABLES TOWARDS ADVANCING OUR UNDERSTANDING OF THE COMPLEX CLINICO-SPATIAL-MOLECULAR FEATURES THAT CONTRIBUTE TO AGING AND AD, WHICH WILL PROVIDE NEEDED RESOURCES TO THE BROADER SCIENTIFIC COMMUNITY.
National Science Foundation
$18.7M
COLUMBIA UNIVERSITY/ R/V MARCUS G. LANGSETH SHIP OPERATIONS - CY2024-2029 -LANGSETH PROVIDES THE U.S. ACADEMIC COMMUNITY WITH A GLOBAL CLASS VESSEL WITH A UNIQUE MULTI-CHANNEL SEISMIC (MCS) CAPABILITY FOR 2D AND 3D REFLECTION SEISMIC IMAGING AND, WITH THE DEPLOYMENT OF OCEAN BOTTOM SEISMOMETERS (OBS), REFRACTION IMAGING AND TOMOGRAPHY. THE SHIP IS ABLE TO DEPLOY MULTIPLE STREAMER HYDROPHONE ARRAYS AND HIGH-QUALITY TUNED SOUND SOURCE ARRAYS, WHICH ENHANCE DATA ACQUISITION. THIS IMAGING CAPABILITY ENABLES SCIENTISTS TO TACKLE A WIDE RANGE OF MARINE EARTH SCIENCE PROBLEMS. THE SEISMIC DATA IS COMPLIMENTED BY TOWED MAGNETICS AND ONBOARD GRAVIMETER MEASUREMENTS. LANGSETH HAS AN EXTENSIVE MAPPING CAPABILITY WITH ITS SET OF SONARS THAT INCLUDE A KONGSBERG EM122 DEEP WATER SWATH BATHYMETRY SYSTEM WITH WATER COLUMN LOGGER, A KNUDSEN SUB-BOTTOM PROFILER, AND AN RDI OS75 ACOUSTIC DOPPLER CURRENT PROFILER (ADCP). AN UNCONTAMINATED SEA WATER SYSTEM WITH THERMOS-SALINOGRAPHS AND AN AUTOMATED PCO2 SYSTEM FOR MEASUREMENTS WHILE UNDERWAY. ONBOARD LABS OFFER POTENTIAL OF SUPPORTING VARIOUS MARINE SCIENCE DISCIPLINES. LANGSETH, IN COMMON WITH THE OTHER SHIPS IN THE US ACADEMIC RESEARCH FLEET, IS MORE THAN JUST AN INSTRUMENT FOR THE COLLECTION OF SCIENTIFIC DATA. IT IS A LEARNING TOOL, A UNIVERSITY EDUCATIONAL FACILITY THAT ALLOWS YOUNG EARTH SCIENTISTS TO LEARN THE HANDS-ON ASPECTS OF THEIR TRADE. THE 2024 SHIP OPERATIONS PROGRAM PROVIDES AN OPPORTUNITY TO COLLECT NEW, HIGHER RESOLUTION DATA IN UNEXPLORED AREAS AND MORE DETAIL IN OTHERS, WHICH WILL ADD SIGNIFICANTLY TO OUR UNDERSTANDING OF FUNDAMENTAL PROBLEMS IN THE EARTH AND OCEAN SCIENCES. OUTREACH EFFORTS INCLUDE SHIP TOURS AND COMMUNITY OUTREACH THROUGH LDEO SPONSORED ACTIVITIES THAT FEATURE LANGSETH. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Department of the Interior
$18.5M
COLUMBIA AIMS TO REVOLUTIONIZE PHARMACOLOGY BY DELIVERING A HIGH RESOLUTION PRECISION MONITORING SYSTEM THAT CAN BE USED IN LARGE POPULATIONS TO ASSESS DRUG EFFICACY AND IN INDIVIDUALS TO TAILOR OPTIMAL DRUG TREATMENT. THEIR GRAND VISION IS TO ENABLE THE TRANSFORMATION OF CLINICAL THERAPEUTICS TO DRAMATICALLY ENHANCE CAPABILITIES TO MANAGE DISEASE SUBSTANTIALLY IMPROVE THERAPEUTIC BENEFITS TO PATIENTS BY DELIVERING PRECISION THERAPEUTICS AND MAXIMIZE BENEFIT TO PHARMACEUTICAL SUPPLIERS THROUGH THE ABILITY TO ANTICIPATE AND REDUCE ADVERSE THERAPEUTIC EFFECTS.SPECIFICALLY THE INDIPHARM TEAM PROPOSES TO 1) AUTOMATE THE IDENTIFICATION OF THOUSANDS OF FDA APPROVED DRUGS DRUG METABOLITES CHEMICALS THAT MODIFY DRUG METABOLISM AND DRUG IMPURITIES. 2) UTILIZE AND VALIDATE THE MASS SPECTROMETRY PLATFORM IN HIGHLY PHENOTYPED COHORTS BY MERGING PHARMACOGENOMIC AND PHARMACOEXPOSOMIC DATA. 3) DELIVER MULTI MODAL NETWORK AND ARTIFICIAL INTELLIGENCE BASED MODELS TO PREDICT DRUG EFFICACY BY INTEGRATING LARGE SCALE PHARMACOGENOMIC AND PHARMACOEXPOSOMIC DATA. 4) DELIVER A DATABASE SOFTWARE INFRASTRUCTURE TO HOUSE CHEMICAL LIBRARIES THAT FACILITATE THE IDENTIFICATION OF TENS OF THOUSANDS OF DRUGS CHEMICALS AND METABOLITES. 5) DEVELOP COMBINED PHARMACOGENOMIC PHARMACOEXPOSOMIC MODELS FOR OPTIMIZING DRUG THERAPIES IN INDIVIDUALS AND POPULATIONS. 6) SCALE THE MASS SPECTROMETRY PLATFORM FOR APPLICATION TO LARGE POPULATION STUDIES (GREATER THAN 100000 PARTICIPANTS) AND FOR A RANGE OF CLINICAL SETTINGS TO ENSURE WIDESPREAD ACCESS. TOGETHER THESE GOALS WILL LEAD TO TRANSFORMATIVE CHANGES IN THE THERAPEUTIC LANDSCAPE PROVIDE IMPROVED THERAPY TO PATIENTS IN AN EQUITABLE MANNER AND HELP ALLEVIATE UNNECESSARY HUMAN SUFFERING. SUBRECIPIENTS ARE BROWN UNIVERSITY EMORY UNIVERSITY PUBLIC HEALTH EMORY UNIVERSITY MEDICINE HARVARD JACKSON LABORATORY MAYO CLINIC
Department of Health and Human Services
$18.3M
TRAINING IN BIOMEDICAL INFORMATICS AT COLUMBIA UNIVERSITY
Department of Health and Human Services
$18.2M
STATE-DEPENDENT DECISION-MAKING IN BRAINWIDE NEURAL CIRCUITS - SUMMARY/ABSTRACT - OVERALL U19 ANIMALS CONSTANTLY MAKE DECISIONS, SUCH AS HOW TO EVALUATE A POTENTIAL THREAT OR WHERE TO LOOK FOR FOOD. YET THE SAME ANIMAL IN THE SAME ENVIRONMENT CAN PRODUCE DIFFERENT DECISIONS ON DIFFERENT OCCASIONS, BECAUSE ITS INTERNAL STATE INTERACTS POWERFULLY WITH EXTERNAL INPUTS TO DETERMINE BEHAVIOR. THIS PROPOSAL’S OVERARCHING GOAL IS TO UNDERSTAND HOW INTERNAL STATES INFLUENCE DECISIONS AND TO IDENTIFY THE UNDERLYING NEURAL MECHANISMS. IN A MOUSE DECISION-MAKING TASK, THESE EXPERIMENTS WILL EXAMINE THE EFFECTS OF THREE TYPES OF INTERNAL STATE CHANGES: THOSE ARISING SPONTANEOUSLY WITH ENGAGEMENT AND DISENGAGEMENT IN A TASK, THOSE RESULTING FROM CHANGING EXPECTATIONS DURING THE TASK, AND THOSE RESULTING FROM LEARNING WITHIN AND ACROSS DAYS. TO DETERMINE HOW INTERNAL STATES AFFECT BRAIN ACTIVITY AND BEHAVIOR, THE TEAM WILL APPLY CUTTING-EDGE TECHNICAL ADVANCES ON A BRAINWIDE SCALE, INCLUDING STATISTICAL TOOLS TO INFER INTERNAL STATES FROM BEHAVIOR; SIMULTANEOUS RECORDINGS FROM LARGE POPULATIONS OF NEURONS ACROSS MANY REGIONS DURING BEHAVIOR AND DURING OPTOGENETIC PERTURBATIONS; ASSAYS THAT MAP FUNCTIONALLY AND MOLECULARLY DEFINED CELL-TYPE-SPECIFIC, CROSS-REGION CONNECTIVITY; AND COMPUTATIONAL APPROACHES TO MODEL HOW CROSS-REGION NEURAL COMMUNICATION DEPENDS ON INTERNAL STATES. THESE AMBITIOUS GOALS GO BEYOND THE CAPABILITIES OF AN INDIVIDUAL LABORATORY AND ARE IDEALLY SUITED FOR AN ALREADY- PRODUCTIVE CONSORTIUM. THIS TEAM IS PART OF THE INTERNATIONAL BRAIN LABORATORY, WHICH HAS ALREADY DEVELOPED A STANDARDIZED MOUSE DECISION-MAKING TASK AND STANDARDIZED METHODS FOR TRAINING, NEURAL MEASUREMENT, AND DATA ANALYSIS, ALONG WITH A WORKING, SCALABLE INFRASTRUCTURE FOR SHARING DATA. THE PROPOSED RESEARCH LEVERAGES THIS EXISTING INFRASTRUCTURE AND TAKES IT IN A NEW DIRECTION. PROJECTS 1-5 WILL EXAMINE SIMULTANEOUSLY RECORDED POPULATION ACTIVITY, EVALUATE CAUSALITY, STUDY NEURAL ACTIVITY AND BEHAVIOR DURING LEARNING IN NORMAL AND AUTISM MODEL MICE, IDENTIFY CELL TYPES BY MEASURING NEURONAL ACTIVITY, GENE EXPRESSION, AND AXONAL PROJECTION PATTERNS IN THE SAME POPULATIONS OF NEURONS, AND BUILD A COMPREHENSIVE COMPUTATIONAL MODEL OF ALL THESE EXPERIMENTAL RESULTS. CORES A-D WILL SUPPORT THE COLLECTION, REPLICABILITY, MANAGEMENT, AND ANALYSIS OF THE LARGE DATASETS PRODUCED BY THIS BRAINWIDE EXAMINATION OF NEURAL CIRCUITS. TAKEN TOGETHER, THE PROPOSED RESEARCH WILL RIGOROUSLY DEFINE THE NEURAL BASIS OF MULTIPLE INTERNAL STATES AND EVALUATE THEIR IMPACT ON THE FLOW OF DECISION-RELEVANT INFORMATION THROUGH THE BRAIN. THE RESULTS WILL GREATLY ADVANCE THE FIELD BY GENERATING A COMPREHENSIVE, MECHANISTIC UNDERSTANDING OF HOW INTERNAL STATES ARE REFLECTED IN THE BRAIN, AND HOW THESE STATES INTERACT WITH EXTERNAL INPUTS TO GUIDE DECISIONS. MOREOVER, THE TEAM WILL PRODUCE AND DISSEMINATE OPEN-SOURCE TOOLS AND PROTOCOLS THAT WILL ENABLE OTHER LABORATORIES TO COLLECT AND MANAGE LARGE-SCALE DATASETS PRODUCED THROUGH BRAINWIDE MEASUREMENTS.
Department of Commerce
$18M
THE CONTINUATION OF THE INTERNATIONAL RESEARCH INSTITUTE FOR CLIMATE AND SOCIETY: 2010 - 2012
National Science Foundation
$17.7M
COLUMBIA UNIVERSITY MRSEC ON PRECISION-ASSEMBLED QUANTUM MATERIALS
Department of Health and Human Services
$17.6M
DNA DOUBLE-STRAND BREAK REPAIR, CHROMOSOMES TRANSLOCATIONS AND CANCER
Department of Health and Human Services
$17.5M
NORTH AMERICAN MITOCHONDRIAL DISEASE CONSORTIUM (NAMDC)
Department of Health and Human Services
$17.4M
SUPPORT OF STRATEGIC INFORMATION ACTIVITIES IN THE KINGDOM OF LESOTHO UNDER PEPFAR
Department of Health and Human Services
$17.2M
PULMONARY VASCULAR CHANGES IN EARLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Department of Health and Human Services
$17.1M
OFFSPRING STUDY OF MECHANISMS FOR RACIAL DISPARITIES IN ALZHEIMER'S DISEASE - PROJECT SUMMARY THE OVERALL AIM OF THIS STUDY IS TO IDENTIFY SOCIAL AND BIOLOGICAL PATHWAYS OF RACIAL/ETHNIC DISPARITIES FOR INCIDENT MILD COGNITIVE IMPAIRMENT (MCI)/ ALZHEIMER'S DISEASE AND RELATED DISORDERS (ADRD) AND COGNITIVE DECLINE THAT EMERGE IN MIDDLE AGE. WE HAVE RECRUITED OVER 1,500 MIDDLE-AGED OFFSPRING OF PARTICIPANTS IN THE WASHINGTON HEIGHTS/INWOOD COLUMBIA AGING PROJECT (WHICAP), AND CHARACTERIZED THEM AT BASELINE USING MEASURES OF NEUROPSYCHOLOGICAL AND PSYCHOSOCIAL FUNCTION, LIFECOURSE MEASURES OF SOCIAL AND ENVIRONMENTAL DETERMINANTS OF HEALTH, STORED BLOOD SAMPLES, AND BRAIN STRUCTURE WITH MRI. THE OFFSPRING STUDY IS UNIQUE AMONG OTHER COHORTS, WITH LARGE NUMBERS OF LATINX AND AFRICAN AMERICAN PARTICIPANTS IN MIDDLE AGE WHO ARE NOT A CONVENIENCE SAMPLE AND ARE REPRESENTATIVE OF THEIR AGE AND CULTURAL GROUPS, AND WHOSE PARENTS ARE WELL-CHARACTERIZED WITH DIRECTLY OBSERVED CLINICAL AND BIOLOGICAL DATA. OUR PRIOR WORK IN THE OFFSPRING COHORT FOUND 1) LOWER MEMORY AND EXECUTIVE FUNCTION AMONG MIDDLE AGED PEOPLE WHOSE PARENTS HAVE MCI/AD, PARTICULARLY AMONG NON-LATINX WHITES COMPARED WITH NON-LATINX BLACKS AND LATINX, 2) AMONG WHITES, PARENTAL COGNITION HAD A STRONGER IMPACT ON OFFSPRING HIPPOCAMPAL VOLUME, AND AMONG BLACKS, PARENTAL COGNITION HAD A STRONGER IMPACT ON OFFSPRING WMH, 3) THE NEGATIVE IMPACT OF AGE ON COGNITIVE FUNCTION AND CORTICAL THICKNESS IS DISPROPORTIONATELY LARGE AMONG BLACK AND LATINX PARTICIPANTS COMPARED WITH WHITES, 4) EARLY LIFE SOCIAL FACTORS SUCH AS PARENTAL SES PROMOTE COGNITIVE RESILIENCE TO PARENTAL AD HISTORY, AND 5) RACIAL DISCRIMINATION HAS A DISPROPORTIONATE NEGATIVE IMPACT ON COGNITIVE TEST PERFORMANCE AMONG BLACK AND SPANISH-SPEAKING LATINX OFFSPRING RELATIVE TO WHITE OFFSPRING. OVER THE NEXT 5 YEARS, WE PROPOSE TO RECRUIT ADDITIONAL OFFSPRING FOR A TOTAL SAMPLE OF 2,500, OBTAIN BASELINE MRI SCANS ON AN ADDITIONAL 1,000 PARTICIPANTS, OBTAIN PLASMA BIOMARKERS FOR AD RISK AND NEURODEGENERATION ON BASELINE BLOOD SAMPLES, AND OBTAIN TWO REPEAT ASSESSMENTS OF COGNITIVE, PSYCHOSOCIAL, AND MEDICAL FUNCTION. OUR OVERARCHING HYPOTHESIS IS THAT VASCULAR AND INFLAMMATORY PATHWAYS OF TRANSMISSION OF PARENTAL AD RISK PLAY A GREATER ROLE AMONG BLACK AND LATINX OLDER ADULTS COMPARED WITH WHITES, AND THAT SOCIOECONOMIC STATUS, EDUCATIONAL QUALITY, AND EXPERIENCE OF DISCRIMINATION WILL MODERATE THE RELATIONSHIP BETWEEN PARENTAL AD STATUS AND BIOMARKERS OF AD ON OFFSPRING COGNITION. SPECIFICALLY, THE PROJECT WILL 1) EXAMINE THE IMPACT OF BIOLOGICAL MARKERS OF VASCULAR AND INFLAMMATORY HEALTH, AD PATHOPHYSIOLOGY, NEURODEGENERATION, BIOLOGICAL AGING, AND GENETIC RISK ON COGNITIVE DECLINE AND INCIDENT IMPAIRMENT ACROSS RACE/ETHNICITY AND SEX/GENDER AND 2) DETERMINE THE LIFECOURSE EDUCATIONAL, ECONOMIC, AND SOCIAL MODERATORS OF PARENTAL AD RISK AND AD BIOMARKERS ON COGNITIVE DECLINE AND INCIDENT IMPAIRMENT ACROSS RACE/ETHNICITY AND SEX/GENDER.
Department of Health and Human Services
$17M
BREAST CANCER FAMILY REGISTRY COHORT
Department of Health and Human Services
$16.8M
EXPLORING COGNITIVE AGING USING REFERENCE ABILITY NEURAL NETWORKS
Department of Health and Human Services
$16.7M
UNDERSTANDING V1 CIRCUIT DYNAMICS AND COMPUTATIONS
Department of Health and Human Services
$16.7M
CDC-RFA-GH-23-0014: TECHNICAL ASSISTANCE TO NATIONAL ENTITIES AND REGIONAL HEALTH BUREAUS (RHBS) IN THE IMPLEMENTATION OF HIV PROGRAMS ACROSS ETHIOPIA UNDER PEPFAR
National Science Foundation
$16.7M
GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP)
Department of Health and Human Services
$16.6M
STRENGTHENING TB/HIV COLLABORATION IN THE KINGDOM OF LESOTHO UNDER PEPFAR
Department of Health and Human Services
$16.5M
MEDICAL SCIENTIST TRAINING PROGRAM
Department of Health and Human Services
$16.4M
GENE-ENVIRONMENT INTERACTIONS IN AN AUTISM BIRTH COHORT
Department of Health and Human Services
$15.8M
WARFARIN VS. ASPIRIN IN REDUCED EJECTION FRACTION (WARCEF)
National Science Foundation
$15.8M
COLUMBIA UNIVERSITY MATERIALS RESEARCH SCIENCE AND ENGINEERING CENTER
Department of Health and Human Services
$15.6M
STRENGTHENING THE DELIVERY OF QUALITY HIV/TB LABORATORY SERVICES INCLUDING QUALITY MANAGEMENT SYSTEMS, EQUIPMENT, & LABORATORY NETWORK OPTIMIZATION FOR EFFICIENT PATIENT MANAGEMENT IN ESWATINI
Department of Health and Human Services
$15.5M
AIDS EDUCATION AND TRAINING CENTERS PROGRAM
Department of Health and Human Services
$15.3M
THE GENETIC ORIGINS AND COMPLICATIONS OF URINARY TRACT ABNORMALITIES
Department of Health and Human Services
$15.2M
COMPUTATIONAL AND CIRCUIT MECHANISMS UNDERLYING MOTOR CONTROL
Department of the Interior
$15.1M
TRAUMAS: TREATMENT AND RECOVERY AUGMENTED WITH ELECTRICAL AND ULTRASOUND-MEDIATED ACTUATION AND SENSING
National Science Foundation
$15M
GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) -THE NATIONAL SCIENCE FOUNDATION (NSF) GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) IS A HIGHLY COMPETITIVE, FEDERAL FELLOWSHIP PROGRAM. GRFP HELPS ENSURE THE VITALITY AND DIVERSITY OF THE SCIENTIFIC AND ENGINEERING WORKFORCE OF THE UNITED STATES. THE PROGRAM RECOGNIZES AND SUPPORTS OUTSTANDING GRADUATE STUDENTS WHO ARE PURSUING RESEARCH-BASED MASTER'S AND DOCTORAL DEGREES IN SCIENCE, TECHNOLOGY, ENGINEERING, AND MATHEMATICS (STEM) AND IN STEM EDUCATION. THE GRFP PROVIDES THREE YEARS OF FINANCIAL SUPPORT FOR THE GRADUATE EDUCATION OF INDIVIDUALS WHO HAVE DEMONSTRATED THEIR POTENTIAL FOR SIGNIFICANT RESEARCH ACHIEVEMENTS IN STEM AND STEM EDUCATION. THIS AWARD SUPPORTS THE NSF GRADUATE FELLOWS PURSUING GRADUATE EDUCATION AT THIS GRFP INSTITUTION. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Department of Health and Human Services
$14.9M
SILENCE ALS: A PLATFORM FOR THE DISCOVERY AND DEVELOPMENT OF ANTISENSE THERAPEUTICS FOR PATIENTS WITH ULTRA-RARE FORMS OF ALS - ALS IS A PROGRESSIVE NEURODEGENERATIVE DISEASE THAT AFFECTS TENS OF THOUSANDS OF AMERICANS. THERAPEUTIC OPTIONS FOR ALS PATIENTS REMAIN SEVERELY LIMITED, BUT FOR THE ~15% OF ALS PATIENTS WITH A DISEASE-CAUSING MUTATION, GENE-BASED THERAPEUTICS, INCLUDING ANTISENSE OLIGONUCLEOTIDES (ASOS), PROVIDE A DIRECT MEANS TO ENGINEER A PRODUCT THAT SPECIFICALLY TARGETS THE MOLECULAR MECHANISM UNDERLYING A PATIENT’S ALS AND ARE THEREFORE AN IMPORTANT ENABLING TECHNOLOGY FOR THE ADVANCEMENT OF INDIVIDUALIZED THERAPIES. THE ABILITY TO TARGET THE DISEASE GENE OR ITS ENCODED MESSENGER RNAS (MRNAS) HAS OPENED NEW OPPORTUNITIES FOR THERAPY DEVELOPMENT. INDUSTRY-SPONSORED EFFORTS FOCUSED ON ALS CAUSED BY MUTATIONS IN C9ORF72, SOD1 AND FUS OFFER HOPE TO ALS PATIENTS AND FAMILIES WITH THESE RELATIVELY COMMON, GENETIC FORMS OF THE DISEASE. SILENCE ALS IS A PARTNERSHIP BETWEEN COLUMBIA UNIVERSITY AND THE N-LOREM FOUNDATION THAT AIMS TO EXTEND THESE GENE-BASED THERAPEUTIC STRATEGIES TO ALS PATIENTS WITH ULTRA-RARE MUTATIONS, EXPANDING ACCESS TO THIS POWERFUL TECHNOLOGY THROUGH A NON-PROFIT, PRECISION MEDICINE APPROACH. WITH SUPPORT FROM THE NINDS URGENT NETWORK, THIS INITIATIVE WILL FOCUS ON GENETIC MUTATIONS THAT CAUSE ALS THROUGH A DOMINANT MECHANISM AMENABLE TO ASO THERAPY. IN A TRAILBLAZING PROJECT, SILENCE ALS WILL FOCUS ON ALS PATIENTS WITH RARE PATHOGENIC MUTATIONS IN TARDBP, WITH THE AIM OF DEVELOPING A SERIES OF INDIVIDUALIZED, ALLELE-SPECIFIC ASOS TARGETING THE MUTATED TDP-43 TRANSCRIPT. THIS EFFORT BUILDS ON THE FIRST SUCCESSFUL SILENCE ALS PROGRAM THAT LED TO FIRST-IN-HUMAN (FIH) DOSING OF AN ALS PATIENT WITH AN ALLELE-SPECIFIC TARDBP ASO IN OCTOBER 2022. A SECOND PROJECT OF THIS URGENT PROPOSAL WILL FOCUS ON THE DEVELOPMENT OF A NON-ALLELE-SPECIFIC ASO TARGETING ULTRA-RARE MUTATIONS IN CHCHD10 ASSOCIATED WITH ALS AND FRONTOTEMPORAL DEMENTIA (FTD). ADDITIONAL PROJECTS WILL TARGET MUTATIONS IN OTHER ALS GENES, INCLUDING KIF5A, PFN1 AND ANXA11. SILENCE ALS WILL TAKE ADVANTAGE OF THE ROBUST CLINICAL AND RESEARCH INFRASTRUCTURE OF THE COLUMBIA UNIVERSITY ALS CENTER AND THE OPTIMIZED ASO DISCOVERY AND DEVELOPMENT PLATFORM AT N-LOREM. OUR PROGRAM WILL INCLUDE PATIENT IDENTIFICATION AND CLINICAL CHARACTERIZATION, CONTINUING THROUGH ASO DESIGN AND SCREENING, IN VITRO AND IN VIVO TESTING, AND GLP TOXICITY STUDIES OF LEAD CANDIDATES MANDATED BY CURRENT FDA GUIDELINES. IN TOTAL, WE EXPECT TO DEVELOP NINE DIFFERENT ASOS TARGETING DIVERSE GENES AND HAPLOTYPES IN ULTRA- RARE FORMS OF ALS, THROUGH IND SUBMISSION AND READINESS FOR THE FIH TRIALS. IN FUTURE EFFORTS, SILENCE ALS AIMS TO FOLLOW ASYMPTOMATIC CARRIERS OF ULTRA-RARE ALS MUTATIONS AND TO PREPARE PERSONALIZED ASO THERAPEUTICS FOR INDIVIDUALS AT RISK. SILENCE ALS IS THE FIRST INITIATIVE OF ITS KIND, BRINGING A DISEASE FOCUS TO THE BROADER, NON-PROFIT, ASO DEVELOPMENT PLATFORM OF N-LOREM. THROUGH THIS URGENT PROPOSAL, WE AIM IS TO CREATE A PARADIGM FOR OTHER ULTRA-RARE DISEASE COMMUNITIES TO FOLLOW, BRINGING TOGETHER ACADEMIC, NON-PROFIT AND PUBLIC STAKEHOLDERS TO DEVELOP ANTISENSE THERAPEUTICS FOR AN UNDERSERVED PATIENT POPULATION, WHILE CREATING KNOWLEDGE, EXPERIENCE AND EFFICIENCIES THAT WILL INFORM OUR UNDERSTANDING AND APPROACH ACROSS DISEASES AND TREATMENT MODALITIES.
Department of Health and Human Services
$14.9M
PRENATAL CYTOGENETIC DIAGNOSIS BY ARRAY-BASED COPY NUMBER ANALYSIS
Department of Health and Human Services
$14.8M
IMPACTS OF RECEIVING ALZHEIMER'S DISEASE GENETIC RISK INFORMATION AMONG LATINOS IN NORTHERN MANHATTAN
Agency for International Development
$14.6M
THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING IN THE AMOUNT OF $5,000,000.
Department of Health and Human Services
$14.5M
PSYCHOSOCIAL FACTORS AND CARDIOVASCULAR DISEASE
Department of Health and Human Services
$14.5M
ENDOTHELIAL DYSFUNCTION, BIOMARKERS AND LUNG FUNCTION
Department of Health and Human Services
$14.5M
COLUMBIA UNIVERSITY SCIENCE OF BEHAVIOR CHANGE RESOURCE AND COORDINATING CENTER: OPEN SCIENCE ADMINISTRATIVE SUPPLEMENT
Department of Health and Human Services
$13.7M
MULTI-OMIC NETWORK-DIRECTED PROTEOFORM DISCOVERY, DISSECTION AND FUNCTIONAL VALIDATION TO PRIORITIZE NOVEL AD THERAPEUTIC TARGETS
Department of Health and Human Services
$13.6M
INSTITUTIONAL CAREER DEVELOPMENT CORE
Department of Health and Human Services
$13.6M
PATHWAY DISCOVERY, VALIDATION AND COMPOUND IDENTIFICATION FOR ALZHEIMER'S DISEASE
Department of Health and Human Services
$13.6M
TECHNICAL ASSISTANCE IN SUPPORT OF HIV PREVENTION, CARE AND TREATMENT PROGRAMS
Department of Health and Human Services
$13.5M
STRENGTHENING NATIONAL EPIDEMIOLOGIC AND RESEARCH CAPACITY TO TRACK THE HIV/TB EPIDEMIC AND IMPROVE HEALTH OUTCOMES IN THE KINGDOM OF ESWATINI UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF
National Aeronautics and Space Administration
$13.4M
23-NUP2023-0090 INTERDISCIPLINARY RESEARCH ON EARTH AND PLANETARY SYSTEM MODELING THE IMPACTS OF CLIMATE CHANGE AND THE HABITABILITY OF OTHER WORLDS 2023-2026
Department of Health and Human Services
$13.4M
STRENGTHENING SCALE UP OF HIV PREVENTION, CARE AND TREATMENT PROGRAMS IN SOUTH SUDAN UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)CDC-RFA-GH-23-0034
Department of Health and Human Services
$13.3M
EPIDEMIOLOGICAL AND GENETIC INVESTIGATIONS OF BLOOD-BASED BIOMARKERS FOR ALZHEIMER'S DISEASE IN THE MULTIETHNIC, WASHINGTON HEIGHTS, INWOOD, COLUMBIA AGING PROJECT (WHICAP) - ABSTRACT. THE ANALYSIS OF CEREBROSPINAL FLUID (CSF) AND MOLECULAR PET BIOMARKERS OF ASS AND PHOSPHO-TAU COMBINED WITH MRI ASSESSMENT OF GLOBAL AND REGIONAL NEURODEGENERATION LED TO THE DEVELOPMENT OF THE “A/T/N” CLASSIFICATION SCHEME FOR ALZHEIMER'S DISEASE (AD) THAT WAS INTENDED TO ADD PRECISION TO THE DIAGNOSIS FOR CLINICAL PURPOSES, THERAPEUTIC TRIALS AND REGULATORY AGENCIES. FOR OBSERVATIONAL EPIDEMIOLOGICAL RESEARCH THE WIDESPREAD USE OF THESE TYPES OF BIOMARKERS IS NOT POSSIBLE BECAUSE OF THE EXPENSE AND LIMITED ACCESS TO CYCLOTRONS NECESSARY FOR MOLECULAR IMAGING AND THE DIFFICULTY IN OBTAINING CSF IN LARGE STUDIES. FURTHER, IT IS CLEAR THAT THE RELATIONSHIP OF BIOMARKER VALUES TO CLINICAL DIAGNOSES CAN ALSO DIFFER BY AGE, SEX AND RACE/ETHNIC GROUP, AND FEW STUDIES HAVE INCLUDED DIVERSE COHORTS, REPRESENTATIVE OF THE POPULATION IN THE US. THE ADVENT OF NEWLY- ESTABLISHED, BLOOD-BASED BIOMARKERS (ASS40, ASS42, P-TAU217, NEUROFILAMENT LIGHT CHAIN OR NFL) COMBINED WITH BRAIN MRI PROVIDES AN OPPORTUNITY TO INVESTIGATE THE APPLICATION OF “A/T/N BIOMARKER PROFILE” IN COMMUNITY-BASED, OBSERVATIONAL STUDY, AND CREATE ENDOPHENOTYPES THAT CAN BE USED TO IDENTIFY GENETIC SUSCEPTIBILITY. THE WASHINGTON HEIGHTS, INWOOD COLUMBIA AGING PROJECT (WHICAP) STUDY IS ONE OF THE FEW COHORTS WHERE THE NEWLY ESTABLISHED BLOOD-BASED BIOMARKERS AND WELL-ESTABLISHED NEUROIMAGING BIOMARKERS FOR AD CAN BE USED TO INVESTIGATE A BLOOD-BASED “A/T/N BIOMARKER PROFILE” ACROSS RACE/ETHNIC GROUPS AND BY AGE AND SEX. AMYLOID (PLASMA ASS40 AND ASS42), TAU (PLASMA TOTAL TAU AND P-TAU217), AND NEURODEGENERATION (PLASMA NEUROFILAMENT LIGHT [NFL], AND MRI (BRAIN VOLUMES AND CORTICAL THICKNESS) WILL BE ASSESSED IN A LONGITUDINAL, MULTI-ETHNIC COMMUNITY-BASED ELDERLY COHORT (24% WHITE NON-HISPANIC, 28% AFRICAN AMERICAN, 48% CARIBBEAN HISPANIC). THE COHORT HAS BEEN GENETICALLY CHARACTERIZED, AND HAS STORED DNA, SERA, AND PLASMA. THE EFFECTS OF CEREBROVASCULAR DISEASE “V” AND PSYCHOSOCIAL FACTORS WILL ALSO BE INVESTIGATED AS POTENTIAL MODULATORS OF THE “A/T/N BIOMARKER PROFILE”. WE WILL USE PUBLICLY AVAILABLE GENETIC DATA IN AFRICAN AMERICAN, CARIBBEAN HISPANIC AND NON-HISPANIC WHITE PARTICIPANTS THAT INCLUDED THE WHICAP COHORT TO CREATE ETHNIC-SPECIFIC POLYGENIC RISK SCORES (EPRS). THIS WILL ALLOW THE IDENTIFICATION OF VARIANTS ASSOCIATED WITH THE ENDOPHENOTYPES UNDERLYING THE “A/T/N BIOMARKER PROFILE” AND AUGMENT THE EPRS ASSOCIATION WITH THE CLINICAL DIAGNOSES OF AD. WE WILL MAINTAIN LONGITUDINAL FOLLOW-UP OF THE WHICAP COHORT, ADDING PARTICIPANTS ONLY TO ACCOUNT FOR ATTRITION, COLLECTING WHOLE BLOOD FOR PLASMA AND SERA, ASCERTAINING PSYCHOSOCIAL AND BIOMEDICAL RISK AND PROTECTIVE FACTORS AND OBTAINING STRUCTURAL MRI MEASURES AT LEAST TWICE IN PARTICIPANTS OVER A FOUR-YEAR PERIOD. THE OVERALL GOALS OF THIS PROJECT ARE TO: 1) INVESTIGATE VARIABILITY IN BLOOD-BASED BIOMARKERS AND MRI MEASURES IN THE “A/T/N BIOMARKER PROFILE” AS IT APPLIES TO CLINICAL DIAGNOSES IN A MULTI-ETHNIC COHORT; 2) INVESTIGATE BLOOD-BASED BIOMARKERS AS ENDOPHENOTYPES IN GENETIC ANALYSES FOR EARLIER DETECTION AND DIAGNOSIS OF AD; 3) INVESTIGATE HOW CEREBROVASCULAR DISEASE AND PSYCHOSOCIAL FACTORS MODULATE THE USE OF BLOOD-BASED AND MRI BIOMARKERS.
Department of Health and Human Services
$13.3M
COLUMBIA GENIE (GENOMIC INTEGRATION WITH EHR)
Department of Health and Human Services
$13.2M
3 OF 7 EPI4K: SEQUENCING, BIOSTATISTICS & BIOINFORMATICS CORE
Department of Health and Human Services
$13.1M
A MULTI-SCALE ATLAS OF SENESCENCE IN DIVERSE TISSUE TYPES - OVERALL: PROJECT SUMMARY DEFINING THE MOLECULAR AND CELLULAR HETEROGENEITY UNDERLYING SENESCENT CELL STATES IS A CRITICAL KNOWLEDGE GAP IN THE FIELD. THE COLUMBIA UNIVERSITY SENESCENCE TISSUE MAPPING (CUSTMAP) CENTER IS UNIQUELY POISED TO ADDRESS THIS GAP BY CREATING A MULTI-SCALE ATLAS OF SENESCENCE IN DIVERSE TISSUE TYPES ACROSS THE ADULT HUMAN LIFESPAN. CUSTMAP IS A HIGHLY COLLABORATIVE EFFORT THAT BUILDS UPON LONG-STANDING AND ESTABLISHED COLLABORATIONS BETWEEN COLUMBIA UNIVERSITY IRVING MEDICAL CENTER (CUIMC), THE UNIVERSITY OF EDINBURGH, NEW YORK UNIVERSITY (NYU), AND THE NEW YORK GENOME CENTER (NYGC). USING STATE-OF-THE-ART SPATIAL GENOMICS TECHNOLOGIES AND LEVERAGING OUR ESTABLISHED EXPERIMENTAL WORKFLOWS AND ANALYTICAL PIPELINES, CUSTMAP WILL GENERATE THREE- DIMENSIONAL MAPS OF SENESCENT CELLS IN TISSUES WITH VULNERABILITY TO AGE-RELATED DEGENERATIVE PROCESSES: THE CENTRAL NERVOUS SYSTEM (BRAIN AND SPINAL CORD) AND THE SKIN. WE WILL PERFORM SPATIALLY RESOLVED TRANSCRIPTOMICS (ST), SINGLE-NUCLEUS RNA-SEQUENCING, AND MULTIPLEXED PROTEOMICS USING ITERATIVE INDIRECT IMMUNOFLUORESCENCE IMAGING (4I) EXPERIMENTS IN CENTRAL NERVOUS SYSTEM (CNS) AND SKIN TISSUES ACROSS THE HUMAN LIFESPAN, ALLOWING FOR UNPRECEDENTED GENOME-WIDE MOLECULAR CHARACTERIZATION AT SINGLE-CELL RESOLUTION IN SPACE. CUSTMAP IS STRUCTURED AROUND THREE SCIENTIFIC CORES, AS WELL AS AN ADMINISTRATIVE CORE TO SUPPORT THESE INTEGRATED EFFORTS. HUMAN TISSUE SAMPLES CHARACTERIZED AND COLLECTED THROUGH THE BIOSPECIMEN CORE (BIO) WILL BE ANALYZED USING THE TOOLS AND TECHNIQUES DEVELOPED THROUGH THE BIOLOGICAL ANALYSIS CORE (BAC) AND DATA ANALYSIS CORE (DAC), LEADING TO DETAILED MAPS OF SENESCENT CELLS AND THEIR EFFECTS IN HUMAN TISSUES AT SINGLE-CELL RESOLUTION. THE SUCCESS OF CUSTMAP IS PREDICATED ON ACCESS TO A CONTINUOUS SUPPLY OF HUMAN TISSUES FROM HEALTHY INDIVIDUALS ACROSS THE LIFESPAN. CUSTMAP INVESTIGATORS HAVE ACCESS TO POST-MORTEM SAMPLES AND PROSPECTIVE TISSUE COLLECTION FROM LOCAL RESOURCES AT CUIMC AS WELL AS THROUGH ESTABLISHED COLLABORATIONS. OUR UNIQUE GEOGRAPHIC LOCATION IN UPPER MANHATTAN ENABLES TISSUE ACQUISITION FROM A LOCAL POPULATION OF PATIENTS THAT IS RICH IN RACIAL AND ETHNIC DIVERSITY. THUS, CUSTMAP IS UNIQUELY POISED TO OBTAIN HIGH-QUALITY TISSUE FROM THESE DIVERSE POPULATIONS AND APPLY CUTTING-EDGE MULTIOMIC APPROACHES TO BUILD INTEGRATED 3D MOLECULAR ATLASES OF SENESCENT CELLS IN CNS AND SKIN TISSUES. OUR APPROACH PROVIDES A UNIQUE PLATFORM FOR DRIVING TRANSFORMATIVE DISCOVERIES OF NOVEL MOLECULAR, CELLULAR AND REGIONAL CORRELATES OF AGE-RELATED CHANGES IN CELLULAR SENESCENCE IN HUMAN TISSUES. THE CUSTMAP WORKFLOW AND COMPUTATIONAL TOOLS ARE READILY GENERALIZABLE TO OTHER TISSUE TYPES AND CAN BE EFFICIENTLY SHARED WITH AND DEPLOYED ACROSS THE SENNET CONSORTIUM.
Department of Health and Human Services
$12.8M
CENTERS FOR INNOVATIVE RESEARCH TO CONTROL AIDS
National Science Foundation
$12.6M
GEOINFORMATICS FACILITIES SUPPORT: INTEGRATED DATA COLLECTIONS FOR THE EARTH & OCEAN SCIENCES: THE MARINE GEOSCIENCE DATA SYSTEM AND THE GEOINFORMA
Department of Health and Human Services
$12.6M
ICAP CLINICAL TRIALS UNIT - PROJECT SUMMARY/ABSTRACT WHILE MUCH HAS BEEN ACHIEVED IN THE GLOBAL HIV RESPONSE, ENORMOUS CHALLENGES REMAIN. ONLY 60% OF PEOPLE LIVING WITH HIV (PLWH) ACCESS TREATMENT AND 1.7M NEW HIV INFECTIONS WERE REPORTED IN 2018. IN SUB- SAHARAN AFRICA, ELIMINATION OF MOTHER TO CHILD TRANSMISSION HAS STALLED, MEN AND YOUTH LAG BEHIND IN KNOWLEDGE OF HIV STATUS, FOUR OF FIVE NEW INFECTIONS AMONG ADOLESCENTS OCCUR AMONG GIRLS, AND YOUNG WOMEN ARE TWICE AS LIKELY AS MEN TO HAVE HIV. IN THE UNITED STATES, ANNUAL NEW HIV INFECTIONS HAVE REMAINED STABLE SINCE 2013, WITH BLACK AND LATINO MEN WHO HAVE SEX WITH MEN (MSM) AND WOMEN OF COLOR DISPROPORTIONATELY AFFECTED. THE ICAP CLINICAL TRIALS UNIT (ICAP CTU), BASED AT ICAP AT COLUMBIA UNIVERSITY, WILL OVERSEE RESEARCH AT FIVE CLINICAL RESEARCH SITES (CRSS): THREE IN NEW YORK CITY (NYC), ONE IN ESWATINI, AND ONE IN WESTERN KENYA. THE NYC SITES SERVE PRIORITY POPULATIONS OF GREAT RELEVANCE TO THE CURRENT HIV EPIDEMIC, BOTH LIVING WITH AND AT RISK FOR HIV, INCLUDING BLACK AND LATINO MSM, WOMEN OF COLOR, YOUNG PEOPLE, AND PEOPLE WHO INJECT DRUGS (PWID). THE ESWATINI AND KENYA SITES, IN COMMUNITIES WITH SOME OF THE HIGHEST RATES OF NEW HIV INFECTIONS IN THE WORLD, HAVE THE CAPACITY TO ENGAGE CHILDREN, ADOLESCENTS, WOMEN AT RISK, MEN AND KEY POPULATIONS. LED BY DRS. WAFAA EL-SADR AND JESSICA JUSTMAN, THE ICAP CTU WILL PURSUE AN INNOVATIVE AND COMPREHENSIVE APPROACH TO HIV PREVENTION AND THERAPEUTIC RESEARCH THAT TAILORS TOOLS AND STRATEGIES TO THE DEMOGRAPHIC CHARACTERISTICS, BEHAVIORAL RISKS, CO-MORBIDITIES AND LIFE CIRCUMSTANCES OF PERSONS LIVING WITH OR AT RISK OF ACQUIRING HIV. RESEARCH UNDERTAKEN BY THE CTU WILL BE MULTI-FACETED, ACCOMMODATING THE COMPLEXITIES OF INDIVIDUAL-LEVEL RESPONSES TO INTERVENTIONS ACROSS NUMEROUS POPULATIONS, AND FOCUSED ON ADVANCES THAT WILL SUPPORT POPULATION-LEVEL REDUCTIONS IN HIV INFECTION AND IMPROVEMENTS IN QUALITY OF LIFE AND SURVIVAL OF PLWH. THE SPECIFIC AIMS OF THE ICAP CTU ARE (1) TO ADVANCE THE SCIENTIFIC AGENDAS OF ALL FOUR NIH HIV NETWORKS BY CONTRIBUTING TO THE DEVELOPMENT OF EFFECTIVE HIV PREVENTION, TREATMENT AND CARE INTERVENTIONS, WITH THE GOAL OF ENHANCING THE LIVES OF PLWH AND STEMMING HIV TRANSMISSION; (2) TO BUILD A STRONG CTU ADMINISTRATIVE STRUCTURE THAT IS OUTSTANDING IN ITS CAPABILITIES AND STREAMLINED IN ITS PROCEDURES, WITH EFFICIENCY, TRANSPARENCY, CLEAR LINES OF AUTHORITY, CONTINUOUS QUALITY IMPROVEMENT, FULL COMMUNITY ENGAGEMENT, AND THE HIGHEST PERFORMANCE STANDARDS; (3) TO ENGAGE FULLY WITH THE COMMUNITIES IT SERVES THROUGH EDUCATION, OUTREACH AND SUPPORT OF CRS COMMUNITY ADVISORY BOARDS; (4) TO SUPPORT CORE CRS TECHNICAL FUNCTIONS, E.G., LABORATORY, PHARMACY, REGULATORY, DATA MANAGEMENT, QUALITY ASSURANCE, TRAINING AND STAFF DEVELOPMENT; AND (5) TO ALIGN THE CONSTITUENT CRSS INTO A COHESIVE AND SYNERGISTIC UNIT THAT IS TRULY PLURIPOTENT AND THAT EFFECTIVELY ADVANCES THE RESEARCH AGENDAS OF THE NETWORKS THROUGH DEVELOPMENT OF NEW RESEARCH CONCEPTS; PARTICIPATION IN NETWORK PROTOCOLS, SCIENTIFIC COMMITTEES AND WORKING GROUPS; AND ROBUST ACCRUAL AND RETENTION OF DIVERSE PARTICIPANTS.
Department of Health and Human Services
$12.5M
DEPRESSION, BIOBEHAVIORAL MECHANISMS, & CHD/MORTALITY OUTCOMES
Department of Health and Human Services
$12.5M
REGIONAL AIDS EDUCATION AND TRAINING CENTERS PROGRAM - PROJECT ABSTRACT PROJECT TITLE: THE NORTHEAST/CARIBBEAN AIDS EDUCATION AND TRAINING CENTER (NECA AETC) APPLICANT ORGANIZATION NAME: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK ADDRESS: 601 WEST 168TH STREET, SUITE 46, NEW YORK, NY 10032 PROJECT DIRECTOR NAME: DARIA BOCCHER-LATTIMORE TELEPHONE NUMBER: 646.774.6978 FAX NUMBER: 646.774.6955 E-MAIL ADDRESS OF PI: DMB82@CUMC.COLUMBIA.EDU FUNDING REQUEST: 4,820,000/YEAR FUNDING PREFERENCES REQUESTED: TRAIN, OR RESULT IN THE TRAINING OF, HEALTH PROFESSIONALS WHO WILL PROVIDE TREATMENT FOR MINORITY INDIVIDUALS WITH HIV AND AT INCREASED RISK; TRAIN, OR RESULT IN THE TRAINING OF, MINORITY-SERVING HEALTH PROFESSIONALS AND MINORITY-SERVING ALLIED HEALTH PROFESSIONALS TO PROVIDE TREATMENT FOR INDIVIDUALS WITH HIV; AND TRAIN, OR RESULT IN THE TRAINING OF, HEALTH PROFESSIONALS AND ALLIED HEALTH PROFESSIONALS TO PROVIDE TREATMENT FOR HEPATITIS B OR C CO-INFECTED INDIVIDUALS THIS PROPOSAL FOR THE NORTHEAST/CARIBBEAN AIDS EDUCATION & TRAINING CENTER (NECA AETC) HAS THE OVERALL GOALS TO 1) EXPAND THE NUMBER OF HEALTH CARE TEAM MEMBERS PROVIDING HIV CARE AND PREVENTION SERVICES, 2) EXPAND THE ABILITY OF HEALTH CARE TEAM MEMBERS TO PROVIDE EFFECTIVE HIV CARE AND PREVENTION SERVICES 3) IMPROVE HEALTH EQUITY BY INTEGRATING HIV CARE AND PREVENTION IN PRIMARY CARE AND OTHER HEALTH CARE SETTINGS THAT PROVIDE SERVICES TO UNDERSERVED POPULATIONS.4) ENHANCE THE CAPACITY OF THE AETC PROGRAM TO TRAIN HEALTH CARE TEAM MEMBERS TO SERVE PEOPLE AT RISK FOR OR WITH HIV. THE PROPOSED GEOGRAPHICAL REGION CORRESPONDS WITH HEALTH AND HUMAN SERVICES PUBLIC HEALTH REGION 2: NEW JERSEY (NJ), NEW YORK (NY), PUERTO RICO (PR) AND THE UNITED STATES VIRGIN ISLANDS (USVI). SINCE THE START OF THE HIV EPIDEMIC NJ, NY, PR AND USVI HAVE BEEN GREATLY IMPACTED. THE REGION IS HOME TO 10% OF THE US POPULATION, NEARLY 33 MILLION PEOPLE, AND 16.5% OF PEOPLE WITH HIV IN THE US, 176,201, OF WHOM 84% ARE RACIAL/ETHNIC MINORITIES . THE NECA AETCS APPROACH AIMS TO: (1) IDENTIFY AND BE RESPONSIVE TO THE TRAINING AND TECHNICAL ASSISTANCE NEEDS OF HEALTH CARE PROVIDERS (HCPS); (2) INCREASE THE SIZE AND HIV-RELATED SKILLS OF HCPS CURRENTLY NOT INVOLVED IN HIV CARE; (3) INCREASE THE ABILITY OF HEALTH CARE TEAM MEMBERS INVOLVED IN HIV CARE TO OFFER QUALITY SERVICES; (4) FACILITATE SYSTEMS CHANGE BY PROVIDING COACHING AND PRACTICE FACILITATION UTILIZING A COMPREHENSIVE LONGITUDINAL TRAINING APPROACH;(5) ASSIST HEALTH PROFESSION PROGRAMS TO INCREASE THE NUMBER OF HCPS PROVIDING QUALITY HIV CARE; (2-5 BASE PROGRAMMING) (6) INCREASE THE CAPACITY OF MINORITY-SERVING HEALTH CARE TEAM MEMBERS, FACILITIES, AND ORGANIZATIONS TO INCREASE ACCESS TO CARE, (MAI) (7) ADDRESS THE UNIQUE TRAINING NEEDS OF THE HEALTH CARE WORKFORCE AND ORGANIZATIONS IN EHE-FUNDED JURISDICTIONS; (EHE) (8) STRENGTHEN PARTNERSHIPS AND COLLABORATIONS WITH OTHER RWHAP PARTS, FEDERAL AND NON-FEDERAL ENTITIES; (8) SYSTEMATICALLY DOCUMENT AND EVALUATE PROGRAM ACTIVITIES TO CONTINUOUSLY ASSESS AND IMPROVE THE PROGRAM; (9) SUSTAIN A REGIONALLY COORDINATED EDUCATION AND TRAINING PROGRAM THAT PROMOTES COLLABORATION, ENSURES HIGH QUALITY CURRICULA, AND RAPIDLY DISSEMINATES INFORMATION. THE NECA AETC CONSISTS OF A CENTRAL OFFICE AT COLUMBIA UNIVERSITY IN NY AND 10 WELL-POSITIONED REGIONAL PARTNERS DRAWING UPON THE CLINICAL AND CAPACITY BUILDING EXPERTISE OF THE MAJOR ACADEMIC MEDICAL CENTERS, CLINICAL PRACTICES AND SYSTEMS CHANGE EXPERTS IN REGION 2. NECA AETC WILL EXPAND THE ESTABLISHED COLLABORATIVE PROCESS WITH ALL RYAN WHITE FUNDED PART A-D AND F ENTITIES IN THE REGION TO SHARE PROGRAM AND EVALUATION DATA AND ADDRESS WORKFORCE AND TRAINING NEEDS.
Department of Health and Human Services
$12.5M
STEM CELLS AND THE ORIGINS OF BARRETT'S ESOPHAGUS
Department of Health and Human Services
$12.5M
RADIOLOGICAL RESEARCH ACCELERATOR FACILITY (RARAF)
Department of Health and Human Services
$12.3M
OBESOGENIC ORIGINS OF MATERNAL AND CHILD METABOLIC HEALTH INVOLVING DOLUTEGRAVIR (ORCHID)
Department of Health and Human Services
$12.3M
CORE SUPPORT FOR VISION RESEARCH
Department of Health and Human Services
$12.3M
POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASE
Department of Health and Human Services
$12.2M
GH15-1580 - STRENGTHENING NATIONAL EPIDEMIOLOGIC AND RESEARCH CAPACITY TO IMPROVE HEALTH OUTCOMES IN THE KINGDOM OF SWAZILAND UNDER THE PRESIDENTS EM
Department of Health and Human Services
$12.1M
COLUMBIA COLLABORATIVE HIV/AIDS CLINICAL TRIALS UNIT
Department of Health and Human Services
$12.1M
REGULATORY T CELLS TO PROMOTE MIXED CHIMERISM FOR TOLERANCE TO ISLETS AND KIDNEYS FROM DECEASED AND LIVING DONORS
Department of Health and Human Services
$11.9M
MECHANISMS OF DOPAMINE NEURON DEGENERATION
National Science Foundation
$11.9M
AI INSTITUTE FOR ARTIFICIAL AND NATURAL INTELLIGENCE -THE AI INSTITUTE FOR ARTIFICIAL AND NATURAL INTELLIGENCE (ARNI) WILL DRAW TOGETHER TOP RESEARCHERS ACROSS THE COUNTRY TO FOCUS ON A NATIONAL PRIORITY: CONNECTING THE MAJOR PROGRESS MADE IN ARTIFICIAL INTELLIGENCE (AI) SYSTEMS TO THE REVOLUTION IN OUR UNDERSTANDING OF THE BRAIN. THE PAST TEN YEARS HAVE SEEN SPECTACULAR PROGRESS IN INTERROGATING NEURAL ACTIVITY, CIRCUITRY, AND LEARNING, YET OUR NEUROSCIENCE INSIGHTS HAVE SO FAR INFORMED AI ONLY SUPERFICIALLY. CONVERSELY, OUR RAPIDLY ADVANCING AI METHODS AND SYSTEMS HAVE ONLY BEGUN TO IMPACT NEUROSCIENCE. ARNI IS A COLLABORATION BETWEEN COLUMBIA UNIVERSITY, TUSKEGEE UNIVERSITY, CITY UNIVERSITY OF NEW YORK, BAYLOR COLLEGE OF MEDICINE, UT HEALTH HOUSTON, MILA QC, HOWARD HUGHES MEDICAL INSTITUTE, UNIVERSITY OF PENNSYLVANIA, HARVARD, AND PRINCETON. INDUSTRY PARTNERS INCLUDE GOOGLE, DEEPMIND, AMAZON, AND META. ARNI WILL MEET THE URGENT NEED FOR NEW PARADIGMS OF INTERDISCIPLINARY TRAINING AND RESEARCH BETWEEN NEUROSCIENCE, COGNITIVE SCIENCE, AND AI. THIS WILL ACCELERATE PROGRESS IN ALL THREE FIELDS AND BROADEN THE TRANSFORMATIVE IMPACT ON SOCIETY IN THE NEXT DECADE. ARNI RESEARCHERS WILL WORK TOGETHER TO TACKLE THE LIMITATIONS AND CHALLENGES OF CURRENT LEARNING SYSTEMS, INCLUDING LEARNING WITH LIMITED DATA, REASONING ABOUT CAUSALITY AND UNCERTAINTY, AND LIFELONG LEARNING, WHICH ARE ALL HALLMARKS OF BIOLOGICAL SYSTEMS, AND WILL ALSO EXTEND THE FRONTIER OF UNDERSTANDING HOW BRAINS COMPUTE AND LEARN. ARNI WILL BRIDGE THE CURRENT SIGNIFICANT GAPS BETWEEN ARTIFICIAL AND BIOLOGICAL NETWORKS AND MAKE ROOM FOR ALL KINDS OF APPLICATIONS, RANGING FROM: INDUSTRIAL APPLICATIONS, SUCH AS ROBUST, INTERPRETABLE MEDICAL DECISIONS AND SMARTER HOME ASSISTANTS; TO SOCIETAL APPLICATIONS, SUCH AS BETTER SOCIAL SAFETY NETS AND ASSISTIVE MULTIMODAL SYSTEMS TO HELP THE VULNERABLE; TO SCIENTIFIC DISCOVERIES SUCH AS PROVIDING HYPOTHESES ABOUT BRAIN FUNCTION AND CREATING POWERFUL TOOLS FOR EXTRACTING INSIGHTS FROM MASSIVE DATA. THE INSTITUTE WILL PROVIDE EDUCATIONAL AND RESEARCH OPPORTUNITIES FOR UNDERGRADUATE, GRADUATE AND POSTDOCTORAL TRAINEES, WITHIN AND AT THE INTERFACE OF AI, NEUROSCIENCE, AND COGNITIVE SCIENCE. OUTREACH PARTNERS, INCLUDING THE NEUROMATCH ACADEMY AND THE NEW YORK HALL OF SCIENCE, WILL HELP INFORM THE PUBLIC OF THESE NEW DEVELOPMENTS AND TEACH CRITICAL SKILLS TO THE NEXT GENERATION OF STUDENTS. THE U.S. DEPARTMENT OF DEFENSE, OFFICE OF THE UNDERSECRETARY OF DEFENSE FOR RESEARCH AND ENGINEERING [DOD-OUSD (R&E)] IS PARTNERING WITH NSF TO PROVIDE FUNDING FOR THIS INSTITUTE. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Department of Energy
$11.8M
JET AND HEAVY FLAVOR PROBES OF THE QUARK-GLUON PLASMA
Agency for International Development
$11.8M
THIS ACTIVITY SEEKS TO ADDRESS REMAINING CHALLENGES AND CLOSE PERSISTENT GAPS TO ACHIEVE THE UNAIDS 95-95-95 GOALS AND THEREFORE REACH AND SUSTAIN HIV/AIDS EPIDEMIC CONTROL IN BURUNDI. IT WILL SET UP INTERVENTIONS TO STRENGTHEN THE HEALTH SYSTEM AND TO IMPROVE COMMUNITY ENGAGEMENT, BUILDING ON BEST PRACTICES FROM OTHER PEPFAR ACTIVITIES IMPLEMENTED TO DATE. THE ACTIVITY WILL COMPLEMENT EXISTING USAID/BURUNDI CLINICAL, COMMUNITY HEALTH, AND SOCIAL-BEHAVIOR SERVICES DELIVERY ACTIVITIES.
Department of Health and Human Services
$11.7M
ENHANCED ACCESS TO HIV CARE FOR DRUG USERS IN SAN JUAN, PUERTO RICO
Department of Health and Human Services
$11.7M
GENETIC EPIDEMIOLOGY AND MULTI-OMICS ANALYSES IN FAMILIAL AND SPORADIC ALZHEIMER'S DISEASE AMONG SECULAR CARIBBEAN HISPANICS AND RELIGIOUS ORDER
Department of Health and Human Services
$11.7M
PREDICTORS OF SEVERITY IN ALZHEIMER'S DISEASE
Department of Health and Human Services
$11.6M
COLUMBIA UNIVERSITY MINORITY/UNDERSERVED SITE NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM
Department of Health and Human Services
$11.6M
SUPPORTING THE PROVISION OF HIGH QUALITY, COMPREHENSIVE, AND SUSTAINABLE HIV SERVICES IN NATIONAL TE
Department of Health and Human Services
$11.4M
EPIDEMIOLOGICAL INTEGRATION OF GENETIC VARIANTS AND METABOLOMICS PROFILES IN WASHINGTON HEIGHTS COLUMBIA AGING PROJECT
National Aeronautics and Space Administration
$11.3M
THE SCOPE OF THE RESEARCH CONDUCTED UNDER THIS COOPERATIVE AGREEMENT REQUIRES THE INTEGRATION OF THE NECESSARY EXPERTISE REQUIRED TO TACKLE MULTIDISCIPLINARY MULTIFACETED PROBLEMS INVOLVING THE OBSERVATION AND MODELING OF THE EARTH S CLIMATE...
Department of Health and Human Services
$11.3M
INVESTIGATING CELL-INTRINSIC AND EXTRINSIC INTERACTIONS IN PROSTATE CANCER AT THE SINGLE CELL LEVEL - PROJECT SUMMARY/ABSTRACT PROSTATE CANCER PROGRESSION TO METASTATIC CASTRATION-RESISTANT DISEASE CONTINUES TO REPRESENT A MAJOR HEALTH ISSUE. RECENT ADVANCES IN SINGLE-CELL APPROACHES HAVE REVEALED EXTENSIVE HETEROGENEITY AND COMPLEXITY OF CELL STATES AND CELL TYPES THAT DRIVE TUMOR PROGRESSION, AND ADDITIONAL STUDIES HAVE DEMONSTRATED THE CENTRAL ROLE OF THE TUMOR MICROENVIRONMENT. CONSEQUENTLY, WE ARE PROPOSING A NEW PROGRAM PROJECT TO INVESTIGATE THE INTERPLAY BETWEEN TUMOR CELLS AND THEIR SURROUNDING STROMAL AND IMMUNE MICROENVIRONMENT IN PROMOTING PROSTATE CANCER PROGRESSION, METASTASIS, AND TREATMENT-RESISTANCE. OUR PROPOSAL IS HIGHLY INTEGRATED AS IT BRINGS TOGETHER A MULTI-INSTITUTIONAL TEAM OF FOUR DISTINGUISHED INVESTIGATORS (MICHAEL SHEN, CHARLES SAWYERS, CORY ABATE-SHEN, MASSIMO LODA) IN THE STUDY OF PROSTATE CANCER WHO HAVE COMPLEMENTARY EXPERTISE AS WELL AS A SUBSTANTIAL TRACK RECORD OF COLLABORATIVE INTERACTIONS. WE HAVE STRUCTURED OUR APPLICATION AROUND THE FOLLOWING PROJECTS AND CORES: PROJECT 1, LED BY CHARLES SAWYERS (MEMORIAL SLOAN-KETTERING CANCER CENTER), WILL INVESTIGATE THE IMMUNE AND STROMAL FACTORS THAT PROMOTE PROSTATE ADENOCARCINOMA AND CASTRATION-RESPONSE. PROJECT 2, LED BY CORY ABATE-SHEN (COLUMBIA UNIVERSITY IRVING MEDICAL CENTER; CUIMC), WILL INVESTIGATE THE CELL INTRINSIC AND EXTRINSIC DRIVERS OF PROSTATE CANCER METASTASIS TO BONE. PROJECT 3, LED BY MICHAEL SHEN (CUIMC), WHO IS ALSO OVERALL PI, WILL ANALYZE THE INTRINSIC AND EXTRINSIC FACTORS THAT PROMOTE PROSTATE NEUROENDOCRINE DIFFERENTIATION. CORE A (PATHOBIOLOGY), LED BY MASSIMO LODA (WEILL CORNELL MEDICINE), WILL PROVIDE MULTIPLE PATHOLOGY-BASED SERVICES TO ALL THREE PROJECTS. FINALLY, CORE B (ADMINISTRATIVE AND DATA MANAGEMENT), LED BY MICHAEL SHEN, WILL SUPPORT EACH PROJECT THROUGH DATA MANAGEMENT, BIOSTATISTICAL SUPPORT, AND COORDINATION OF THE OVERALL PROGRAM, RESOURCE MANAGEMENT, AND REVIEW BY THE INTERNAL AND EXTERNAL ADVISORY BOARDS. TOGETHER, THIS HIGHLY SYNERGISTIC PROGRAM WILL ELUCIDATE THE INTEGRATION OF INTRINSIC AND EXTRINSIC SIGNALS THAT DRIVE CASTRATION-RESISTANCE, METASTATIC TROPISM, AND NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER, AND WILL PROVIDE TRANSLATIONAL INSIGHTS INTO THE STROMAL AND IMMUNE MICROENVIRONMENTS FOR IMPROVED THERAPEUTIC APPROACHES.
Department of Health and Human Services
$11.3M
NEUROPHYSIOLOGY UNDERLYING NEURAL REPRESENTATIONS OF VALUE
Department of Health and Human Services
$11.2M
RADIATION BYSTANDER EFFECTS: MECHANISMS
Department of Commerce
$11.2M
COOPERATIVE INSTITUTE FOR CLIMATE APPLICATIONS AND RESEARCH (CICAR)
Department of Health and Human Services
$11.2M
TISSUE ENGINEERING RESOURCE CENTER-TREATMENT OF COVID-19 INDUCED ACUTE RESPIRATORY DISTRESS BY INHALATION OF EXOSOMES
Department of Health and Human Services
$11.2M
INTERDISCIPLINARY TRAINING IN ENVIRONMENTAL HEALTH
Department of Health and Human Services
$11M
GH15-1572, S. SUDAN: STRENGTHENING THE CAPACITY TO SCALE-UP HIV PREVENTION, CARE AND TREATMENT PROGRAMS IN SOUTH SUDAN UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) - SOUTH SUDAN
Department of Health and Human Services
$11M
IDENTIFYING NEWBORNS AT RISK OF ADVERSE NEURODEVELOPMENTAL OUTCOMES AND OBESITY FROM AIR POLLUTION.
Department of Health and Human Services
$10.9M
THERAPEUTIC GENE EDITING AND MULTIMODAL IMAGING IN JUVENILE MACULAR DEGENERATION
Department of Health and Human Services
$10.9M
CENTERS FOR CANCER SYSTEMS THERAPEUTICS (CAST)
Department of Health and Human Services
$10.9M
THE CONTE CENTER FOR SCHIZOPHRENIA RESEARCH
Department of Health and Human Services
$10.8M
IMPLEMENTATION OF PREVENTION CARE AND TREATMENT PROGRAMS FOR INDIVIDUALS WITH HI
Department of Health and Human Services
$10.7M
CENTER FOR SOLUTIONS FOR ME/CFS
Department of Health and Human Services
$10.7M
CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) UM1 AT COLUMBIA UNIVERSITY - PROJECT SUMMARY OUR CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) HUB IS SITUATED IN UPPER MANHATTAN AT THE IRVING INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH (IRVING INSTITUTE) OF COLUMBIA UNIVERSITY (CU), BASED AT THE CU IRVING MEDICAL CENTER (CUIMC). OUR EVOLUTION AS INSTITUTIONAL LEADERS AND MATURATION AS A COMPREHENSIVE CTSA HUB ENABLES US TO DRIVE INNOVATIVE CLINICAL AND TRANSLATIONAL SCIENCE (CTS) AND CLINICAL AND TRANSLATIONAL RESEARCH (CTR), IN COLLABORATION WITH OUR HOSPITAL PARTNER NEWYORK-PRESBYTERIAN. THE MISSION OF OUR HUB IS TO IMPROVE THE HEALTH AND WELLBEING OF PATIENTS AND COMMUNITIES THROUGH OUR STRATEGIC VISION AND GOALS TO CATALYZE ALL PHASES OF CTS AND CTR TO ACHIEVE A FULLY INTEGRATED RESEARCH ENVIRONMENT LOCALLY AND ACROSS THE CTSA PROGRAM. WE NOW PRIORITIZE SYSTEMATIC AND DEEP ENGAGEMENT WITH ALL OUR STAKEHOLDERS TO ACHIEVE THE GREATEST IMPACT ON RESEARCH AND HEALTH THROUGH CTS AND CTR. PROGRAMS AND SERVICES WILL BE DEPLOYED THROUGH USER-FRIENDLY RESEARCH NAVIGATION AND OPTIMIZATION USING DISSEMINATION AND IMPLEMENTATION SCIENCE (IS) TO INFORM OUR CYCLICAL APPROACH TO IDENTIFY, DEVELOP, DEMONSTRATE, AND DISSEMINATE (ID3) INNOVATIONS THAT ADDRESS CTR GAPS AND OPPORTUNITIES. OUR RECORD OF INNOVATION PERMEATES OUR EDUCATION, SERVICES, AND RESEARCH AND GUIDES OUR EVALUATION AND CONTINUOUS QUALITY IMPROVEMENT STRATEGY. CTS INNOVATIONS ARE PROPOSED FOR NEAR-PEER MENTORING, DIGITAL HEALTH IN COMMUNITIES, DATA AND DESIGN, CELL THERAPEUTICS, RESEARCH CORE UTILIZATION, HEALTH SYSTEM- EMBEDDED TRIALS, FEDERATED LEARNING, ARTIFICIAL INTELLIGENCE (AI) AND RETURN OF RESEARCH RESULTS TO PARTICIPANTS. IRVING INSTITUTE LEADERS ARE INTEGRATED INTO CUIMC GOVERNANCE TO SUCCESSFULLY IMPLEMENT OUR VISION AND GOALS. MODULE B STRATEGIC MANAGEMENT APPROACH AND INFRASTRUCTURE WILL BE OPTIMIZED TO CATALYZE CTS INNOVATIONS. THE ID3 APPROACH, ENHANCED BY TAILORED ENGAGEMENT AND IS, WILL INTEGRATE INSTITUTIONAL AND COMMUNITY PRIORITIES, STIMULATE CTS INNOVATIONS ACROSS THE T0–T4 SPECTRUM, AND BROADLY DISSEMINATE SERVICES AND PROGRAMS WITH GREATEST POTENTIAL TO ADDRESS MAJOR CTR GAPS. THROUGH PERSONALIZED TRAINING, MODULE C1 WILL CREATE AND EXPAND MODELS TO TRAIN A SKILLED, INTERDISCIPLINARY WORKFORCE TO ADVANCE RIGOROUS CTR AND CTS AND ENHANCE PARTICIPATION OF THE WORKFORCE AND COMMUNITIES IN CTR. MODULE C2 WILL DEPLOY BIDIRECTIONAL ENGAGEMENT WITH OUR COMMUNITY AMBASSADORS, PATIENTS, AND LOCAL COMMUNITIES TO DEVELOP AND DISSEMINATE PROGRAMS THAT ADDRESS COMMUNITY PRIORITIES TO IMPROVE HEALTH. MODULES D1 AND D3 WILL USE RESEARCH NAVIGATION AND OPTIMIZATION TO DEVELOP AND CYCLICALLY REFINE RESEARCH-FRIENDLY SERVICE PROGRAMS AS WELL AS INNOVATIONS IN AI, INFORMATICS, PRECISION MEDICINE, AND FEDERATED LEARNING TO ACCELERATE CTR AND CTS. THROUGH OUR MODULE D2 PILOTS AND ELEMENT E CTS PROGRAM, WE WILL WORK DIRECTLY WITH STAKEHOLDERS TO TACKLE MAJOR CTS CHALLENGES, SUCH AS A SYSTEM FOR RETURN OF INDIVIDUAL RESULTS TO RESEARCH PARTICIPANTS AS WELL AS OPPORTUNITIES IN CELL THERAPY, -OMIC CORE UTILIZATION IN CTR, AND AI IN RESEARCH, OPERATIONS AND HEALTH. THROUGH THESE INNOVATIONS, OUR HUB WILL DRIVE RESEARCH EFFICIENCY, QUALITY, AND IMPACT AND ALIGN WITH CTSA PROGRAM GOALS TO DELIVER MORE TREATMENTS TO MORE PATIENTS MORE QUICKLY.
Department of Health and Human Services
$10.7M
2/2-A COMPARISON OF LONG-ACTING INJECTABLE MEDICATIONS FOR SCHIZOPHRENIA -ACLAIMS
Department of Health and Human Services
$10.6M
ANTI-VIRAL THERAPY IN ALZHEIMER'S DISEASE
Department of Health and Human Services
$10.5M
ELUCIDATING THE DEPENDENCIES OF TUMOR INITIATING AND DRUG-RESISTANT NICHES IN HUMAN MALIGNANCIES BY GENOME- WIDE MOLECUALR PROFILING OF SINGLE CELLS
Department of Health and Human Services
$10.4M
ICAP MSM INITIATIVE IN SOUTH AFRICA
Department of Health and Human Services
$10.3M
MOLECULAR STRATEGIES FOR EARLY DETECTION AND TARGETING OF CANCER
Department of Health and Human Services
$10.3M
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)
Department of Health and Human Services
$10.3M
TOPOLOGY OF CANCER EVOLUTION AND HETEROGENEITY
Department of Health and Human Services
$10.3M
WARFARIN VS ASPIRIN IN REDUCED EJECTION FRACTION - STAT
Department of Defense
$10.2M
RACIAL DISPARITIES IN THE INITIATION AND INTENSITY OF ADJUVANT THERAPY FOR BREAST CANCER
Department of Health and Human Services
$10.2M
METAL EXPOSURES, OMICS, AND AD/ADRD RISK IN DIVERSE US ADULTS - SUMMARY METALS ARE NEUROTOXIC AT HIGH DOSES YET CAN CONTRIBUTE TO MOTOR AND COGNITIVE DEFICITS EVEN AT ENVIRONMENTALLY RELEVANT DOSES. METALS CONTRIBUTE TO AMYLOID Β MISFOLDING AND TAU HYPERPHOSPHORYLATION, WHICH ARE PATHOLOGICAL HALLMARKS OF ALZHEIMER’S DISEASE (AD) AND AD-RELATED DEMENTIA (ADRD) RISK AS WELL AS COGNITIVE DECLINE. METALS ALSO INTERACT WITH THE APOE4 ALLELE TO INFLUENCE AD RISK, ADVANCE NEURODEGENERATION, AND HAVE VASCULAR EFFECTS THAT MAY FURTHER CONTRIBUTE TO DEMENTIA RISK. METALS MAY THUS REPRESENT MULTIPLE HITS FOR RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA. YET, FEW COHORT STUDIES HAVE COMPREHENSIVELY EVALUATED THE ASSOCIATION OF METAL EXPOSURES WITH MILD COGNITIVE IMPAIRMENT (MCI) AND AD/ADRD. TO FILL THIS KNOWLEDGE GAP, WE PROPOSE TO LEVERAGE THE NIH-FUNDED ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) AND MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORTS OF DIVERSE US ADULTS TO TEST THE HYPOTHESIS THAT WIDESPREAD EXPOSURE TO METALS—DETERMINED BY ESTABLISHED AND NOVEL BIOMARKERS—IS ASSOCIATED WITH MCI AND AD/ADRD RISK AND WITH KEY PATHOPHYSIOLOGICAL PROCESSES THAT EXPLAIN THIS RISK. ARIC AND MESA HAVE RICH BIOREPOSITORIES, AS WELL AS EXAMINATION, LABORATORY, OMICS AND CLINICAL DATA. IN THESE UNIQUE AND DIVERSE COHORTS, WE PROPOSE TO ADD A METALLOME PROFILE TO QUANTIFY METAL EXPOSURE AND INTERNAL DOSE FOR EACH PARTICIPANT BY MEASURING METALS IN URINE, BLOOD, AND SERUM AT REPEATED VISITS IN ALL PARTICIPANTS, AS WELL AS IN BRAIN-DERIVED EXTRACELLULAR VESICLES IN A SUBSET OF PARTICIPANTS. PRIORITY METALS INCLUDE LEAD, CADMIUM, COPPER, MERCURY, MANGANESE AND ZINC, ALTHOUGH OTHER METALS WILL ALSO BE MEASURED. WE WILL CONNECT THESE METALLOME PROFILES WITH RICH BRAIN HEALTH AND MULTI-OMICS DATA (WHOLE GENOME SEQUENCING, EPIGENOMIC/METHYLOMIC, TRANSCRIPTOMIC, PROTEOMICS, TARGETED AND UNTARGETED METABOLOMICS). WE WILL USE POWERFUL, STATE-OF-THE-ART ANALYSES TO DETERMINE THE PROSPECTIVE ASSOCIATIONS OF LONG-TERM METAL EXPOSURES WITH RISK OF COGNITIVE DECLINE, MCI AND AD/ADRD RISK (AIM 1), AND WITH THE TRAJECTORY OF PLASMA AD AND BRAIN IMAGING BIOMARKERS (AIM 2) IN DIVERSE US ADULTS OVERALL AND BY SEX, RACE/ETHNICITY, AND APOE4 GENOTYPE. WE WILL THEN DEVELOP A PREDICTIVE MULTI-OMICS FINGERPRINT THAT QUANTIFIES RISK OF MCI, AD/ADRD, AND COGNITIVE DECLINE DUE TO METAL EXPOSURES (AIM 3). BECAUSE METAL EXPOSURES ARE PREVENTABLE AND TREATABLE, ADDING HIGH-QUALITY MEASURES OF THE METALLOME PROFILE TO DIVERSE COHORTS WITH LONGITUDINAL BRAIN HEALTH AND EXTENSIVE OMICS DATA WILL ENABLE THIS PROJECT TO CONTRIBUTE KEY KNOWLEDGE OF THE MOLECULAR/BIOLOGICAL PATHWAYS INVOLVED IN DEVELOPMENT OF COGNITIVE DECLINE AS WELL AS IDENTIFY NEW TARGETS FOR THE PREVENTION AND TREATMENT OF AD/ADRD. THIS WORK WILL GENERATE CRITICAL KNOWLEDGE AND SERVE AS A ROBUST MODEL FOR GENERATING HIGHLY VALUABLE DATA THAT CAN BE LEVERAGED TO PREVENT/MITIGATE HARMFUL METAL EXPOSURES AND PROTECT COGNITIVE HEALTH.
National Aeronautics and Space Administration
$10.2M
THE OFFICIAL ADMINISTRATIVE VEHICLE FOR THE COOPERATIVE RELATIONSHIP BETWEEN COLUMBIA UNIVERSITY AND THE NASA GODDARD IN STITUTE FOR SPACE STUDIES I
Department of Health and Human Services
$10.2M
OFFPSRING STUDY OF MECHANISMS FOR RACIAL IN ALZHEIMER'S DISEASE
Department of Health and Human Services
$10.1M
EPIDEMIOLOGY OF BIOMARKERS OF RISK AND PROGRESSION IN LOAD
Department of Health and Human Services
$10.1M
NEW YORK COLUMBIA COLLABORATIVE SPOTRIAS
Department of Health and Human Services
$10M
CORE RESEARCH COMPUTING FACILITY
Department of Health and Human Services
$9.9M
TECHNICAL ASSISTANCE TO CENTRAL ASIAN NATIONAL HIV PROGRAMS TO ACHIEVE AND SUSTAIN HIV EPIDEMIC CONTROL UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)
Department of Health and Human Services
$9.9M
COLUMBIA UNIVERSITY AND NORTHERN PLAINS PARTNERSHIP FOR THE SUPERFUND RESEARCH PROGRAM - SUMMARY TRIBAL LANDS ARE IMPACTED BY MORE THAN 15,000 HAZARDOUS WASTE SITES AND 7,000 ABANDONED MINES THAT CAN DISRUPT THE REDOX CHEMISTRY OF AQUIFERS AND RELEASE TOXIC METALS. IN COLLABORATION WITH TRIBAL COMMUNITIES FROM NORTH/SOUTH DAKOTA, WE FOUND THAT ARSENIC (AS) AND URANIUM (U) AFFECT DRINKING WATER IN PRIVATE WELLS AND RURAL WATER SYSTEMS IN THE NORTHERN PLAINS. OUR DATA ALSO SHOW THAT IN THE 1990S/EARLY 2000S NATIVE AMERICANS FROM THE NORTHERN PLAINS EXPERIENCED URINARY AS AND U LEVELS 2.5 TO 5 TIMES HIGHER THAN OTHER US POPULATIONS, LIKELY CONTRIBUTING TO A HIGH BURDEN OF CARDIOVASCULAR DISEASE. KNOWLEDGE IS NEEDED ON CURRENT METAL EXPOSURE LEVELS, SOURCES (LOCAL AND DISTAL), HEALTH EFFECTS (CONCURRENT, LATENT, JOINT), MECHANISTIC PATHWAYS, AND EFFECTIVE REMEDIATION SYSTEMS. TO ADDRESS THESE SCIENTIFIC AND TECHNOLOGY GAPS, WE HAVE ESTABLISHED THE COLUMBIA UNIVERSITY NORTHERN PLAINS SUPERFUND RESEARCH PROGRAM. THIS NEW PARTNERSHIP HAS FIVE PROJECTS AND FOUR CORES AND WILL USE SYSTEMS SCIENCE, LOCAL KNOWLEDGE, AND INNOVATIVE TECHNOLOGY THROUGH THE FOLLOWING AIMS: (1) DEVELOP HOUSEHOLD-LEVEL SPATIAL AND TEMPORAL MODELS OF GROUNDWATER METAL CONCENTRATIONS INTEGRATING NEW MEASURES OF WATER AS, U, AND REDOX PARAMETERS WITH USGS AND IHS DATA. THESE MODELS CAN IDENTIFY SAFE WATER VS. WHERE MITIGATION INTERVENTIONS ARE NEEDED. (2) TRACE SOURCES AND CYCLING OF METALS IN WATER AND BIOLOGICAL SPECIMENS THROUGH STABLE ISOTOPE MEASUREMENTS (U, SE) TO REVEAL REDOX STATE AND INFORM ON LOCAL AND DISTAL SOURCES OF CONTAMINATION, DIRECTLY ADDRESSING OUR COMMUNITIES’ CONCERN. (3) DETERMINE LATENT AND CONCURRENT CARDIOMETABOLIC EFFECTS OF AS AND U IN HUMANS (STRONG HEART AS/U LIFELONG STUDY, SHAUL), AND IN HUMAN- RELEVANT MOUSE MODELS. THESE DATA WILL ENHANCE THE ASSESSMENT OF CAUSALITY AND THE ROLE OF EARLY LIFE EXPOSURES. (4) INTEGRATE MOLECULAR MECHANISMS OF AS AND U TOXICITY USING MULTI-OMICS (EPIGENOMICS, METABOLOMICS) IN LONGITUDINAL STUDIES IN HUMANS (SHAUL) AND MICE. THE CROSS-SPECIES COMPARISON CAN IDENTIFY ROBUST SIGNATURES AND MECHANISMS TO HELP GENERATE INTERVENTION STRATEGIES. (5) DEVELOP SUSTAINABLE INTERVENTIONS USING LIGHT- BASED, POINT-OF-USE WATER REMEDIATION TECHNOLOGY FOR AS/U. THIS SYSTEM WILL PRODUCE AND RECYCLE ADSORPTION MEDIA WITH PHOTOSYNTHETIC BACTERIA AND ALERT RESIDENTS BEFORE TREATMENT FAILURE. THE COMMUNITY ENGAGEMENT CORE WILL BE CENTRALLY LOCATED IN THE NORTHERN PLAINS, CONTRIBUTING TO ALL RESEARCH ACTIVITIES AND LOCAL DISSEMINATION. THE DATA MANAGEMENT AND ANALYSIS AND ADMINISTRATIVE CORES WILL OPTIMIZE USE OF THE COMPLEX DATA GENERATED WHILE RESPECTING TRIBAL DATA SOVEREIGNTY AND PROMOTING EVIDENCE-BASED POLICIES AND PRACTICES TO ADDRESS HAZARDOUS TOXIC METALS AND CONTRIBUTE TO DISEASE PREVENTION. WE WILL TRAIN THE NEXT GENERATION OF SCIENTISTS IN SYSTEMS SCIENCE, TECHNOLOGY, INDIGENOUS RESEARCH ETHICS, AND COMMUNITY OUTREACH. THE BREADTH, DEPTH, AND INNOVATION OF OUR APPROACHES, THE COMMUNITY’S CENTRAL ROLE, THE INSTITUTIONAL SUPPORT, AND OUR EXPERIENCE WORKING TOGETHER WILL LAY THE GROUNDWORK FOR INTERVENTIONS THAT ADDRESS KEY CONCERNS FOR WATER QUALITY AND HUMAN HEALTH IN COMMUNITIES IN THE NORTHERN PLAINS AND NEAR ABANDONED MINES AND SUPERFUND SITES.
Department of Health and Human Services
$9.8M
ROLE OF NCRNA SURVEILLANCE COMPLEX "RNA EXOSOME" IN CLASS SWITCH RECOMBINATION AN
Department of Health and Human Services
$9.8M
MULTICENTER STUDY ON EXCEPTIONAL SURVIVAL IN FAMILIES
Department of Health and Human Services
$9.7M
STRUCTURE-FUNCTION OF CALCIUM CHANNEL COMPLEXES IN CARDIAC PHYSIOLOGY AND DISEASE - SUMMARY HEART DISEASE IS THE LEADING CAUSE OF DEATH IN THE UNITED STATES AND WORLDWIDE, WITH A WORSENING TRAJECTORY DUE TO INCREASINGLY AGING POPULATIONS. PRECISE UNDERSTANDING OF THE MOLECULAR MECHANISMS UNDERLYING NORMAL CARDIAC PHYSIOLOGY, AND HOW THEY ARE COMPROMISED IN DISEASE, IS CRITICAL FOR IDENTIFYING NEW DRUG TARGETS AND DEVELOPING EFFECTIVE NEW THERAPEUTICS TO COMBAT HEART DISEASE. CA2+ CYCLING INVOLVING LOCAL SIGNALING BETWEEN SURFACE L-TYPE CA2+ (CAV1.2) CHANNELS AND INTRACELLULAR RYANODINE RECEPTORS (RYR2) IS RESPONSIBLE FOR THE CA2+- INDUCED CA2+ RELEASE (CICR) THAT UNDERLIES CARDIAC EXCITATION-CONTRACTION COUPLING. DYSREGULATION OF BOTH CAV1.2 AND RYR2 CONTRIBUTES TO ABNORMAL CALCIUM SIGNALING THAT IS AN ADVERSE HALLMARK OF CARDIAC DISEASE. SS-ADRENERGIC AUGMENTATION OF CARDIAC CONTRACTILITY IS CRUCIAL FOR THE FIGHT-OR-FLIGHT RESPONSE AND IS MEDIATED BY INCREASED CAV1.2 CURRENT AND SENSITIZATION OF RYR2; YET, EXCESSIVE ACTIVATION OF THIS PATHWAY UNDER CHRONIC STRESS RESULTS IN POST- TRANSLATIONAL MODIFICATIONS OF RYR2 CHANNELS THAT CAUSE THEM TO BECOME ‘LEAKY’ AND CAUSE CARDIAC PATHOLOGY, AND ALSO A POTENTIAL HARMFUL SUBCELLULAR REDISTRIBUTION OF CAV1.2. THERE ARE SIGNIFICANT GAPS IN KNOWLEDGE REGARDING CAV1.2 AND RYR2 FUNCTIONAL ORGANIZATION AND REGULATION IN HEART UNDER BOTH AND DISEASE CONDITIONS; HOW THEIR DYSREGULATION OR DYSFUNCTION CONTRIBUTES TO HEART DISEASE PROGRESSION; AND WHETHER AND HOW THEY CAN BE TARGETED FOR EFFECTIVE TREATMENT OF HEART FAILURE (HF) AND OTHER CARDIAC DISEASES. THIS PROGRAM PROJECT GRANT (PPG) COMPRISES FOUR PROJECTS AND TWO SCIENTIFIC CORES THAT HAVE BEEN PUT TOGETHER TO HELP ADDRESS THESE CRITICAL GAPS. THE OVERARCHING GOAL IS TO DEFINE THE MECHANISMS THAT REGULATE LOCAL CA2+ SIGNALING BY CAV1.2 AND RYR2 IN NORMAL AND FAILING HEARTS WITH UNPRECEDENTED PRECISION. WHILE EACH PROJECT STANDS ON ITS OWN FOOTING AS FAR AS BEING COMPRISED OF INNOVATIVE AND EXCITING RESEARCH, ALL ARE DEPENDENT ON THE EXPERTISE PROVIDED BY THE CORES AND ARE ENRICHED BY INTERPROJECT COLLABORATIONS THAT ARE GREATLY ENHANCED BY THE PPG STRUCTURE. ALL FOUR PROJECTS LEVERAGE THE PAKISTAN GENOME RESOURCE (PGR) (CORE A), A UNIQUE COHORT OF INDIVIDUALS WITH EXTENSIVE PHENOTYPE AND GENOTYPE DATA ON HF AND OTHER CARDIAC DISEASES AND HIGH RATES OF CONSANGUINITY ENABLING IDENTIFICATION OF INDIVIDUALS HOMOZYGOUS FOR RARE TRUNCATING MUTATIONS (I.E., HUMAN KNOCKOUTS) AND OTHER MISSENSE VARIANTS. MOREOVER, ALL FOUR PROJECTS INVOLVE EXPERIMENTS THAT SPAN FUNDAMENTAL STUDIES ON SINGLE MOLECULES AND CELLS TO ANIMAL MODELS (CORE B; MOUSE CARDIAC PHYSIOLOGY CORE). COMBINING HUMAN MISSENSE / LOSS OF FUNCTION MUTATIONS FOUND IN THE PGR COHORT IN CAV1.2, RYR2 OR KEY REGULATORY PROTEINS WITH IN-DEPTH STRUCTURE-FUNCTION EXPERIMENTS PROMISES TO ADVANCE NEW UNDERSTANDING OF GENOTYPE-PHENOTYPE RELATIONSHIPS IN HUMAN CARDIOVASCULAR DISEASES INVOLVING CA2+ CYCLING PROTEINS IN THE HEART. WE EXPECT THE PROPOSED STUDIES TO YIELD NEW INSIGHTS INTO STRUCTURE-FUNCTION AND REGULATION OF CAV1.2 AND RYR2 AND ADVANCE THEIR UTILITY AS THERAPEUTIC TARGETS FOR CARDIAC DYSFUNCTION. THE PIS OF THE FOUR PROJECTS HAVE A COLLABORATION HISTORY AND TRACK RECORD OF DEVELOPING INNOVATIVE APPROACHES FOR STUDIES OF CAV1.2 AND RYR2 MOLECULAR PHYSIOLOGY.
Department of Health and Human Services
$9.7M
CELLULAR AND GENETIC BASIS OF ANAPLASTIC MEDULLOBLASTOMA
Department of Defense
$9.6M
THE PURPOSE OF THIS AGREEMENT IS TO FUND RESEARCH SUPPORTING THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY DARPA DEFENSE SCIENCES OFFICES DSO STRENGTHENING RESILIENT EMOTIONS AND NIMBLE COGNITION THROUGH ENGINEERING NEUROPLASTICITY STRENGTHEN PROGRAM. THIS EFFORT SHALL BE CARRIED OUT GENERALLY AS SET FORTH IN EXHIBIT B, RESEARCH DESCRIPTION DOCUMENT, DATED AUGUST 3, 2023, AND IN THE RECIPIENTS REVISED PROPOSAL TITLED, REALIGNING EMOTION AND COGNITION VIA PRECISION REGULATION OF NETWORKS RECOVERS, DATED JANUARY 23, 2023, COPIES OF WHICH ARE IN THE POSSESSION OF BOTH PARTIES.
Department of Health and Human Services
$9.6M
INTERDISCIPLINARY RESEARCH TO UNDERSTAND THE INTERPLAY OF DIABETES, CEREBROVASCULAR DISEASE AND ALZHEIMERS DISEASE
Source: Federal Audit Clearinghouse (fac.gov)
Total Audits
10
Clean Audits
10
Material Weakness
No
Noncompliance Issues
No
| Year | Status | Financial Report | Federal Expenditure | Low Risk | Accepted |
|---|---|---|---|---|---|
| 2025 | Clean | Unmodified (Clean) | $1.6B | Yes | 2026-03-30 |
| 2024 | Clean | Unmodified (Clean) | $1.7B | Yes | 2025-03-31 |
| 2023 | Clean | Unmodified (Clean) | $1.6B | Yes | 2024-03-28 |
| 2022 | Clean | Unmodified (Clean) | $1.6B | Yes | 2023-03-27 |
| 2021 | Clean | Unmodified (Clean) | $1.5B | Yes | 2022-05-18 |
| 2020 | Clean | Unmodified (Clean) | $1.3B | Yes | 2021-05-13 |
| 2019 | Clean | Unmodified (Clean) | $1.3B | Yes | 2020-03-23 |
| 2018 | Clean | Unmodified (Clean) | $1.3B | Yes | 2019-03-07 |
| 2017 | Clean | Unmodified (Clean) | $1.3B | Yes | 2018-03-14 |
| 2016 | Clean | Unmodified (Clean) | $1.2B | Yes | 2017-03-01 |
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.6B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.7B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.6B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.6B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.5B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.3B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.3B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.3B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.3B
Financial Report
Unmodified (Clean)
Federal Expenditure
$1.2B
Tax Year 2022 · Source: IRS e-Filed Form 990Schedule J available
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023 | $6.7B | $2B | $6.4B | $23.6B | $18.7B |
| 2022IRS e-File | $6.7B | $2B | $6.4B | $23.6B | $18.7B |
| 2021 | $6.6B | $1.8B | $5.6B | $24.7B | $19.6B |
| 2020 | $5.9B | $1.8B | $5.5B |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | PDF not yet published by IRSView Filing → |
| 2022 | 990 | DataIRS e-File |
Financial data: IRS e-Filed Form 990 (Tax Year 2022)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2022)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File
Tax-deductibility: IRS Publication 78
| Total |
|---|
| Lee C Bollinger | President (through 6/30/23) | 59.9 | $4.4M | $0 | $545.5K | $5M |
| Gerald M Rosberg | Senior Exec Vice President | 59.9 | $1M | $0 | $60.8K | $1.1M |
| Mary Boyce | Provost (through 6/30/23) | 59.9 | $960.2K | $0 | $58.5K | $1M |
| Jane E Booth | Chf Legal Off (as Of 1/1/23) | 60 | $957.1K | $0 | $56.8K | $1M |
| Anne R Sullivan | Executive VP For Finance & It | 59.8 | $916.5K | $0 | $62.1K | $978.6K |
| Felice Rosan | General Counsel (as Of 1/1/23) | 60 | $512.2K | $0 | $103.1K | $615.3K |
| Jerome Davis | Secretary | 60 | $485.2K | $0 | $62.3K | $547.5K |
Lee C Bollinger
President (through 6/30/23)
$5M
Hrs/Wk
59.9
Compensation
$4.4M
Related Orgs
$0
Other
$545.5K
Gerald M Rosberg
Senior Exec Vice President
$1.1M
Hrs/Wk
59.9
Compensation
$1M
Related Orgs
$0
Other
$60.8K
Mary Boyce
Provost (through 6/30/23)
$1M
Hrs/Wk
59.9
Compensation
$960.2K
Related Orgs
$0
Other
$58.5K
Jane E Booth
Chf Legal Off (as Of 1/1/23)
$1M
Hrs/Wk
60
Compensation
$957.1K
Related Orgs
$0
Other
$56.8K
Anne R Sullivan
Executive VP For Finance & It
$978.6K
Hrs/Wk
59.8
Compensation
$916.5K
Related Orgs
$0
Other
$62.1K
Felice Rosan
General Counsel (as Of 1/1/23)
$615.3K
Hrs/Wk
60
Compensation
$512.2K
Related Orgs
$0
Other
$103.1K
Jerome Davis
Secretary
$547.5K
Hrs/Wk
60
Compensation
$485.2K
Related Orgs
$0
Other
$62.3K
Highest compensated employees who are not officers or directors.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Lawrence Gerald Lenke | Professor Of Surgery | 60 | $5.5M | $0 | $67.1K | $5.6M |
| Ronald Arthur Lehman Jr | Professor Of Surgery | 60 | $3.5M | $0 | $75.1K | $3.6M |
| David N Silvers | Clinical Professor | 60 | $3.3M | $0 |
Lawrence Gerald Lenke
Professor Of Surgery
$5.6M
Hrs/Wk
60
Compensation
$5.5M
Related Orgs
$0
Other
$67.1K
Ronald Arthur Lehman Jr
Professor Of Surgery
$3.6M
Hrs/Wk
60
Compensation
$3.5M
Related Orgs
$0
Other
$75.1K
David N Silvers
Clinical Professor
$3.4M
Hrs/Wk
60
Compensation
$3.3M
Related Orgs
$0
Other
$64.9K
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Abigail Elbaum | Trustee | 4 | $0 | $0 | $0 | $0 |
| Adam Pritzker | Trustee | 4 | $0 | $0 | $0 | $0 |
| Andrew Barth | Trustee | 4 | $0 | $0 | $0 | $0 |
| Claire Shipman | Trustee | 4 | $0 | $0 | $0 | $0 |
| David Greenwald | Trustee | 4 | $0 | $0 | $0 | $0 |
| Dean Dakolias | Trustee | 4 |
Abigail Elbaum
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Adam Pritzker
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Andrew Barth
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Individuals who previously served as officers or key employees.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Lee Goldman | EVP Health Sciences (former) | 60 | $1M | $0 | $61.5K | $1.1M |
| Ira Katznelson | Int Provost (former) | 60 | $759.3K | $0 | $65.4K | $824.7K |
| Peter Holland | Ceo/evp Imc (former) | 60 | $763.4K | $0 |
Lee Goldman
EVP Health Sciences (former)
$1.1M
Hrs/Wk
60
Compensation
$1M
Related Orgs
$0
Other
$61.5K
Ira Katznelson
Int Provost (former)
$824.7K
Hrs/Wk
60
Compensation
$759.3K
Related Orgs
$0
Other
$65.4K
Peter Holland
Ceo/evp Imc (former)
$787.5K
Hrs/Wk
60
Compensation
$763.4K
Related Orgs
$0
Other
$24.1K
| $21B |
| $16.3B |
| 2019 | $5.6B | $1.6B | $5.3B | $19.9B | $16B |
| 2018 | $5.9B | $1.9B | $5B | $19.6B | $15.7B |
| 2017 | $5.7B | $1.8B | $4.8B | $18.5B | $14.7B |
| 2016 | $4.7B | $1.4B | $4.4B | $16.7B | $13.2B |
| 2015 | $4.9B | $1.2B | $4.1B | $16.8B | $13.6B |
| 2014 | $4.5B | $1.2B | $3.9B | $16B | $13B |
| 2013 | $4.4B | $1.4B | $3.8B | $14.6B | $11.6B |
| 2012 | $4.2B | $1.4B | $3.7B | $13.6B | $10.6B |
| 2011 | $4.7B | $2B | $3.6B | $13.4B | $10.6B |
| 2021 | 990 | Data | PDF not yet published by IRS |
| 2020 | 990 | Data |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data |
| 2012 | 990 | Data |
| 2011 | 990 | Data |
| 2010 | 990 | — |
| 2009 | 990 | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990 | — |
| 2001 | 990 | — |
| $64.9K |
| $3.4M |
| Emile Bacha | Professor Of Surgery | 60 | $3.2M | $0 | $107.2K | $3.3M |
| Craig Smith | Professor Of Surgery | 60 | $3.1M | $0 | $65.6K | $3.2M |
| Kim Lew | CEO Of Imc | 60 | $2.9M | $0 | $58.7K | $3M |
| Amelia Alverson | Exec VP - Univ Dvlp&alum Rlts | 60 | $1.7M | $0 | $43K | $1.7M |
| Anil Rustgi | Int EVP Sci (through 2/28/22) | 60 | $1.7M | $0 | $34.6K | $1.7M |
| Katrina Armstrong | EVP Health Sciences | 60 | $1.3M | $0 | $32.8K | $1.3M |
| Amy Hungerford | Exec Vp-a&s | 59.9 | $894.1K | $0 | $69.9K | $964K |
| David Greenberg | Exec VP Facilities | 60 | $631K | $0 | $62.7K | $693.7K |
Emile Bacha
Professor Of Surgery
$3.3M
Hrs/Wk
60
Compensation
$3.2M
Related Orgs
$0
Other
$107.2K
Craig Smith
Professor Of Surgery
$3.2M
Hrs/Wk
60
Compensation
$3.1M
Related Orgs
$0
Other
$65.6K
Kim Lew
CEO Of Imc
$3M
Hrs/Wk
60
Compensation
$2.9M
Related Orgs
$0
Other
$58.7K
Amelia Alverson
Exec VP - Univ Dvlp&alum Rlts
$1.7M
Hrs/Wk
60
Compensation
$1.7M
Related Orgs
$0
Other
$43K
Anil Rustgi
Int EVP Sci (through 2/28/22)
$1.7M
Hrs/Wk
60
Compensation
$1.7M
Related Orgs
$0
Other
$34.6K
Katrina Armstrong
EVP Health Sciences
$1.3M
Hrs/Wk
60
Compensation
$1.3M
Related Orgs
$0
Other
$32.8K
Amy Hungerford
Exec Vp-a&s
$964K
Hrs/Wk
59.9
Compensation
$894.1K
Related Orgs
$0
Other
$69.9K
David Greenberg
Exec VP Facilities
$693.7K
Hrs/Wk
60
Compensation
$631K
Related Orgs
$0
Other
$62.7K
| $0 |
| $0 |
| $0 |
| $0 |
| Duchesne Drew | Trustee | 4 | $0 | $0 | $0 | $0 |
| Fermi Wang | Trustee | 4 | $0 | $0 | $0 | $0 |
| Jeh Johnson | Trustee | 4 | $0 | $0 | $0 | $0 |
| Jonathan Lavine | Trustee | 4 | $0 | $0 | $0 | $0 |
| Jonathan Rosand | Trustee | 4 | $0 | $0 | $0 | $0 |
| Joseph A Greenaway Jr | Trustee | 4 | $0 | $0 | $0 | $0 |
| Kathy Surace-Smith | Trustee | 4 | $0 | $0 | $0 | $0 |
| Keith Goggin | Trustee | 4 | $0 | $0 | $0 | $0 |
| Kikka Hanazawa | Trustee (as Of 3/4/23) | 4 | $0 | $0 | $0 | $0 |
| Lisa Carnoy | Trustee (through 9/4/22) | 4 | $0 | $0 | $0 | $0 |
| Lu Li | Trustee | 4 | $0 | $0 | $0 | $0 |
| Mark Gallogly | Trustee | 4 | $0 | $0 | $0 | $0 |
| Rolando T Acosta | Trustee | 4 | $0 | $0 | $0 | $0 |
| Shirley Wang | Trustee | 4 | $0 | $0 | $0 | $0 |
| Shoshana Shendelman | Trustee (as Of 9/5/22) | 4 | $0 | $0 | $0 | $0 |
| Victor Mendelson | Trustee | 4 | $0 | $0 | $0 | $0 |
| Wanda Holland Greene | Trustee | 4 | $0 | $0 | $0 | $0 |
Claire Shipman
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
David Greenwald
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Dean Dakolias
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Duchesne Drew
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Fermi Wang
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Jeh Johnson
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Jonathan Lavine
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Jonathan Rosand
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Joseph A Greenaway Jr
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Kathy Surace-Smith
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Keith Goggin
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Kikka Hanazawa
Trustee (as Of 3/4/23)
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Lisa Carnoy
Trustee (through 9/4/22)
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Lu Li
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Mark Gallogly
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Rolando T Acosta
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Shirley Wang
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Shoshana Shendelman
Trustee (as Of 9/5/22)
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Victor Mendelson
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
Wanda Holland Greene
Trustee
$0
Hrs/Wk
4
Compensation
$0
Related Orgs
$0
Other
$0
| $24.1K |
| $787.5K |
| John Coatsworth | Provost (former) | 60 | $673.8K | $0 | $70.9K | $744.8K |
John Coatsworth
Provost (former)
$744.8K
Hrs/Wk
60
Compensation
$673.8K
Related Orgs
$0
Other
$70.9K